Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) xx ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 OR oo TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-36467 RESONANT INC. (Exact Name of Registrant as Specified in Its charter) Delaware (State or Other Jurisdiction of Incorporation or Organization) 45-4320930 (I.R.S. Employer Identification No.) 110 Castilian Drive, Suite 100, Goleta, California 93117 (Address of Principal Executive Offices) (Zip Code) (805) 308-9803 (Registrant’s Telephone Number, Including Area Code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Common Stock, $0.001 par value Name of each exchange on which registered The NASDAQ Stock Market LLC Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes o No x Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes o No x Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act (Check one): Large accelerated filer o Non-accelerated filer o (Do not check if smaller reporting company) Accelerated filer o Smaller reporting company x Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes o No x As of June 30, 2014, the aggregate market value of the voting and non-voting common equity held by non-affiliates was $33 million, based As of June 30, 2014, the aggregate market value of the voting and non-voting common equity held by non-affiliates was $33 million, based on the closing price on that date. As of March 25, 2015, the registrant had 7,158,276 shares of common stock issued and outstanding. DOCUMENTS INCORPORATED BY REFERENCE Portions of the registrant’s Proxy Statement for the registrant’s 2015 Annual Meeting of Stockholders are incorporated by reference in Part III of this Annual Report on Form 10-K. Such Proxy Statement will be filed with the Securities and Exchange Commission within 120 days of December 31, 2014, the last day of the fiscal year covered by this Annual Report on Form 10-K. Table of Contents RESONANT INC. FORM 10-K TABLE OF CONTENTS Special Note Regarding Forward-Looking Statements PART I Item 1. Item 1A. Item 1B. Item 2. Item 3. Item 4. PART II Item 5. Item 6. Item 7. Item 7A. Item 8. Item 9. Item 9A. Item 9B. PART III Item 10. Item 11. Item 12. Item 13. Item 14. PART IV Item 15. Signatures Business Risk Factors Unresolved Staff Comments Properties Legal Proceedings Mine Safety Disclosures Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities Selected Financial Data Management’s Discussion and Analysis of Financial Condition and Results of Operations Quantitative and Qualitative Disclosures about Market Risk Financial Statements and Supplementary Data Changes in and Disagreements with Accountants on Accounting and Financial Disclosure Controls and Procedures Other Information Directors, Executive Officers and Corporate Governance Executive Compensation Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters Certain Relationships and Related Transactions and Director Independence Principal Accountant Fees and Services Exhibits and Financial Statement Schedules 2 Page 3 5 15 28 28 28 28 29 30 31 39 40 65 65 66 67 67 68 68 69 70 S-1 Table of Contents SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS This Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. The words “believe,” “may,” “will,” “potentially,” “estimate,” “continue,” “anticipate,” “intend,” “could,” “would,” “project,” “plan,” “expect” and similar expressions that convey uncertainty of future events or outcomes are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements concerning the following: · the status of filter designs under development; · the prospects for licensing filter designs upon completion of development; · plans for other filter designs not currently in development; · potential customers for our designs; · the timing and amount of future royalty streams; · our plans regarding the use of proceeds from our IPO and the expected duration of our capital resources; · our hiring plans; · the impact of our designs on the mobile device market; · our business strategy; · our intentions, expectations and beliefs regarding anticipated growth, market penetration and trends in our business; · the timing and success of our plan of commercialization; · our dependence on growth in our customers’ businesses; · the effects of market conditions on our stock price and operating results; · our ability to maintain our competitive technological advantages against competitors in our industry and the related costs associated with defending intellectual property infringement and other claims; · our ability to timely and effectively adapt our existing technology and have our technology solutions gain market acceptance; · our ability to introduce new offerings and bring them to market in a timely manner; · our ability to maintain, protect and enhance our intellectual property; · our expectations concerning our relationships with our customers and other third parties and our customers’ relationships with their manufacturers; · the attraction and retention of qualified employees and key personnel; · future acquisitions of or investments in complementary companies or technologies; and 3 Table of Contents · our ability to comply with evolving legal standards and regulations, particularly concerning requirements for being a public company and United States export regulations. These forward-looking statements speak only as of the date of this Form 10-K and are subject to uncertainties, assumptions and business and economic risks. As such, our actual results could differ materially from those set forth in the forward-looking statements as a result of the factors set forth below in Part I, Item 1A, “Risk Factors,” and in our other reports filed with the Securities and Exchange Commission. Moreover, we operate in a very competitive and rapidly changing environment, and new risks emerge from time to time. It is not possible for us to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this Form 10-K may not occur, and actual results could differ materially and adversely from those anticipated or implied in our forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events and circumstances described in the forward-looking statements will be achieved or occur. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this Form 10-K to conform these statements to actual results or to changes in our expectations, except as required by law. You should read this Annual Report on Form 10-K and the documents that we reference in this Annual Report on Form 10-K and have filed with the Securities and Exchange Commission as exhibits thereto with the understanding that our actual future results and circumstances may be materially different from what we expect. 4 Table of Contents PART I ITEM 1. BUSINESS Overview Resonant is a late-stage development company creating innovative filter designs for radio frequency, or RF, front-ends for the mobile device industry. The RF front-end is the circuitry in a mobile device responsible for analog signal processing and is located between the device’s antenna and its digital baseband. We use a fundamentally new technology called Infinite Synthesized Networks , or ISN , to configure and connect resonators, the building blocks of RF filters. Filters are a critical component of the RF front-end used to select desired radio frequency signals and reject unwanted signals. We are using ISN to develop new classes of filter designs. ® ® We believe licensing our designs is the most direct and effective means of delivering our solutions to the market. Our target customers make part or all of the RF front-end. We intend to retain ownership of our designs, and we expect to be compensated through license fees and royalties based on sales of RF front-end modules that incorporate our designs. We do not intend to manufacture or sell any physical products or operate as a contract design company developing designs for a fee. We are currently developing our first filter design, a duplexer, for our first customer, a leading manufacturer of RF front-ends for mobile devices. Duplexers are two filters combined into a single component which simultaneously select both the transmit and receive signals. The customer has an option to license our duplexer design at already agreed-upon royalty rates upon completion. The terms of the license would give the customer exclusivity on our filter designs for a limited time on the relevant duplexer band. We have delivered a completed duplexer design for consideration to our first customer. Our design does not meet all the specifications in the development agreement, however, we believe our design delivers competitive performance and is competing with other products. The customer is evaluating it, and there is no assurance that our design has acceptable performance and therefore will be used. Even if it has acceptable performance, there are a number of other considerations influencing the customer’s decision whether to use our design, many of which are beyond our control. On March 9, 2015, we announced a development project with a second customer for the design of our next single-band RF filter. The goal of the project is to develop a new duplexer design for our customer to market to RF front-end manufacturers and mobile device OEMs. The design, which is estimated to take less than a year to develop, is intended to replace a BAW (bulk acoustic wave) filter with a less expensive SAW (surface acoustic wave) filter. The customer has not committed to use the resulting design and terms for a license have not been finalized. Resonant Inc. was incorporated in Delaware in January 2012. Resonant LLC was formed in California during May 2012. Resonant LLC commenced business in July 2012 with initial funding from our founders. Resonant Inc. acquired all of the outstanding membership interests of Resonant LLC in June 2013 in an exchange transaction, and Resonant LLC became a wholly-owned subsidiary of Resonant Inc. Resonant Inc. had been dormant until that time. Our principal executive offices are located at 110 Castilian Drive, Suite 100, Goleta, California 93117, and our telephone number is 805-308-9803. Our website address is www.resonant.com. The information contained on, or that can be accessed through, our website is not a part of this prospectus. Our History Our technology was originally pioneered by Superconductor Technologies Inc., or STI. STI commercialized discoveries in high temperature superconductors by developing unique RF filter technology and creating high performance RF filters for cellular towers. STI had a program from 2007 to 2010 to develop electronically tunable RF filters for mobile devices using surface acoustic wave, or SAW, filter technology. STI halted work on the RF filter program in 2010 in order to devote its resources to the development of high temperature superconducting wire. 5 Table of Contents Dr. Robert Hammond, STI’s Chief Technology Officer during the RF filter program, continued to believe in the potential of STI’s RF filter technology for mobile devices and championed its further development. Terry Lingren, then serving as Vice President of Engineering at Kyocera Communications, Inc., and Neal Fenzi, who was then serving as Chief Engineer at STI, joined Dr. Hammond to co-found Resonant. We were founded as Resonant LLC on May 29, 2012 (our inception date). We commenced business on July 6, 2012 with initial contributions from our founders and STI. The founders contributed $200,000 and agreed to work full-time without pay until we secured adequate funding. STI contributed a patent portfolio, software, equipment, temporary office space and an early version of our first development agreement. The founders loaned us an aggregate of $200,000 during the first quarter of 2013, and we issued a series of warrants to the founders in connection with these loans. We refer to the founder loans as Bridge Loans and the founder warrants as Bridge Loan Warrants. We repaid the Bridge Loans in the second quarter of 2013. We changed our form of ownership from a limited liability company to a corporation in an exchange transaction on June 17, 2013. The founders exchanged all of their units and warrants of Resonant LLC for common stock and warrants of Resonant Inc. STI exchanged all of its units of Resonant LLC for a $2.4 million subordinated convertible note of Resonant Inc., or Subordinated Convertible Note. The Subordinated Convertible Note was scheduled to mature on September 17, 2014, was interest free, was secured by all of our assets and was subordinated to our senior convertible notes. We closed our first financing on June 17, 2013. We issued $7.0 million of senior convertible notes, or Senior Convertible Notes, in a private placement. The Senior Convertible Notes were scheduled to mature on September 17, 2014, bore interest at 6.0% per annum and were secured by all of our assets. We paid MDB Capital Group, LLC, or MDB, which served as placement agent, a commission of $700,000 and issued it warrants to purchase 208,763 shares of common stock, which we refer to as the Financing Warrant. We also issued MDB on June 17, 2013 warrants to purchase 222,222 shares of common stock for business consulting services, which we refer to as the Consulting Warrant. We closed our initial public offering, or IPO, on June 3, 2014. We issued 3,105,000 shares of common stock (which includes the exercise in full by the underwriter of its over-allotment option) at a price of $6.00 per share. We received aggregate net proceeds, after deducting underwriting discounts and commissions and estimated offering expenses, of $16.2 million. Our common stock commenced trading on the Nasdaq Capital Market under the symbol “RESN” on May 29, 2014, our IPO Date. The Securities and Exchange Commission, or SEC, declared effective a registration statement relating to these securities on May 28, 2014. Effective upon completion of our IPO, our Senior Convertible Notes automatically converted into 2,087,667 shares of common stock, and our Subordinated Convertible Note automatically converted into 700,000 shares of common stock. MDB acted as the sole underwriter for our IPO. Simultaneous with the funding of the IPO, we issued the underwriter a 5-year warrant to purchase 310,500 shares of common stock at an exercise price of $7.50 per share. The warrant became exercisable on November 24, 2014 (180-days from the date of the underwriting agreement). We refer to this warrant as the Underwriting Warrant. Industry Background Glossary The following is a glossary of useful terms: · Band, channel or frequency band—a designated range of radio wave frequencies used to communicate with a mobile device. · Bulk acoustic wave (BAW)—an acoustic wave traveling through a material exhibiting elasticity. · Duplexer—a bi-directional device that connects the antenna to the transmitter and receiver of a wireless device and simultaneously filters both the transmit signal and receive signal. 6 Table of Contents · Filter—a series of interconnected resonators designed to pass (or select) a desired radio frequency signal and block unwanted signals. · Resonator—a device that naturally oscillates (or resonates) at specific frequencies. The oscillations in a resonator can be either electromagnetic or mechanical (including acoustic). Resonators are the building blocks for filters. · RF front-end—the circuitry in a mobile device responsible for the analog signal processing which is located between the antenna and the digital baseband. · Surface acoustic wave (SAW)—an acoustic wave traveling along the surface of a material exhibiting elasticity, with an amplitude that typically decays exponentially with depth into the substrate. The Mobile Internet Rising consumer demand for always-on wireless broadband connectivity is creating an unprecedented need for high performance RF front-ends for mobile devices. Mobile devices such as smartphones and tablets are quickly becoming the primary means of accessing the internet. According to Cisco, worldwide mobile data traffic will grow at a compounded annual growth rate of 57 percent from 2014 to 2019. Cisco also reported that data traffic from wireless devices exceeded traffic from wired devices in 2014. The exponential growth in mobile data traffic is testing the limits of existing wireless bandwidth. Carriers and regulators have responded by opening new RF spectrum, driving up the number of frequency bands in mobile devices. As a prime example, the AWS-3 spectrum auction conducted by the FCC, which closed on January 29, 2015, raised a record $44.9 billion for an additional 65MHz of spectrum in the United States. Similar auctions are occurring worldwide. Adding RF spectrum is not a complete solution. The added spectrum does not come in large contiguous blocks, but rather in small channels or bands of varying size and frequency. Thus, more data means more bands, and the result is a rapid and substantial increase in the channels or bands of varying size and frequency. Thus, more data means more bands, and the result is a rapid and substantial increase in the number of bands in mobile devices. Challenges Faced by the Mobile Device Industry This substantial increase in frequency bands has created at least two significant problems. Both problems involve a critical front-end component called a filter. A filter selects a desired radio frequency signal and rejects unwanted signals. Two filters often are combined into a single component called a duplexer, which simultaneously selects both the transmit and receive signals of a mobile device. Today’s RF front- ends have multiple filters and duplexers, and they constitute a large percentage of the physical size and cost of the front-end. We believe that filters and duplexers will comprise almost half of the cost to the RF front-end market by 2017. The first problem is that many of the new bands require filters and duplexers that use a relatively expensive BAW technology. Mobile device manufacturers would prefer to use SAW technology because of its lower cost and smaller size. However, conventional filter designs using SAW technology do not perform adequately in high frequency bands or in bands with closely spaced receive and transmit channels, typical of many new bands. The second, and bigger problem, is that the rapid increase in bands is causing a corresponding increase in the number of filters and duplexers in mobile devices because traditional RF front-end solutions typically require one duplexer for each frequency band. For example, over the past two years the duplexer count in a leading smartphone increased from nine to twenty-three duplexers and corresponding large increase in the number of individual filters. This is dramatically driving up the cost of RF front-ends. The growing number of duplexers is also increasing the total size of the RF front-end. In some cases, size constraints require the device manufacturer to fragment its product offering into multiple versions, each with a limited set of duplexers customized for just one carrier network. Multiple versions of a product increases manufacturing, inventory and distribution costs. Device manufacturers would prefer to make one version of a product containing a full set of duplexers that can be electronically selected as required for a particular carrier network. 7 Table of Contents Our Solutions We plan to commercialize our technology by creating two families of filter designs that address these problems: · Single-Band Designs—We plan to develop a series of SAW filter designs for RF frequency bands presently limited to the larger and more expensive BAW filters. We believe we can design innovative SAW filters that meet the performance requirements for many of these bands but at less than half the cost of BAW filter. We completed our first single-band filter design (a duplexer) during the first quarter of 2015. · Tunable Designs—We also plan to develop a series of tunable filter designs that can be electronically programmed in real time for different RF frequency bands. We believe our tunable filter designs will replace multiple filters and significantly lower the cost and size of RF front-ends. We began development of a prototype tunable design in the fourth quarter of 2014 for demonstrating our value proposition to prospective customers. Our Technology Modern mobile devices utilize RF filters based on a design patented in 1931 by Lloyd Espenschied. The conventional design process starts with Espenschied’s ‘‘acoustic wave ladder’’ design—a single, fixed topology. Other RF filter engineers presume the ladder design offers the best topology and do not explore alternative structures. Their focus is on incremental optimization of this single design. Consequently, the current design process has not bred any fundamentally new structures. In addition, we believe better designs have eluded RF engineers because exploring the countless alternative structures presents a series of intractable mathematical and design problems. We have used ISN in a laboratory setting to solve those problems and demonstrate that many alternative and superior designs exist. Our design process starts at the beginning by efficiently finding and analyzing a series of potentially viable design structures. We believe it’s possible with our ISN technology to find multiple, viable design structures for any given set of design parameters. We then use our ISN technology to analyze the trade-offs in performance, cost and size to determine the optimal structure for a specific function. Our ISN technology enables us to find the best solution from among the countless possible structures for any given design problem. ISN is systematic process that employs a comprehensive suite of patented and proprietary circuit design methods and tools to create filters. Our process starts from the ground up and is not limited to the prevailing design. We use ISN to develop new classes of design that have eluded other RF engineers. We have had filters manufactured at high volume fabrication facilities with competitive performance, but our designs have not yet been selected for commercial production by any customer. We believe ISN-developed filter designs will disrupt the RF front-end market through the following advantages: · Significant cost reductions; · Smaller size; · Fewer components; and · Improved performance. We believe our ISN technology will generate designs that can be manufactured entirely with existing components and existing high- volume fabrication processes. RF Front-Ends Mobile devices are two-way communication devices that work by transmitting and receiving digital information encoded as analog RF signals between the mobile device and a cellular base station. Every mobile device has a digital baseband system and an analog RF front-end. 8 Table of Contents The RF front-end is responsible for the analog signal processing required to transmit and receive RF signals between the mobile device and the cellular base station. The RF front-end is generally defined as the circuitry between the antenna and the digital baseband system. The RF front-end performs the following functions: · Amplification of low-level signals (for both the transmitted and received signals); · Filtering to select and isolate the signals to meet performance requirements and to prevent interference; and · Transmitting and receiving those signals to and from the cellular base station via the antenna. The RF front-end is a critical part of the mobile device. Trade-offs in overall system performance, power consumption, and size are determined between the RF front-end and the baseband system. On the receive side, the RF front-end sets the stage for what digital bit-error- rate performance is possible at final bit detection. It is here that the receiver can, within limits, be designed for the best potential signal to noise ratio. And on the transmit side, the power amplifier is still one of the largest consumers of battery life. Making better decisions here can greatly improve a device’s single-charge longevity or, conversely, allow for a smaller battery with equivalent performance. The Challenge Moore’s Law predicts that transistor density on integrated circuits will double approximately every two years, and the digital baseband of mobile devices has improved exponentially as predicted by Moore’s Law. However, major improvements to the analog RF front-end have been limited by existing filter technology, with only incremental updates to decades-old practices. Consequently, the RF-front end is taking up an ever-growing share of the cost and size of mobile devices. As the number of bands continues to increase, so will the cost of wireless components using today’s conventional RF technology. Many mobile devices sold today operate on ‘‘fourth generation’’ wireless technology, or 4G. There are nearly fifty 4G bands recognized worldwide today, and the list is growing. Under traditional design methods, this requires duplication of many of the RF components since many of them will only work on a single band. The RF front-end gets more complex as more bands are added. This complexity presents a significant challenge to the RF front-end. The RF front-end must meet the growing data demands while reducing cost and size and improving battery life. Our solution involves a radically new approach to RF component design, enabled by our ISN technology. Four types of RF components dominate the size and cost of the RF front-end of mobile devices. We believe our ISN designs will enable our customers to combine three of them into a single, low-cost, multi-function and multi-band component. Our Filter Designs Filter design for communications dates back more than 100 years. The RF filter designs currently utilized in mobile devices have changed very little over the past century. The modern mobile device RF front-end has kept pace with increased demands primarily through dramatic progress in manufacturing methods for RF integrated circuits. However, filter design has lagged behind. We plan to change that with our ISN technology. Our ISN technology enables a fundamentally new filter design process. The current transmit filters are merely optimized versions of Espenschied’s ubiquitous ‘‘acoustic wave ladder’’ used in today’s mobile devices. Countless alternative designs are possible, but RF engineers lack the technology to effectively generate viable alternative structures. By contrast, our universal approach starts from the beginning by finding and evaluating a set of alternative structures. ISN makes possible an approach that allows components to be moved, even eliminated or added, in order to achieve a particular set of specifications. We have created several proprietary RF circuit design methodologies, which are supported by dozens of custom software circuit design modules. The conventional Espenschied structure uses a fixed topology and allows only minor optimization. Our approach exploits added complexity to produce what we believe will be smaller, lower cost solutions. 9 Table of Contents We have used our ISN technology to produce filter designs that are different from and superior to the conventional filter designs. Our designs have improved performance in terms of the key parameters of loss and steepness of rejection. Even more significantly, the mobile device industry has long sought the ability to design tunable filters capable of processing multiple bands. The conventional approach is to use a different filter for each band and use an antenna switch to alternate between multiple filters. The goal of a tunable filter is to replace multiple filters with a single tunable filter, saving both cost and valuable space. Our ISN technology has enabled us to produce in a laboratory setting tunable designs that operate in multiple bands. We have produced a design in a laboratory setting for a two-band SAW filter electronically tunable between two alternate bands. Circuitry was fabricated and performed as predicted. The design incorporates SAW resonators, non-resonant components and switches to create a tunable SAW filter that can be adapted to each of the frequency bands. This demonstrated the feasibility of reusing the same set of resonators to create multiple passbands. We believe that a 3-band tunable filter offers sufficient advantages in terms of cost and size to be a commercially viable product. We plan to use the same ISN process to create tunable filters for more than two bands. We cannot assure investors that we will be successful in designing commercially viable filters with 2 or more passbands. Plan of Commercialization Single-Band Designs SAW filters are preferred in modern RF front-ends because of their high performance, small size and low cost. However, traditional SAW filter designs, as well as the new “temperature compensated” (or TC) SAW filter designs, do not perform well in high frequency bands or bands with closely spaced receive and transmit channels, typical of many new bands. Therefore, larger and more expensive BAW filters are typically used for these bands. We have demonstrated in a test environment our ability to design SAW filters that perform well in frequency bands presently limited to the larger and more expensive BAW filters. Our designs avoid some of the limitations of traditional designs. For example, traditional designs are inherently symmetric, and most specifications are inherently asymmetric. Our flexible ISN approach allows us to create asymmetric designs that more closely match the typical performance specifications. We plan to develop a series of SAW duplexer designs for these frequency bands. We believe we can design SAW duplexers for many of these bands that can be manufactured at less than half the cost of BAW duplexers. We also believe our designs will be competitive with TC SAW filters, a growing trend in the filter market. There is a rapidly growing need for duplexers. According to Navian, the market for RF front-end duplexers in mobile devices was $1.8 billion in 2013 and is forecasted to reach $3.3 billion by 2017. This represents a compound annual growth rate of approximately 16%. 10 Table of Contents Figure 1—Projected growth of the market for RF front-end filters in mobile devices from 2013 through 2017 (in billions of filters). Source: Navian. Tunable Designs We plan to develop a series of tunable filter designs that replace multiple filters. Our initial designs are likely to use SAW filters and build on our expertise in SAW filter technology. We have fabricated circuitry in a laboratory test that demonstrates the feasibility of our tunable filter designs. We believe we can design tunable filters that can be electronically reprogrammed in real time for different RF frequency bands, significantly lowering the cost and size of RF front-ends. We have ongoing discussions with several prospective customers for the design of tunable filters with the goal of securing a lead customer. We began development in the fourth quarter of 2014 of a prototype tunable filter for demonstrating our value proposition to prospective customers. According to Navian, the market for RF front-end filters in mobile devices (including duplexers) was $2.7 billion in 2013 and is forecasted to reach $5.2 billion by 2017. This represents a compound annual growth rate of approximately 18%. Figure 3—Projected growth of the market for RF front-end filters in mobile devices (including duplexers) from 2013 through 2017 (in billions of dollars). Source: Navian. Future Designs Our immediate focus is to address the problems in the RF front-end with innovative single-band and tunable designs made possible with our ISN technology. These designs present the greatest near-term potential for commercialization of our ISN technology. We expect the trend towards spectrum proliferation in addition to carrier aggregation will require complex filter multiplexing. We believe our ISN technology will enable cost effective designs for these applications. Our First Commercial Duplexer Design We are developing our first filter design, a duplexer, for our first customer. We are funding our portion of the development work and will own our duplexer design and all related intellectual property. Our customer is funding certain costs and devoting engineering resources to testing and qualification. The customer is an innovator in high performance analog semiconductors and a leading supplier of RF front- ends for mobile devices. We have started with fixed band designs because we believe it gives us the opportunity to quickly demonstrate our ISN process. 11 Table of Contents We recently delivered a completed duplexer design to our first customer for consideration. Our design does not meet all the specifications in the development agreement, however, we believe our design delivers competitive performance and is competing with other products. The customer is evaluating our design, and there is no assurance that it has acceptable performance and therefore will be used. Even if it has acceptable performance, there are a number of other considerations influencing the customer’s decision whether to use our design, many of which are beyond our control. There is no assurance that our design will be selected by the customer for use in its products. The customer has an option to license the filter design at already agreed-upon royalty rates. We will own our duplexer design and all related intellectual property. The terms of the license would give the customer exclusivity on our filter designs for a limited time on the relevant duplexer band. The exclusivity will not affect our ability to design filters in other bands. Business Model We believe licensing our designs is the most direct and effective means of delivering our solutions to the market. Our target customers make part or all of the RF front-end. We intend to retain ownership of our designs and charge royalties based on sales of RF front-end modules that incorporate our designs. We generally do not intend to manufacture or sell any physical products or operate as a contract design company developing designs for a fee. Our strategy is to develop and license filter designs that offer improvements in cost, size and performance of RF front-ends. The goal of our designs is to improve profit margins and increase market share for our customers. We will license specific, custom designs to our customers. Our plan is to charge royalties at a fixed amount per filter and not as a percentage of sales. We expect to generate substantially all of our revenues with these types of licensing arrangements. Each filter design and related royalty stream is expected to have a finite commercial life as mobile devices continue to evolve. Our plan is to offer our customers replacement designs as existing designs become obsolete. We anticipate a significant delay between the start of a design and the start of royalty payments under a particular license. In some cases, we may grant the customer a limited period of exclusivity on a specific design or frequency band to enable the customer to be the first to market with the design. We do not expect any of these exclusivity provisions to have any long-term duration nor prevent us from concurrently working on filter designs in other bands for other customers. We have advantages that we believe present significant barriers to entry for potential competitors: · a large and growing portfolio of patents; · a suite of proprietary software design tools; · a highly experienced design team; and · a multi-year technology lead. We plan to pursue filter design projects with potential customers and other strategic partners. These types of arrangements may subsidize filter design costs, as well as offer complementary technology and market intelligence. However, we intend to retain ownership of our technology, designs and related improvements. Our goal is to establish and leverage alliances with new customers, who will help grow the market for our designs by integrating them with their own proprietary technology and products, thus combining their own particular strengths with ours to provide an extensive array of Resonant-based solutions. Our products will be designed for manufacture with existing high-volume fabrication processes allowing rapid time to market, but we do not plan to manufacture or sell any physical components. Unlike a traditional manufacturing company, we intend to create designs for manufacturers eliminating for us the costs and problems associated with manufacturing and inventory. This allows us to concentrate on our unique expertise, leaving the hardware manufacturers to drive their own economies of scale. 12 Table of Contents Intellectual Property We have an active program of protecting our proprietary technology through the filing of patents. Our patent portfolio reflects both the initial technology contribution of STI, as well as our own patent filings since our founding. We have plans to file additional patents this year. Our patent portfolio comprises more than 50 issued and pending patents. Our patent portfolio relates primarily to the following subject matter: · filter circuit structures and topologies; · filter synthesis and design methods; and · resonator structures. We also have an active and ongoing program to identify, protect and commercialize our intellectual property. This program includes the development of a comprehensive patent strategy. We routinely use specialized outside firms to assist in these endeavors. These firms assist with invention identification, intellectual property strategy and competitive landscape analysis. Our research has not identified any public information, such as patents or published articles, relating to our technology that would affect our freedom to operate. However, there can be no assurance that our pending patent applications or any future patent applications will be approved or will not be challenged successfully by third parties, that any issued patents will protect our technology or will not be challenged by third parties, or that the patents of others will not have an adverse effect on our ability to do business. Furthermore, there can be no assurance that others will not independently develop similar or competing technology or design around any patents that have been or may be issued to us. We also rely on trademark, copyright and trade secret laws to protect our intellectual property. We have registered U.S. trademarks for ‘‘Resonant,’’ ‘‘ISN” and “Integrated Synthesized Networks.’’ We protect our trade secrets and other proprietary information by requiring confidentiality agreements from all our employees, consultants and third parties having access to such information. Despite these efforts, there can be no assurance that others will not gain access to our trade secrets, or that we can meaningfully protect our technology. In addition, effective trademark, copyright and trade secret protection may be unavailable or limited in certain foreign countries. Although we intend to protect our rights vigorously, there can be no assurance that such measures will be successful. Competition Our potential customers typically source their filter designs internally from their own engineers. We intend to offer our customers filter designs that we believe do not currently exist. Our competitive challenge is to convince customers that our unconventional, proprietary designs offer significant size, cost and performance advantages over any design they can produce themselves or procure from a filter manufacturer. Thus, we will ‘‘compete’’ indirectly with the existing filter designs and design capabilities of our target customers or their filter manufacturers. These companies include, among others, Skyworks Solutions Inc., Qorvo, Inc., Avago Technologies Limited, Murata Manufacturing Co., Ltd., TDK Epcos and Taiyo Yuden. We must demonstrate that switching from their designs to our designs will give them a significant competitive advantage by improving the cost, size and performance of their products, and the improvement must be large enough to justify our royalty rates. We believe that all previous attempts to produce tunable filters have focused on varying the frequencies of the resonators by changing their capacitance. This is traditionally performed by incorporating variable capacitors or switched capacitors into the resonator. This approach has proven unsuccessful at meeting the performance requirements of the RF front-end market. ISN technology avoids this problem because it does not require varying any aspect of the resonators. However, several RF devices are in development that may improve the ability to vary it does not require varying any aspect of the resonators. However, several RF devices are in development that may improve the ability to vary the frequencies of the resonators. These include digitally-switched capacitors, MEMS (micro-electro-mechanical) tuned capacitors, BST (barium strontium titanate) tuned capacitors, and MEMS RF switches. Thus, these previous attempts to produce tunable filters may become more competitive than they are today. 13 Table of Contents Some companies are exploring pure digital solutions as alternatives to tunable filters. Pure digital solutions advance steadily, as predicted by Moore’s Law. As a result of the many decades of this progress to date, a great many traditionally analog tasks are now handled digitally. However, RF front-end analog tasks represent a much more demanding challenge. One of the most significant challenges is the large dynamic range, which means simultaneously processing a transmit signal power up to 100 trillion times larger than the receive signal power inside a small, mobile device. Digital solutions have advanced significantly, but they still have dynamic ranges thousands of times smaller than required. Employees We have twenty-two employees. Our three founders divide their time between filter designs and administrative matters. We have twelve other employees on our technical staff and seven employees devoted to finance, marketing and administrative matters. We also use several outside consultants. 14 Table of Contents ITEM 1A. RISK FACTORS Investing in our common stock involves a high degree of risk. You should carefully consider the risks and uncertainties described below, together with all of the other information in this Form 10-K, including our consolidated financial statements and related notes, before investing in our common stock. If any of the following risks materialize, our business, financial condition, results of operations and prospects could be materially and adversely affected. In that event, the price of our common stock could decline, and you could lose part or all of your investment. Risks Related to Our Business and Our Industry We are a have a history of operating losses and we may never achieve or maintain profitability. We have a limited operating history and only a preliminary business plan upon which investors may evaluate our prospects. We have never generated revenues and we have a history of losses from operations. As of December 31, 2014, we had an accumulated deficit of $21.2 million. Our principal sources of liquidity consist of existing cash balances and investments of $13.8 million. We believe our current resources will provide sufficient funding for planned operations into the first half of 2016. If we do not generate adequate cash from revenues in 2016 in order to reach positive cash flows, we likely will be required to obtain additional financing to continue with our plan of commercialization and we might be forced to make substantial reductions in our operating expenses, which could adversely affect our ability to implement our business plan and ultimately our viability as a company. No assurance can be given that any form of additional financing can be obtained, that the terms of such financing will be acceptable or that such financing would not be dilutive to existing stockholders. Thus, our ability to achieve revenue-generating cash flows and, ultimately, achieve profitability may depend on whether we can obtain additional capital when we need it and will depend on whether we complete the development of our technology and find customers who will license our designs. There can be no assurance that we will ever generate revenues or achieve profitability. We may not be able to complete a design that meets our first customer’s specifications. Even if we succeed in developing a design that meets all the specifications for our customer, the customer could decline to use our design in its product. Further, our customer’s product could fail in the marketplace. Any of these events would have a material adverse effect on our business and potentially threaten our viability. We are currently working on a filter design for our first customer, and the customer has given us stringent performance specifications. We will also compete against other technologies for inclusion into the customer’s product. Our customer’s final product will then compete against other products and technologies for inclusion into mobile devices in the marketplace. There can be no assurance that we can complete our design or that our final design will have acceptable performance and meet our customer’s specifications. The decision to use our design is solely within our customer’s discretion. We have delivered a completed duplexer design for consideration to our first customer. Our design does not meet all the specifications in the development agreement, however, we believe our design delivers competitive performance and is competing with other products. The customer is evaluating it, and there is no assurance that our design has acceptable performance and therefore will be used. Even if it has acceptable performance, there are a number of other considerations influencing the customer’s decision whether to use our design, many of which are beyond our control. Further, if selected for inclusion in its product by our customer, there is no guarantee that its final product will win out over its competition for inclusion into mobile devices. Either failure (to be selected at the design stage or the device stage) would have a material adverse effect on our business and potentially threaten our viability. We are required to fabricate test samples of the duplexer designs for our first customer using a customer-approved manufacturer, and We are required to fabricate test samples of the duplexer designs for our first customer using a customer-approved manufacturer, and the customer will not license our design unless the manufacturer can demonstrate the ability to economically produce the duplexer design in large volumes. We believe our designs can be manufactured using existing technology, but we will be dependent on a single, customer approved manufacturer for the fabrication of our first duplexer design. Even if we successfully design a fully compliant duplexer, the customer will not license our design unless the manufacturer can demonstrate the ability to economically produce the design in large volumes. We do not have any control over the manufacturer. We cannot assure you that the manufacturer will have the necessary technology, skills and resources to successfully manufacture of our design in commercial quantities. 15 Table of Contents We are actively working on filter designs with only two customers and expect to derive all of our revenues from a small number of customers. Our failure to retain or expand customer relationships will have an adverse effect on our revenues. We are currently working on filter designs with only two customers. Neither customer has agreed to license our technology, and they may decide not to continue their relationship with us. We expect to derive our revenues from a small number of customers. Our revenues may fluctuate significantly in the future should we develop our technology and enter into new customer relationships. Our failure to retain or expand customer relationships, or any problems we experience in collecting receivables from them, would harm our financial condition and results of operations. Our designs may not gain widespread acceptance unless they significantly lower costs as compared to existing radio frequency, or RF, filter designs. RF front-end manufacturers are primarily concerned with the cost of RF filters, and our designs may not gain widespread acceptance unless they significantly lower costs as compared to existing RF filter designs. We cannot assure you that our surface acoustic wave, or SAW, filter designs will cost sufficiently less to manufacture than existing bulk acoustic wave, or BAW, filters, or that our tunable filter designs can replace a sufficient number of conventional filter designs, to prove economically attractive to RF front-end manufacturers. We develop and test our designs under laboratory conditions using low volume production samples. Once in production, our designs may not perform as well or prove reliable due to manufacturing variations and operating conditions. This could adversely affect our business. We develop and test our designs under laboratory conditions using low volume production samples. The transition from product development to commercial production requires high volume manufacturing which introduces product variations. These variations can adversely affect performance and reliability. Similarly, our designs may not perform as well or prove sufficiently reliable under actual operating conditions. This could adversely affect our business. Our SAW-based circuit designs will be complex and may prove difficult to manufacture in commercial quantities. We will be relying on our prospective customers and their circuit suppliers to manufacture our designs. Our business could fail if they encounter difficulties manufacturing our designs in commercial quantities. We are developing complex RF circuit designs. We have never manufactured any of our designs beyond an initial prototype. Furthermore, we will be relying on our prospective customers and their circuit suppliers to manufacture our designs. They will need to manufacture our designs in commercial quantities at an acceptable cost, and we will have little or no control over the manufacturing process. They may encounter difficulties in scaling up production of our designs currently in development or other future designs, including problems with quality control and assurance, component supply shortages, increased costs, shortages of qualified personnel and/or difficulties associated with compliance with regulatory requirements. Our business could fail if our customers and their suppliers encounter difficulties manufacturing our designs in commercial quantities. We will be dependent on third-party manufacturers to produce our filter designs, and our revenues may be adversely affected if these manufacturers experience shortages of raw materials or breakdowns in production equipment. We will be dependent on our prospective customers and their circuit suppliers to manufacture our designs. We will have little or no control over the manufacturing process. Manufacturing integrated circuits is inherently challenging. The manufacturers must secure adequate supplies of raw materials, and they may encounter periodic shortages. They must also operate and maintain sophisticated manufacturing equipment, and equipment failures can have adverse consequences on production volumes and schedules. Either of these problems may adversely affect the timing and amount of our future revenues. 16 Table of Contents Our business success relies on manufacturers to fabricate our circuit designs, and market acceptance of our designs could be adversely affected if the manufacturers decline to manufacture our designs. We are a design company and will not commercially manufacture any products. Our business model contemplates licensing our We are a design company and will not commercially manufacture any products. Our business model contemplates licensing our designs to customers, who will manufacture our circuit designs themselves or rely on third party manufacturers, commonly referred to as fab houses, to fabricate our circuit designs for integration into the customer’s overall product. Many fab houses offer potentially competitive filter technology as part of their standard product line or offer the services of in-house design teams which may consider us competition. In this case, our customers may face resistance by their fab houses to manufacture our designs. We believe the economics can be structured to make it attractive to the fab houses to manufacture our designs for our potential customers but we cannot be assured of the success in convincing them of the value of manufacturing our designs. The reluctance of fab houses to manufacture our designs could adversely affect the market acceptance of our designs. We plan to be a design firm licensing our SAW-based circuit designs to manufacturers of RF front-ends for mobile devices. If our circuit designs do not achieve widespread market acceptance among RF front-end manufacturers, we will not be able to generate the revenue necessary to support our business. Achieving acceptance among RF front-end manufacturers of our circuit designs will be crucial to our continued success. We have no history of marketing any circuit design and we may fail to generate significant interest in our initial commercial circuit designs or any other circuit designs we may develop. These and other factors may affect the rate and level of market acceptance, including: · our pricing relative to other competing designs and technologies; · perception by RF front-end manufacturers and mobile device manufacturers; · press and blog coverage, social media coverage, and other publicity and public relations factors which are not within our control; and · regulatory developments related to manufacturing, marketing and selling our designs. If we are unable to achieve or maintain market acceptance, our business would be harmed. The complexity of our designs could result in unforeseen delays or expenses from latent defects that could reduce the market acceptance for our designs damage our reputation with prospective customers and adversely affect our future revenues and operating costs. We are developing highly complex filters designs using a new approach. We have not previously produced any designs that have gone into commercial production and therefore cannot be certain our methods and testing procedures are adequate to detect latent design defects. If any of our designs contain latent defects, we may be unable to correct these problems. Consequently, our reputation may be damaged and customers may be reluctant to buy our designs, which could harm our ability to attract customers and negatively impact our financial results. These problems may also result in claims against us by our customers or others. Our technologies are not yet verified in practice or on a commercial scale. Our technologies have not been tested in a commercial setting or on a commercial scale. There is no assurance that we will be able to fully develop or license our proposed designs on a timely basis, or at all. There can be no assurance that we will be successful in developing commercially viable designs or obtaining revenues or that any revenues we may obtain will be sufficient for our operations to continue. We may require additional capital to support growth, and such capital might not be available on terms acceptable to us, if at all, which may in turn hamper our growth and adversely affect our business. We intend to continue to make investments to support our business growth and may require additional funds to respond to business challenges, including the need to develop new technology, improve our operating infrastructure or acquire complementary businesses and technologies. Our principal sources of liquidity consist of existing cash balances and investments of $13.8 million. We believe our current resources will provide sufficient funding for planned operations into the first half of 2016. Accordingly, we may need to engage in equity, equity-linked or debt financings to secure additional funds. If we raise additional funds through future issuances of equity or convertible debt securities, our existing stockholders could suffer significant dilution, and any new equity 17 Table of Contents securities we issue could have rights, preferences and privileges superior to those of holders of our common stock. Any debt financing that we secure in the future could involve restrictive covenants relating to our capital raising activities and other financial and operational matters, including the ability to pay dividends. This may make it more difficult for us to obtain additional capital and to pursue business opportunities. We may not be able to obtain additional financing on terms favorable to us, if at all. If we are unable to obtain adequate financing or financing on terms satisfactory to us when we require it, our ability to continue to support our business growth and respond to business challenges could be significantly impaired, and we might be forced to make substantial reductions in our operating expenses, which could adversely affect our ability to implement our business plan and ultimately our viability as a company. Our industry is subject to intense competition and rapid technological change, which may result in circuit designs, products or new solutions that are superior to our designs under development. If we are unable to anticipate or keep pace with changes in the marketplace and the direction of technological innovation and customer demands, our designs may become less useful or obsolete and our operating results will suffer. We operate in an industry which is subject to intense and increasing competition and rapidly evolving technologies. Because our designs are expected to have long development cycles, we must anticipate changes in the marketplace and the direction of technological innovation and customer demands. To compete successfully, we will need to demonstrate the advantages of our designs and technologies. Our future success will depend in large part on our ability to establish and maintain a competitive position in current and future technologies. Rapid technological development may render our designs under development, or any future designs we may have, and its technologies obsolete. Many of our competitors have or may have greater corporate, financial, operational, sales and marketing resources, and more experience in research and development than we have. We cannot assure you that our competitors will not succeed in developing or marketing technologies or products that are more effective or commercially attractive than our designs or that would render our technologies and designs obsolete. We may not have or be able to raise or develop the financial resources, technical expertise, or support capabilities to compete successfully in the future. Our success will depend in large part on our ability to maintain a competitive position with our technologies. Our business model is based on licensing filter designs. Historically, our target customers have relied on their own filter designs or purchased finished filters from a manufacturer. They have not licensed third-party designs, and we may not succeed in our licensing strategy. The failure of our business model would have a material adverse effect on our potential for generating revenues and potentially threaten our viability. Our business model is based on licensing our proprietary filter designs. We do not intend to manufacture or sell any physical products or operate as a contract design company developing designs for a fee. We believe licensing our designs is the most direct and effective means of delivering our solutions to the market. We intend to retain ownership of our designs and charge royalties based on sales of RF front-end modules that incorporate our designs. Our target customers make part or all of the RF front-end. These customers have historically used their own filter designs or purchased finished filters from a manufacturer. Our business model is new to the filter industry, and we may encounter resistance to our licensing strategy. The failure of our business model would have a material adverse effect on our potential for generating revenues and potentially threaten our viability. If our principal end markets fail to grow or experience declines, our net revenue may not meet our business plan expectations. According to our business plan, our initial circuit designs will be incorporated into mobile wireless devices. Accordingly, demand for our designs is dependent on the ability of mobile wireless device manufacturers to successfully sell wireless devices that incorporate our designs. We cannot be certain whether these manufacturers will be able to create or sustain demand for their wireless devices that contain our designs or how long they will remain competitive in their business, if at all. The success of these mobile wireless device manufacturers and the demand for their wireless devices can be affected by a number of factors, including: · market acceptance of their mobile wireless devices that contain our designs; · the impact of slowdowns or declines in sales of mobile wireless devices in general; 18 Table of Contents · their ability to design products with features that meet the evolving tastes and preferences of consumers; · fluctuations in foreign currency; · relationships with wireless carriers in particular markets; · the implementation of, or changes to, mobile wireless device certification standards and programs; · technological advancements in the functionality and capabilities of mobile wireless devices; · the imposition of restrictions, tariffs, duties, or regulations by foreign governments on mobile wireless device manufacturers; · failure to comply with governmental restrictions or regulations; · cost and availability of components for their products; and · inventory levels in the sales channels into which mobile wireless device manufacturers sell their products. Our proprietary rights may be difficult to enforce, which could enable others to copy or use aspects of our intellectual property without compensating us, thereby eroding our competitive advantages and harming our business. Our success depends, in part, on our ability to protect proprietary methods and technologies that we develop under the intellectual property laws of the United States, so that we can prevent others from using our inventions and proprietary information. If we fail to protect our intellectual property rights adequately, our competitors might gain access to our technology, and our business might be adversely our intellectual property rights adequately, our competitors might gain access to our technology, and our business might be adversely affected. We rely on trademark, copyright, trade secret and patent laws, confidentiality procedures and contractual provisions to protect our proprietary methods and technologies. We currently hold several patents and have pending patent applications related to our technology solutions. Valid patents may not be issued from our pending applications, and the claims allowed on any issued patents may not be sufficiently broad to protect our technology or offerings and services. Any patents we currently hold or that may be issued to us in the future may be challenged, invalidated or circumvented, and any rights granted under these patents may not actually provide us with adequate defensive protection or competitive advantages. Additionally, the process of obtaining patent protection is expensive and time-consuming, and we may not be able to prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner. Policing unauthorized use of our technology is difficult. Additional uncertainty may result from changes to intellectual property legislation enacted in the United States, including the recent America Invents Act, and other countries and from interpretations of the intellectual property laws of the United States and other countries by applicable courts and agencies. In addition, the laws of some foreign countries may not be as protective of intellectual property rights as those of the United States, and mechanisms for enforcement of our proprietary rights in such countries may be inadequate. From time to time, legal action by us may be necessary to enforce our intellectual property rights, to protect our trade secrets, to determine the validity and scope of the proprietary rights of others, or to defend against claims of infringement. Such litigation could result in substantial costs and the diversion of limited resources and could negatively affect our business, operating results and financial condition. If we are unable to protect our proprietary rights (including aspects of our technology platform) we may find ourselves at a competitive disadvantage to others who have not incurred the same level of expense, time and effort to create and protect their intellectual property. Furthermore, we acquired many of the patents we currently hold from Superconductor Technologies, Inc., or STI. Although we believe we have obtained valid assignments of patent rights from STI and STI has obtained valid assignments of patent rights from all inventors, if an inventor did not adequately assign his or her patent right to STI or STI did not adequately assign its patent rights to us, a third party could obtain a license to the patent from such inventor or STI. This could preclude us from enforcing the patent against such third party. In addition, because we acquired our patents from STI, some of the inventors of our patents are not our employees and they are not obligated to assist us in prosecuting, maintaining, defending and enforcing such patents. Without the cooperation of the inventors of our patents, it may be difficult for us to prevail in any legal action involving the intellectual property rights under our patents. Additionally, the inventors may have information, trade secrets and know-how learned while at STI that is not our property and if disclosed could provide competitors with insights that allow them to invent around our patented technology. 19 Table of Contents Accordingly, despite our efforts, we may be unable to obtain adequate patent protection, or to prevent third parties from infringing upon, misappropriating or inventing around our intellectual property. We may be subject to intellectual property rights claims by third parties, which are extremely costly to defend, could require us to pay significant damages and could limit our ability to use certain technologies. Third parties may assert claims of infringement of intellectual property rights in proprietary technology against us for which we may be liable or have an indemnification obligation. Any claim of infringement by a third party, even those without merit, could cause us to incur substantial costs defending against the claim and could distract our management from our business. Although third parties may offer a license to their technology, the terms of any offered license may not be acceptable and the failure to obtain a license or the costs associated with any license could cause our business, results of operations or financial condition to be materially and adversely affected. In addition, some licenses may be non-exclusive, and therefore our competitors may have access to the same technology licensed to us. Alternatively, we may be required to develop non-infringing technology, which could require significant effort and expense and ultimately may not be successful. Furthermore, a successful claimant could secure a judgment or we may agree to a settlement that prevents us from licensing certain circuit designs or performing certain services or that requires us to pay substantial damages, including treble damages if we are found to have willfully infringed the claimant’s patents or copyrights, royalties or other fees. Any of these events could seriously harm our business, operating results and financial condition. Our customer agreements will likely include indemnity provisions and may expose us to substantial liability for intellectual property infringement and other losses. Our customer agreements will likely will include indemnification provisions under which we agree to indemnify third parties for losses suffered or incurred as a result of claims of intellectual property infringement, damages caused by us to property or persons, or other liabilities relating to or arising from our circuit designs, services, or other contractual obligations. The term of these indemnity provisions generally survives termination or expiration of the applicable agreement. Large indemnity payments could harm our business, operating results and financial condition. We use highly specialized commercially available software pursuant to annual licenses, and the inability to renew any of these licenses could adversely affect our ability to design new RF filters and thus our potential for generating revenues. In addition to our proprietary software, we also use highly specialized but commercially available computer software in our design process. We do not own this software and use it under the terms of annual licenses. These licenses are made available to us at prices and on terms generally available to any customer. If we were unable to renew any of these software licenses, we would have to locate or develop alternative software. We cannot assure you that suitable alternative software would be available on commercially reasonable terms or could be developed by us at reasonable cost. The loss any one of these software licenses could adversely affect our ability to produce new RF filter designs and thus our potential for generating revenues. Our limited operating history makes it difficult to evaluate our business and prospects and may increase the risks associated with your investment. We have only a limited operating history upon which our business and future prospects may be evaluated. We have encountered and will continue to encounter risks and difficulties frequently experienced by companies in rapidly developing and changing industries, including challenges related to recruiting, integrating and retaining qualified employees; making effective use of our limited resources; achieving market acceptance of our existing and future solutions; competing against companies with greater financial and technical resources; and developing new solutions. Our current operational infrastructure may require changes for us to scale our business efficiently with additional technical personnel and effectively to keep pace with demand for our solutions, and achieve long-term profitability. If we fail to implement these changes on a timely basis or are unable to implement them effectively, our business may suffer. We cannot assure you that we will be successful in addressing these and other challenges we may face in the future. As a company in a rapidly evolving industry, our business prospects depend in large part on our ability to: 20 Table of Contents · build a reputation for a superior solution and create trust and long-term relationships with our potential customers; · distinguish ourselves from competitors in our industry; · develop and offer a competitive technology that meet our potential customers’ needs as they change; · respond to evolving industry standards and government regulations that impact our business; · expand our business internationally; and · attract, hire, integrate and retain qualified and motivated employees. If we are unable to meet one or more of these objectives or otherwise adequately address the risks and difficulties that we face, our business may suffer, our revenue may decline and we may not be able to achieve growth or long-term profitability. Our management team and financial reporting group is limited in size and experience which may impact the implementation and administration of financial and reporting controls and procedures. Although our management team makes certain representations about the financial and reporting controls and procedures in our offering documentation, our management team has limited experience in implementing and maintaining our operations and our financial processes. Financial and reporting controls and procedures implemented and maintained by our management team, now or in the future, may not be adequate, with the result that there may be substantial deficiencies that will need remediation in the future. If there are inadequate controls and procedures, our financial statements and our reporting may be inaccurate or untimely. For example, during the third quarter of 2014, we identified a material weakness in our internal control over financial reporting relating to our lack of sufficient policies and procedures in the review of complex financial instruments and a clerical error in the computation of loss per share, which resulted in restatements to our financial statements included in our previously filed Quarterly Report on Form 10-Q for the period ended June 30, 2014. As a result, our internal control over financial reporting was not effective as of June 30, 2014 and September 30, 2014. While we have taken actions that we believe remediated the material weakness, we may again experience control and procedure deficiencies in the future. Investors may not wish to invest in a company with identified control and procedure deficiencies. The loss of the services of our key management and personnel or the failure to attract additional key personnel could adversely affect our ability to operate our business. A loss of one or more of our current officers or key employees could severely and negatively impact our operations. Specifically, the loss of the services of any of the following would be material to us: Terry Lingren, our Chief Executive Officer; Robert Hammond, our Chief Technology Officer; and Neal Fenzi, our Chief Operating Officer. We have no present intention of obtaining key-man life insurance on any of our executive officers or management. Additionally, competition for highly skilled technical, managerial and other personnel is intense. As our business develops, we might not be able to attract, hire, train, retain and motivate the highly skilled managers and employees we need to be successful. If we fail to attract and retain the necessary technical and managerial personnel, our business may not grow, may suffer and might fail. We may have difficulty managing growth in our business. Because of our small size, growth in accordance with our business plan, if achieved, will place a significant strain on our financial, technical, operational and management resources. As we expand our activities, there will be additional demands on these resources. The failure to continue to upgrade our technical, administrative, operating and financial control systems or the occurrence of unexpected expansion difficulties, including issues relating to our research and development activities and retention of experienced scientists, managers and engineers, could have a material adverse effect on our business, financial condition and results of operations and our ability to timely execute our business plan. If we are unable to implement these actions in a timely manner, our results may be adversely affected. 21 Table of Contents If our estimates or judgments relating to our critical accounting policies are based on assumptions that change or prove to be incorrect, our operating results could fall below the expectations of securities analysts and investors, resulting in a decline in our stock price. The preparation of financial statements in conformity with generally accepted accounting principles, or GAAP, requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, as provided in the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” the results of which form the basis for making judgments about the carrying values of assets, liabilities, equity, revenue and expenses that are not readily apparent from other sources. Our operating results may be adversely affected if our assumptions change or if actual circumstances differ from those in our assumptions, which could cause our operating results to fall below the expectations of securities analysts and investors, resulting in a decline in our stock price. Significant assumptions and estimates used in preparing our consolidated financial statements include those related to the fair values of convertible debt instruments, derivative instruments, other financial instruments and income taxes. Changes in current laws or regulations or the imposition of new laws or regulations could impede the license of our designs or otherwise harm our business. Wireless networks can only operate in the frequency bands, or spectrum, allowed by regulators and in accordance with rules governing how the spectrum can be used. The Federal Communications Commission, or the FCC, in the United States, as well as regulators in foreign countries, have broad jurisdiction over the allocation of frequency bands for wireless networks. We therefore will rely on the FCC and international regulators to provide sufficient spectrum and usage rules. For example, countries such as China, Japan or Korea heavily regulate all aspects of their wireless communication industries, and may restrict spectrum allocation or usage. If this were to occur, it would make it difficult for us to license our designs for use in mobile devices in that region. Risks Relating to the Securities Markets and Ownership of Our Common Stock Two securities class action lawsuits have been filed against us and could have a material adverse effect on our business, results of operations and financial condition. Two putative class action lawsuits were filed in March 2015 against the Company and certain of our members of the Board of Directors and executives, as described in Item 3-Legal Proceedings. These lawsuits may divert financial and management resources that would otherwise be used to benefit our operations. Although the Company denies the material allegations of both lawsuits and intends to defend vigorously both, defending the lawsuits could result in substantial costs. No assurances can be given that the results of these matters will be favorable to us. An adverse resolution of either of these lawsuits could have a material adverse effect on our results of operations and financial condition. In addition, we may be the target of securities-related litigation in the future, both related and unrelated to the existing class action lawsuits. Such litigation could divert our management’s attention and resources, result in substantial costs, and have an adverse effect on our business, results of operations and financial condition. We maintain director and officer insurance that we regard as reasonably adequate to protect us from potential claims; however, we cannot assure you that it will. Further, as a result of this litigation the costs of insurance may increase and the availability of coverage may decrease. As a result, we may not be able to maintain our current levels of insurance at a reasonable cost, or at all, which might make it more difficult to attract qualified candidates to serve as executive officers or directors of Resonant. The price of our common stock may be volatile and the value of your investment could decline. Technology stocks have historically experienced high levels of volatility. The trading price of our common stock may fluctuate substantially, depending on many factors, some of which are beyond our control and may not be related to our operating performance. These fluctuations could cause you to lose all or part of your investment in our common stock. Factors that could cause fluctuations in the trading price of our common stock include the following: · the progress, completion or failure of efforts to design our first commercial duplexer; · a customer decision regarding incorporation of our first duplexer design into a commercial product; · the loss of any customer relationship; · the addition of a new customer relationship; · mergers and acquisitions involving us, our customers or our competitors; · price and volume fluctuations in the overall stock market from time to time; · significant volatility in the market price and trading volume of technology companies in general; · fluctuations in the trading volume of our shares or the size of our public float; · actual or anticipated changes or fluctuations in our results of operations; Table of Contents 22 · whether our results of operations meet the expectations of securities analysts or investors; · actual or anticipated changes in the expectations of investors or securities analysts; · litigation involving us, our industry, or both; · regulatory developments in the United States, foreign countries, or both; · general economic conditions and trends; · major catastrophic events; · lockup releases, sales of large blocks of our common stock; · departures of key employees; or · an adverse impact on the company from any of the other risks cited herein. In addition, if the market for technology stocks or the stock market, in general, experience a loss of investor confidence, the trading price of our common stock could decline for reasons unrelated to our business, results of operations or financial condition. The trading price of our common stock might also decline in reaction to events that affect other companies in our industry even if these events do not directly affect us. Securities class action litigation has often been instituted against companies following periods of volatility in the overall market and in the market price of a company’s securities. Two putative class action lawsuits were filed in March 2015 against the Company and certain of our members of the Board of Directors and executives, as described in “Item 3-Legal Proceedings.” In addition, we may be the target of securities-related litigation in the future, both related and unrelated to the existing class action lawsuits. Such litigation could divert our management’s attention and resources, result in substantial costs, and have an adverse effect on our business, results of operations and financial condition. Sales of substantial amounts of our common stock in the public markets, including when the “lock-up” or “market standoff” period ends, or the perception that sales might occur, could reduce the price of our common stock and may dilute your voting power and ownership interest in us. Sales of a substantial number of shares of our common stock in the public market could adversely affect the market price of our common stock. All of the shares of common stock sold in our initial public offering, as well as the shares issued on conversion of our Senior Convertible Notes, are freely tradable without restrictions or further registration under the Securities Act of 1933, as amended, or the Securities Act, except for any shares held by our “affiliates” as defined in Rule 144 under the Securities Act. Subject to certain exceptions, the founders and other employees agreed not to offer, sell or agree to sell, directly or indirectly, any shares of common stock without the permission of the underwriter before May 28, 2015 (12 months from the IPO). When the lockup period expire, the founders and employees will be able to sell shares in the public market. In addition, the underwriter may, in its sole discretion, release all or some portion of the shares subject to lock-up agreements prior to the expiration of the applicable lock-up period. Sales of a substantial number of such shares upon expiration, or the perception that such sales may occur, or early release of the lock-up, could cause our share price to fall or make it more difficult for you to sell your common stock at a time and price that you deem appropriate. Certain holders of our common stock have rights, subject to some conditions, to require us to file registration statements covering the sale of their shares or to include their shares in registration statements that we may file for ourselves or other stockholders. We may issue our shares of common stock or securities convertible into our common stock from time to time in connection with a financing, acquisition, investments or otherwise. Any such issuance could result in substantial dilution to our existing stockholders and cause the trading price of our common stock to decline. Insiders have substantial control over us, which could limit your ability to influence the outcome of key transactions, including a change of control. Our directors, executive officers and each of our stockholders who own greater than 5% of our outstanding common stock, in the aggregate, beneficially own approximately 33.77% of the outstanding shares of our common stock as of December 31, 2014. As a result, these stockholders will be able to influence or control matters requiring approval by our stockholders, including the election of directors and the approval of mergers, acquisitions or other extraordinary transactions. They may also have interests that differ from yours and may vote in a manner that is adverse to your interests. This concentration of ownership may have the effect of deterring, delaying or preventing a change of control of our company, could deprive our stockholders of an opportunity to receive a premium for their common stock as part of a sale of our company and might ultimately affect the market price of our common stock. 23 Table of Contents We have broad discretion in the use of net proceeds that we received in our initial public offering, and if we do not use those proceeds effectively, your investment could be harmed. The principal purposes of our initial public offering were to raise additional capital, to create a public market for our common stock and to facilitate our future access to the public equity markets. We have not yet determined the specific allocation of the net proceeds that we received in our initial public offering. We intend to use such net proceeds for product development to commercialize our technology, research and development, the development of our patent strategy and expansion of our patent portfolio, to pay accrued interest on outstanding indebtedness, and for working capital and general corporate purposes. We also may use a portion of such net proceeds to acquire or invest in technologies, solutions or businesses that complement our business, although we have no present commitments to complete any such transactions at this time. Accordingly, our management will have broad discretion over the specific use of the net proceeds that we received in our initial public offering and might not be able to obtain a significant return, if any, on investment of these net proceeds. If we do not use the net proceeds that we received in our initial public offering effectively, our business, results of operations and financial condition could be harmed. The requirements of being a public company may strain our resources, divert our management’s attention and affect our ability to attract and retain qualified board members. As a public company, we are subject to the reporting requirements of the Exchange Act, and are required to comply with the applicable requirements of the Sarbanes-Oxley Act and the Dodd-Frank Wall Street Reform and Consumer Protection Act, the listing requirements of The NASDAQ Stock Market and other applicable securities rules and regulations. Compliance with these rules and regulations have increased our legal and financial compliance costs, made some activities more difficult, time-consuming or costly and increased demand on our systems and resources. Among other things, the Exchange Act requires that we file annual, quarterly and current reports with respect to our business and results of operations and maintain effective disclosure controls and procedures and internal controls over financial reporting. In order to maintain and, if required, improve our disclosure controls and procedures and internal controls over financial reporting to meet this standard, significant resources and management oversight may be required. As a result, management’s attention may be diverted from other business concerns, which could harm our business and results of operations. Although we have already hired additional employees to comply with these requirements, we may need to hire even more employees in the future, which will increase our costs and expenses. In addition, we expect that these new rules and regulations will make it more expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced coverage or incur substantially higher costs to obtain coverage. These factors could also make it more difficult for us to attract and retain qualified members of our board of directors, particularly to serve on our audit committee and compensation committee, and qualified executive officers. We are an “emerging growth company,” and we cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make our common stock less attractive to investors. For so long as we remain an “emerging growth company” as defined in the JOBS Act, we may take advantage of certain exemptions from various requirements that are applicable to public companies that are not “emerging growth companies,” including not being required to comply with the independent auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. We may take advantage of these exemptions for so long as we are an “emerging growth company,” which could be as long as five years following the completion of our initial public offering. Investors may find our common stock less attractive because we rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock, and our stock price may be more volatile and may decline. 24 Table of Contents In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of an extended transition period for complying with new or revised accounting standards. However, we chose to “opt out” of such extended transition period, and as a result, we will comply with new or revised accounting standards on the relevant dates adoption of such standards is required for non-emerging growth companies. Our decision to opt out of the extended transition period for complying with new or revised accounting standards is irrevocable. We will remain an emerging growth company until the earliest of (a) the last day of our fiscal year during which we have total annual gross revenue of at least $1.0 billion; (b) the last day of our fiscal year following the fifth anniversary of the completion of our initial public offering; (c) the date on which we have, during the previous three-year period, issued more than $1.0 billion in non-convertible debt; or (d) the date on which we are deemed to be a “large accelerated filer” under the Securities Exchange Act of 1934, as amended, which would occur if the market value of our stock that are held by non-affiliates exceeds $700 million as of the last business day of our most recently completed second fiscal quarter. Once we cease to be an emerging growth company, we will not be entitled to the exemptions provided in the JOBS Act. We will be required to evaluate our internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act of 2002, and any adverse results from such evaluation could result in a loss of investor confidence in our financial reports and have an adverse any adverse results from such evaluation could result in a loss of investor confidence in our financial reports and have an adverse effect on our stock price. Pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, we will be required to furnish a report by our management on our internal control over financial reporting the year following our first annual report required to be filed with the SEC. When required, such report will contain, among other matters, an assessment of the effectiveness of our internal control over financial reporting as of the end of our fiscal year, including a statement as to whether or not our internal control over financial reporting is effective. This assessment must include disclosure of any material weaknesses in our internal control over financial reporting identified by management. If we are unable to assert that our internal control over financial reporting is effective, we could lose investor confidence in the accuracy and completeness of our financial reports, which could have an adverse effect on our stock price. During the third quarter of 2014, we identified a material weakness in our internal control over financial reporting relating to our lack of sufficient policies and procedures in the review of complex financial instruments and a clerical error in the computation of loss per share, which resulted in restatements to our financial statements included in our previously filed Quarterly Report on Form 10-Q for the period ended June 30, 2014. As a result, our internal control over financial reporting was not effective as of June 30, 2014 and September 30, 2014. While we have taken actions that we believe remediated the material weakness, we may again experience control and procedure deficiencies in the future. Our independent registered public accounting firm is not required to formally attest to the effectiveness of our internal control over financial reporting until the later of the year following our first annual report required to be filed with the SEC, or the date we are no longer an “emerging growth company.” At such time, our independent registered public accounting firm may issue a report that is adverse in the event it is not satisfied with the level at which our controls are documented, designed or operating. Our remediation efforts may not enable us to avoid a material weakness in the future. If securities or industry analysts do not publish research or reports about our business, or publish inaccurate or unfavorable research reports about our business, our share price and trading volume could decline. The trading market for our common stock will, to some extent, depend on the research and reports that securities or industry analysts publish about us or our business. We do not have any control over these analysts. If one or more of the analysts who cover us should downgrade our shares or change their opinion of our business prospects, our share price would likely decline. If one or more of these analysts ceases coverage of our company or fails to regularly publish reports on us, we could lose visibility in the financial markets, which could cause our share price or trading volume to decline. 25 Table of Contents We do not intend to pay dividends for the foreseeable future and, consequently, your ability to achieve a return on your investment will depend on appreciation in the price of our common stock. We have never declared or paid any dividends on our common stock. We intend to retain any earnings to finance the operation and expansion of our business, and we do not anticipate paying any cash dividends in the future. As a result, you may only receive a return on your investment in our common stock if the market price of our common stock increases. Our charter documents and Delaware law could discourage takeover attempts and lead to management entrenchment. Our amended and restated certificate of incorporation and amended and restated bylaws contain provisions that could delay or prevent a change in control of our company. These provisions could also make it difficult for stockholders to elect directors that are not nominated by the current members of our board of directors or take other corporate actions, including effecting changes in our management. These provisions include: · the ability of our board of directors to issue shares of preferred stock and to determine the price and other terms of those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquirer; · the exclusive right of our board of directors to elect a director to fill a vacancy created by the expansion of our board of directors or the resignation, death or removal of a director, which prevents stockholders from being able to fill vacancies on our board of directors; · a prohibition on stockholder action by written consent, which forces stockholder action to be taken at an annual or special meeting of our stockholders; · the requirement that a special meeting of stockholders may be called only by the chairman of our board of directors, the chief executive officer, the president (in the absence of a chief executive officer) or a majority vote of our board of directors, which could delay the ability of our stockholders to force consideration of a proposal or to take action, including the removal of directors; · the requirement for the affirmative vote of holders of at least 66-2/3% of the voting power of all of the then-outstanding shares of the voting stock, voting together as a single class, to amend the provisions of our amended and restated certificate of incorporation relating to the management of our business or our amended and restated bylaws, which may inhibit the ability of an acquirer to effect such amendments to facilitate an unsolicited takeover attempt; acquirer to effect such amendments to facilitate an unsolicited takeover attempt; · the ability of our board of directors, by majority vote, to amend our amended and restated bylaws, which may allow our board of directors to take additional actions to prevent an unsolicited takeover and inhibit the ability of an acquirer to amend our amended and restated bylaws to facilitate an unsolicited takeover attempt; and · advance notice procedures with which stockholders must comply to nominate candidates to our board of directors or to propose matters to be acted upon at a stockholders’ meeting, which may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer’s own slate of directors or otherwise attempting to obtain control of us. In addition, as a Delaware corporation, we are subject to Section 203 of the Delaware General Corporation Law. These provisions may prohibit large stockholders, in particular those owning 15% or more of our outstanding voting stock, from merging or combining with us for a certain period of time. Risks Related to Government Regulation Our failure to comply with U.S. laws and regulations relating to the export and import of goods, technology, and software could subject us to penalties and other sanctions and restrict our ability to license and develop our circuit designs. We are obligated by law to comply with all U.S. laws and regulations governing the export and import of goods, technology, and services, including the International Traffic in Arms Regulations, or ITAR, the Export Administration Regulations, 26 Table of Contents or EAR, regulations administered by the Department of Treasury’s Office of Foreign Assets Control, and regulations administered by the Bureau of Alcohol Tobacco Firearms and Explosives governing the importation of items on the U.S. Munitions Import List. Pursuant to these regulations, we are responsible for determining the proper licensing jurisdiction and export classification of our circuit designs, and obtaining all necessary licenses or other approvals, if required, for exports and imports of technical data, and software, or for the provision of technical assistance or other defense services to or on behalf of foreign persons. We are also required to obtain export licenses, if required, before employing or otherwise utilizing foreign persons in the performance of our contracts if the foreign person will have access to export- controlled technical data or software. The violation of any of the applicable laws and regulations could subject us to administrative, civil, and criminal penalties. These regulations could restrict our ability to license existing circuit designs and develop new designs. For example, as a result of ITAR requirements, we are unable to supply certain products to China satellite companies or end users, which comprise a significant part of the overall satellite market. Changes in our designs or changes in export and import regulations may create delays in the introduction of our designs in international markets, prevent our customers with international operations from deploying products incorporating our designs throughout their global systems or, in some cases, prevent the export or import of product including our designs to certain countries altogether. Any change in export or import regulations or related legislation, shift in approach to the enforcement or scope of existing regulations, or change in the countries, persons, or technologies targeted by such regulations, could result in decreased use of our designs by, or our ability to export or license our designs to, existing or potential customers with international operations and decreased revenue. Additionally, failure to comply with these laws could result in sanctions by the U.S. government, including substantial monetary penalties, denial of export privileges, and debarment from government contracts. If we fail to comply with anti-bribery laws, including the U.S. Foreign Corrupt Practices Act, or FCPA, we could be subject to civil and/or criminal penalties. As a result of our potential international operations, we may be subject to anti-bribery laws, including the FCPA, which prohibits companies from making improper payments to foreign officials for the purpose of obtaining or keeping business. If we fail to comply with these laws, the U.S. Department of Justice, the Securities and Exchange Commission, or SEC, or other U.S. or foreign governmental authorities could seek civil and/or criminal sanctions, including monetary fines and penalties against us or our employees, as well as additional changes to our business practices and compliance programs, which could have a material adverse effect on our business, results of operations, or financial condition. 27 Table of Contents ITEM 1B. UNRESOLVED STAFF COMMENTS None. ITEM 2. PROPERTIES We maintain our principal office, totaling approximately 5,500 square feet of office and laboratory space, in Santa Barbara, California under a lease that expires in July 2017 and provides us with an option for an additional three years. We lease an additional 1,800 square feet of office space in Burlingame, California under a lease that expires in November 2015 and provides us with an option for an additional two years. This facility is a satellite office and is used by several members of our technical team resident in the San Francisco Bay additional two years. This facility is a satellite office and is used by several members of our technical team resident in the San Francisco Bay area. We believe our current facilities will be adequate through the second quarter of 2015. We believe that suitable additional space will be available to accommodate our planned growth. ITEM 3. LEGAL PROCEEDINGS On March 17, 2015, a putative class action lawsuit was commenced against the Company, Terry Lingren and John Philpott, in the United States District Court for the Central District of California, captioned John Paggos v. Resonant Inc., et al., No. 2:15-cv-01970-SJO- VBK. The plaintiff alleges that the Company and the individual defendants violated Section 10(b) of the Securities Exchange Act of 1934 (the “Exchange Act”), Rule 10b-5 promulgated thereunder and Section 20(a) of the Exchange Act. The plaintiff purports to be acting on behalf of a class consisting of purchasers or acquirers of the Company’s common stock between August 14, 2014 and February 26, 2015 (the “Paggos Class Period”). The plaintiff alleges that, as a result of the defendants’ allegedly false and/or misleading statements and/or omissions concerning our business, operations, prospects and performance, our common stock traded at artificially inflated prices throughout the Paggos Class Period. The plaintiff seeks compensatory damages and fees and costs, among other relief, but has not specified the amount of damages being sought in the action. On March 19, 2015, a putative class action lawsuit was commenced against the Company, Terry Lingren and John Philpott, in the United States District Court for the Central District of California, captioned John Devouassoux v. Resonant Inc., et al., No. 2:15-cv-02054- JFW-VBK. The plaintiff alleges that the Company and the individual defendants violated Section 10(b) of the Exchange Act, Rule 10b-5 promulgated thereunder and Section 20(a) of the Exchange Act. The plaintiff purports to be acting on behalf of a class consisting of purchasers or acquirers of the Company’s common stock between November 6, 2014 and February 26, 2015 (the “Devouassoux Class Period”). The plaintiff alleges that, as a result of the defendants’ allegedly false and/or misleading statements and/or omissions concerning our financial well-being and prospects, our common stock traded at artificially inflated prices throughout the Devouassoux Class Period. The plaintiff seeks compensatory damages and fees and costs, among other relief, but has not specified the amount of damages being sought in the action. We deny the material allegations of both the Paggos and Devouassoux actions and intends to defend vigorously both. We are not party to any other legal proceedings. We may, from time to time, be party to litigation and subject to claims incident to the ordinary course of business. As our growth continues, we may become party to an increasing number of litigation matters and claims. The outcome of litigation and claims cannot be predicted with certainty, and the resolution of any future matters could materially affect our future financial position, results of operations or cash flows. ITEM 4. MINE SAFETY DISCLOSURES Not applicable. 28 Table of Contents PART II ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES Market Information for Common Stock Our common stock has been listed on the NASDAQ Capital Market under the symbol ‘RESN” since May 29, 2014. Prior to that date, there was no public trading market for our common stock. The following table sets forth for the periods indicated the high and low sale prices per share of our common stock as reported on the NASDAQ Capital Market: Fiscal 2014 Second Quarter (from May 29, 2014) Third Quarter Fourth Quarter High Low $ $ $ 11.54 8.24 12.00 $ $ $ 7.25 6.02 4.93 On March 24, 2015, the last reported sale price of our common stock on the NASDAQ Capital Market was $8.63 per share. Holders of Record As of December 31, 2014, we had 107 holders of record of our common stock. The actual number of stockholders is greater than this number of record holders and includes stockholders who are beneficial owners but whose shares are held in street name by brokers and other nominees. Dividend Policy We have never declared or paid cash dividends on our common stock. We currently intend to retain all available funds and any future earnings for use in the operation of our business and do not anticipate paying any dividends on our common stock in the foreseeable future, if at all. Any future determination to declare dividends will be made at the discretion of our board of directors and will depend on our future, if at all. Any future determination to declare dividends will be made at the discretion of our board of directors and will depend on our financial condition, results of operations, capital requirements, general business conditions and other factors that our board of directors may deem relevant. Purchases of Equity Securities by the Issuer and Affiliated Purchasers None. Recent Sale of Unregistered Securities During the fourth quarter of 2014, we issued a warrant to purchase 6,000 shares of common stock to an investor relations consultant which vests monthly over twelve months. The warrant has an exercise price of $6.50 and expires on September 30, 2018. The consultant provided us with written representations confirming her status as an “accredited investor” under Regulation D and her intent to acquire the securities for her own account and not with a view to resale or distribution in violation of the Securities Act of 1933. We did not engage in general solicitation or advertising, and the securities issued in the transaction bear appropriate restrictive legends concerning the registration requirements of the Securities Act of 1933. We believe this transaction was exempt from the registration requirements of the Securities Act of 1933 based on Regulation D and Section 4(2) of the Securities Act of 1933. Use of Proceeds On June 3, 2014, we closed our initial public offering of 3,105,000 shares of our common stock, which included 405,000 shares of common stock sold upon the full exercise of the underwriter’s overallotment option. The offer and sale of all of the shares in the initial public offering were registered under the Securities Act pursuant to registration statements on Form S-1 (File Nos. 333-193552 and 333-196340), which were declared effective by the SEC on May 28, 2014. MDB Capital Group, LLC acted as the underwriter for the offering. The public offering price of the shares sold in the offering was $6.00 per share. The total gross proceeds from the offering to us were $18.6 million. After deducting underwriting discounts and commissions of $1.6 million and offering expenses payable by us of $0.8 million, we received approximately $16.2 million. There has been no material change in the planned use of proceeds from our initial public offering as described in our final prospectus filed with the SEC on May 29, 2014 pursuant to Rule 424(b) of the Securities Act. Table of Contents ITEM 6. SELECTED FINANCIAL DATA Not applicable. Table of Contents 29 30 ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS You should read the following discussion and analysis of our financial condition and results of operations in conjunction with the consolidated financial statements and the related notes to the consolidated financial statements included later in this Annual Report on Form 10-K. In addition to historical financial information, the following discussion contains forward-looking statements that reflect our plans, estimates, beliefs and expectations that involve risks and uncertainties. Our actual results and the timing of events could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in this Annual Report on Form 10-K, particularly in “Risk Factors” and “Special Note Regarding Forward-Looking Statements.” Overview Resonant is a late-stage development company creating innovative filter designs for radio frequency, or RF, front-ends for the mobile device industry. The RF front-end is the circuitry in a mobile device responsible for analog signal processing and is located between the device’s antenna and its digital baseband. We use a fundamentally new technology called Infinite Synthesized Networks®, or ISN®, to configure and connect resonators, the building blocks of RF filters. Filters are a critical component of the RF front-end used to select desired radio frequency signals and reject unwanted signals. We are using ISN to develop new classes of filter designs. We believe licensing our designs is the most direct and effective means of delivering our solutions to the market. Our target customers make part or all of the RF front-end. We intend to retain ownership of our designs, and we expect to be compensated through license fees and royalties based on sales of RF front-end modules that incorporate our designs. We do not intend to manufacture or sell any physical products or operate as a contract design company developing designs for a fee. We are currently developing our first design, a duplexer, for our first customer, a leading manufacturer of RF front-ends for mobile devices. Duplexers are two filters combined into a single component which simultaneously selects both transmit and receive signals. Our customer has an option to license our duplexer design at already agreed-upon royalty rates upon completion. We recently delivered a completed duplexer design to the customer for consideration. Our design does not meet all the We recently delivered a completed duplexer design to the customer for consideration. Our design does not meet all the specifications in the development agreement, however, we believe our design delivers competitive performance and is competing with other products. The customer is evaluating our design, and there is no assurance that it has acceptable performance and therefore will be used. Even if it has acceptable performance, there are a number of other considerations influencing the customer’s decision whether to use our design, many of which are beyond our control. There is no assurance that our design will be selected by the customer for use in its products. On March 9, 2015, we announced a development project with a second customer for the design of our next single-band RF filter. The goal of the project is to develop a new duplexer design for our customer to market to RF front-end manufacturers and mobile device OEMs. The design, which is estimated to take less than a year to develop, is intended to replace a BAW (bulk acoustic wave) filter with a less expensive SAW (surface acoustic wave) filter. The customer has not committed to use the resulting design and terms for a license have not been finalized. We were founded as Resonant LLC on May 29, 2012 (our inception date). We commenced business on July 6, 2012 with initial contributions from our founders and Superconductor Technologies Inc., or STI. The founders contributed $200,000 and agreed to work full-time without pay until we secured adequate funding. STI contributed a patent portfolio, software, equipment, temporary office space and an early version of the development agreement with our first customer. The founders loaned us an aggregate of $200,000 during the first quarter of 2013, and we issued a series of warrants to the founders in connection with these loans. We refer to the founder loans as Bridge Loans and the founder warrants as Bridge Loan Warrants. We repaid the Bridge Loans in the second quarter of 2013. We changed our form of ownership from a limited liability company to a corporation in an exchange transaction on June 17, 2013. The founders exchanged all of their units and warrants of Resonant LLC for common stock and warrants of Resonant Inc. STI exchanged all of its units of Resonant LLC for a $2.4 million subordinated convertible note of Resonant Inc., or Subordinated Convertible Note. The Subordinated Convertible Note was scheduled to mature on September 17, 2014, was interest free, was secured by all of our assets and was subordinated to our senior convertible notes. 31 Table of Contents We closed our first financing on June 17, 2013. We issued $7.0 million of senior convertible notes, or Senior Convertible Notes, in a private placement. The Senior Convertible Notes were scheduled to mature on September 17, 2014, bore interest at 6.0% per annum and were secured by all of our assets. We paid MDB Capital Group, LLC, or MDB, which served as placement agent, a commission of $700,000 and issued it warrants to purchase 208,763 shares of common stock, which we refer to as the Financing Warrant. We also issued MDB on June 17, 2013 warrants to purchase 222,222 shares of common stock for business consulting services, which we refer to as the Consulting Warrant. We closed our initial public offering, or IPO, on June 3, 2014. We sold 3,105,000 shares of common stock (which includes the exercise in full by the underwriter of its over-allotment option) at a price of $6.00 per share. We received aggregate net proceeds, after deducting underwriting discounts and commissions and estimated offering expenses, of $16.2 million. Our common stock commenced trading on the Nasdaq Capital Market under the symbol “RESN” on May 29, 2014, our IPO Date. The Securities and Exchange Commission declared effective a registration statement relating to these securities on May 28, 2014. MDB acted as the sole underwriter for our IPO. Simultaneous with the funding of the IPO, we issued the underwriter a 5-year warrant to purchase 310,500 shares of common stock at an exercise price of $7.50 per share. The warrant is not exercisable until November 24, 2014 (180-days from the date of the underwriting agreement). We refer to this warrant as the Underwriting Warrant. Our Senior Convertible Notes automatically converted into 2,087,667 shares of common stock effective upon the completion of the IPO. We paid in cash the accrued interest of $404,000. Similarly, our Subordinated Convertible Note automatically converted into 700,000 shares of common stock. There was no accrued interest on this note. The shares issued on conversion of the Senior Convertible Note were subject to a 180-day lockup that expired on November 24, 2014, and the shares issued on conversion of the Subordinated Convertible Note are subject to a 12-month lockup expiring May 28, 2015. We have earned no revenue since inception, and our operations have been funded with the initial capital contributions and debt. We have incurred accumulated losses totaling $21.2 million from inception through December 31, 2014. These losses are primarily the result of research and development costs associated with commercializing our technology, combined with start-up and financing costs. We expect to continue to incur substantial costs for commercialization of our technology on a continuous basis because our business model involves developing and licensing custom filter designs. Our consolidated financial statements contemplate the continuation of our business as a going concern. However, we are subject to the risks and uncertainties associated with a new business. We do not yet have the ability to earn revenue and have incurred significant losses from operations since inception. At December 31, 2013 and 2014, we had an Accumulated Deficit of $11.5 million and $21.2 million, respectively, and cash and cash equivalents of $3.3 million and $5.8 million, respectively. Additionally, as of December 31, 2014 we had $8.0 million in short-term investments. Plan of Operation We plan to commercialize our technology by creating filter designs that address the problems created by the growing number of frequency bands in the RF front-end of mobile devices. First, we plan to develop a series of single-band surface acoustic wave, or SAW, filter designs for frequency bands presently dominated by larger and more expensive bulk acoustic wave, or BAW, filters. Second, we plan filter designs for frequency bands presently dominated by larger and more expensive bulk acoustic wave, or BAW, filters. Second, we plan to develop tunable filter designs that replace multiple filters. In order to succeed, we must convince RF front-end suppliers that our filter designs can significantly reduce the size and cost of their products. We plan to pursue filter design projects with potential customers and other strategic partners. These types of arrangements may subsidize filter design costs, as well as offer complementary technology and market intelligence and other avenues to revenue. However, we intend to retain ownership of our technology, designs and related improvements. We expect to pursue development of multiple designs for multiple customers, and grant each customer a royalty-bearing license to a specific design with some limited period of exclusivity. 32 Table of Contents We are using the net proceeds from our IPO for product development to commercialize our technology, research and development, the development of our patent strategy and expansion of our patent portfolio, as well as for working capital and other general corporate purposes. Our anticipated costs include employee salaries and benefits, compensation paid to consultants, capital costs for research and other equipment, costs associated with development activities including travel and administration, legal expenses, sales and marketing costs, general and administrative expenses, and other costs associated with a late-stage, publicly-traded technology company. We anticipate significantly increasing the number of employees this year. However, this is highly dependent on the nature of our development efforts and our success in commercialization. We anticipate adding employees for research and development, as well as general and administrative functions, to support our efforts. We expect to incur consulting expenses related to technology development and other efforts as well as legal and related expenses to protect our intellectual property. The amounts that we actually spend for any specific purpose may vary significantly and will depend on a number of factors including, but not limited to, the pace of progress of our commercialization and development efforts, actual needs with respect to product testing, development and research, market conditions, and changes in or revisions to our marketing strategies. In addition, we may use a portion of any net proceeds to acquire complementary products, technologies or businesses; however, we do not have plans for any acquisitions at this time. We will have significant discretion in the use of any net proceeds. Investors will be relying on the judgment of our management regarding the application of the proceeds of any sale of our common stock. We cannot assure you that our technology will be accepted, that we will ever earn revenues sufficient to support our operations or that we will ever be profitable. We believe our current cash and investments of approximately $13.8 million will provide sufficient funding for planned operations into the first half of 2016. If we do not generate adequate cash from revenues in 2016 in order to reach positive cash flows, we likely will be required to obtain additional financing to continue with our plan of commercialization. Furthermore, since we have no committed source of financing, we cannot assure you that we will be able to raise money as and when we need it to continue our operations. If we cannot raise funds as and when we need them, we might be forced to make substantial reductions in our operating expenses, which could adversely affect our ability to implement our business plan and ultimately our viability as a company. Results of Operations The consolidated statements of operations presented in our consolidated financial statements represent the activities of (a) Resonant LLC, as predecessor company, for the period from January 1, 2013 to June 16, 2013, and (b) Resonant Inc., as successor company, for the period from June 17, 2013 to December 31, 2013 and the year ended December 31, 2014. Consequently, the fiscal year 2013 period combines the statements of operations of Resonant LLC and of Resonant Inc. as shown in the following table: 33 Table of Contents Revenue Operating Expenses: Research and development expenses General and administrative expenses Depreciation and amortization Total operating expenses Operating loss Other income (expense): Interest income (expense), net Fair value adjustments to warrant and derivative liabilities Bridge warrant expense Other income (expense) Total other income (expense) Loss before income taxes Provision for income taxes Net loss $ Resonant LLC Period From January 1, 2013 to June 16, 2013 Resonant Inc. Period From June 17, 2013 to December 31, 2013 Total Fiscal Year 2013 Period $ — $ — $ — 195,403 135,993 4,905 336,301 (336,301) (199,961) — (247,669) — (447,630) (783,931) (800) (784,731) $ 926,095 1,485,313 14,424 2,425,832 (2,425,832) (1,355,425) (4,520,736) (312,486) (333) (6,188,980) (8,614,812) (1,256) (8,616,068) $ 1,121,498 1,621,306 19,329 2,762,133 (2,762,133) (1,555,386) (4,520,736) (560,155) (333) (6,636,610) (9,398,743) (2,056) (9,400,799) Comparison of the Years Ended December 31, 2013 and 2014 Research and Development. Research and development expenses increased from $1.1 million in the year ended December 31, 2013, or 2013, to $2.9 million in the year ended December 31, 2014, or 2014. The increase of $1.8 million is the result of the increased payroll, benefit costs, stock compensation expenses, consulting costs and development costs related to increased activity on our duplexer design under development. There were no employees until late June 2013 when we completed the Senior Convertible Note financing and we have expanded our research and development employees to 13 as of the end of December 31, 2014. General and Administrative Expenses. General and administrative expenses increased from $1.6 million in 2013 to $2.9 million in 2014. The increase of $1.3 million consists primarily of payroll and related expenses associated with increased staffing following our June 2013 financing and our June 2014 IPO. The 2013 period consisted primarily of a non-cash charge of $716,000 for the fair value of the warrants issued for business consulting services. The consulting services were completed in 2013, and therefore we did not incur similar charges in 2014. Excluding the effect of the warrant charges from 2013, general and administrative expenses for 2014 increased by $2.0 million. The increase was due primarily to increased payroll, benefit costs, D&O insurance, finance costs, stock compensation and accounting expenses. We anticipate that our general and administrative expenses will continue to increase as a result of planned growth and the costs associated with operating as a public company. Depreciation and Amortization Expense. Depreciation and amortization expense increased by $201,000 from $19,000 in 2013 to $220,000 in 2014 primarily as a result of our increases in fixed assets associated with our new corporate headquarters and increase in employees in 2014 and our investment in patents. Interest Income. Interest income increased by $28,000 from $1,000 in 2013 to $29,000 in 2014 primarily due to the increased cash balances from the net proceeds from the IPO. We expect interest income to increase modestly in 2015 as we earn interest on our increased cash balances. Interest Expense. Interest expense increased by $1.2 million, from $1.6 million in 2013 to $2.8 million in 2014. The increase consists primarily of amortization and write-off of debt discounts and deferred financing costs due to the conversion of the convertible notes: $1.5 million for the Senior Convertible Notes, $151,000 for the Subordinated Convertible Note and $745,000 for the deferred financing costs. We also incurred and paid $404,000 of interest on the Senior Convertible Notes for 2014. We repaid the Bridge Loans in June 2013. The Senior Convertible Notes and the Subordinated Convertible Note were converted into common stock in June 2014 in connection with our IPO. Debt discounts and deferred financing cost amortizations ceased upon conversion of these notes. 34 Table of Contents Fair Value Adjustments to Warrant and Derivative Liabilities. We recorded all of our warrant and derivative liabilities at their fair value at issuance and adjusted the liabilities quarterly to reflect changes in their fair value. Periodic adjustments to the fair value of these liabilities generated non-cash expense if they increased and non-cash income if they decreased. The fair value of these liabilities may have fluctuated significantly from quarter to quarter until the IPO Date. There was an increase of the fair value of the warrant and derivative liabilities as of December 31, 2013 resulting in non-cash cost of $4.5 million for 2013. For 2014, the net fair value of all these liabilities increased resulting in non-cash expense of $2.0 million for 2014. The increase in the fair value of these liabilities in 2014 is primarily due to our increasing share price and the related enterprise valuation. Due to the expiration of the redemption and put option features included in the Bridge Loan Warrants, Financing Warrant and Consulting Warrant as of the IPO Date and the conversion of the Senior Convertible Notes upon the IPO which terminated the derivative liability, there will be no further fair value adjustments of such warrants and derivative liabilities in the future. Warrant Expense. We incurred bridge warrant expense of $560,000 in 2013 and none in 2014. This represents the non-cash expense associated with the original issuance of the Bridge Loan Warrants in the first quarter of 2013 by Resonant LLC. We repaid the Bridge Loans in June 2013. Consequently, we did not incur any bridge warrant expense in 2014 and will not incur further expense for these warrants. Other Income. Other income consisted of a $1.2 million non-cash gain from the write-off of the derivative liability associated with our Senior Convertible Notes. Due to the conversion of these notes, the derivative liability balance was accounted for as an extinguishment of debt with a portion recognized as a gain and classified in other income for 2014. Consequently, we will not incur any further charges associated with fluctuations in the fair value of the derivative liability. Income Taxes. We have no revenues and are currently operating at a loss. Consequently, our only tax liabilities for both periods were for minimum taxes in the States where we conduct business. Liquidity and Capital Resources Financing Activities We have earned no revenue since inception. Our operations have been funded with capital contributions, debt and equity. We began operations in July 2012 with initial capital contributions from our founders and STI. The founders contributed $200,000 and agreed to work full-time without pay until we secured adequate funding. STI contributed a patent portfolio, software, equipment, temporary office space and an early version of our first development agreement. The founders received Class B units in Resonant LLC, but later exchanged their Class B units for common stock of Resonant Inc. STI received Class C units in Resonant LLC, but later exchanged its Class C units for the $2.4 million Subordinated Convertible Note of Resonant Inc. Class C units for the $2.4 million Subordinated Convertible Note of Resonant Inc. The Bridge Loans provided $200,000 of additional funding during the first and second quarters of 2013. We raised $6.3 million of net proceeds from the sale of Senior Convertible Notes in June 2013, and we used part of the proceeds to repay the Bridge Loans. In June 2014, we sold 3,105,000 shares of common stock in an IPO generating net proceeds of $16.2 million. We had current assets of $13.9 million and current liabilities of $720,000 at December 31, 2014, resulting in working capital of $13.2 million. This compares to a working capital deficit of $8.8 million at December 31, 2013. The change in working capital is primarily the result of the net proceeds from our IPO and the related conversion of all outstanding notes to common stock. Our principal sources of liquidity consist of existing cash balances and investments of $13.8 million. We believe our current resources will provide sufficient funding for planned operations into the first half of 2016. If we do not generate adequate cash from revenues in 2016 in order to reach positive cash flows, we likely will be required to obtain additional financing to continue with our plan of commercialization. There is no assurance that additional financing (public or private) will be available on acceptable terms or at all. If we issue additional equity securities to raise funds, the ownership percentage of our existing stockholders would be reduced. New investors may demand rights, preferences or privileges senior to those of existing holders of common stock. If we cannot raise any needed funds, we might be forced to make substantial reductions in our operating expenses, which could adversely affect our ability to implement our business plan and ultimately our viability as a company. 35 Table of Contents Our consolidated financial statements have been prepared assuming that we will continue as a going concern. The factors described above raise substantial doubt about our ability to continue as a going concern. These consolidated financial statements do not include any adjustments that might result from this uncertainty. Cash Flow Analysis The consolidated statements of cash flows presented in our consolidated financial statements represent the activities of (a) Resonant LLC, as predecessor company, for the period from January 1, 2013 to June 16, 2013, and (b) Resonant Inc., as successor company, for the period from June 17, 2013 to December 31, 2013 and the year ended December 31, 2014. Operating activities used cash of $162,000 for the period from January 1, 2013 to June 16, 2013, $1.9 million for the period from June 17, 2013 to December 31, 2013, and $4.6 million for the year ended December 31, 2014. The increase is primarily the result of increased expenses following our first financing in June 2013 and an increase in costs associated with being a public company. These cash uses were partially offset by non-cash related costs for stock-based compensation, fair value adjustments for the warrants and the derivative liability, amortization of deferred financing and debt discount costs. Investing activities used cash of $76,000 for the period from January 1, 2013 to June 16, 2013, $321,000 for the period from June 17, 2013 to December 31, 2013, and $9.1 million for the year ended December 31, 2014. The increase of $8.7 million in 2014 consisted primarily of an $8.0 million investment of excess cash balances in a short-term debt instrument, the build-out of our new corporate headquarters, the purchase of equipment and computers due to the increase in employees in 2014 and our investment in patents. Financing activities provide cash of $201,000 for the period from January 1, 2013 to June 16, 2013, $5.5 million for the period from June 17, 2013 to December 31, 2013, and $16.2 million for the year ended December 31, 2014. The 2013 figures are primarily the result of the net proceeds from the issuance of the Senior Convertible Notes in June 2013. For 2014, cash provided by financing activities was primarily the result of the proceeds from our IPO of $18.6 million offset by $2.4 million in cash expended for IPO costs in 2014. Off-Balance Sheet Transactions We do not have any off-balance sheet arrangements. Contractual Obligations and Known Future Cash Requirements Indemnification Agreements In the ordinary course of business, we may enter into agreements of varying scope and terms pursuant to which we agree to indemnify customers, vendors, lessors, business partners and other parties with respect to certain matters, including, but not limited to, losses arising out of breach of such agreements, services to be provided by us or from intellectual property infringement claims made by third parties. In addition, we have entered into indemnification agreements with directors and certain officers and employees that will require us, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers or employees. No demands have been made upon us to provide indemnification under such agreements and there are no claims that we are aware of that could have a material effect on our consolidated balance sheets, consolidated statements of operations, consolidated statements of stockholders’ equity (deficit) or consolidated statements of cash flows. Operating Leases We lease various office facilities, including our corporate headquarters in Santa Barbara, California and our office in Burlingame, California, under operating lease agreements that expire through July 2017. The terms of the lease agreements provide for rental payments on a graduated basis. We recognize rent expense on a straight-line basis over the lease periods. a graduated basis. We recognize rent expense on a straight-line basis over the lease periods. Commitments As of December 31, 2014, our principal commitments consisted of obligations under the operating leases for our offices. The following table summarizes our future minimum payments under these arrangements as of December 31, 2014: 36 Table of Contents Contractual Obligations Total Less Than 1 Year 1-3 Years 3-5 Years More Than 5 Years Payments Due by Period Operating lease commitments $ 411,000 $ 183,000 $ 228,000 None None Critical Accounting Policies and Estimates Our discussion and analysis of financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in conformity with accounting principles generally accepted in the United States of America. Certain accounting policies and estimates are particularly important to the understanding of our financial position and results of operations and require the application of significant judgment by our management or can be materially affected by changes from period to period in economic factors or conditions that are outside of our control. As a result, they are subject to an inherent degree of uncertainty. In applying these policies, our management uses their judgment to determine the appropriate assumptions to be used in the determination of certain estimates. Those estimates are based on our historical operations, our future business plans and projected financial results, the terms of existing contracts, our observance of trends in the industry, information provided by our customers and information available from other outside sources, as appropriate. While our significant accounting policies are described in the notes to our consolidated financial statements appearing elsewhere in this Annual Report on Form 10-K, we believe that the following critical accounting policies are most important to understanding and evaluating our reported financial results. Investments—Securities held-to-maturity: Management determines the appropriate classification of debt securities at the time of purchase and reevaluates such designation as of each statement of financial position date. Debt securities are classified as held-to-maturity when we have the positive intent and ability to hold the securities to maturity. Held-to-maturity securities are stated at amortized cost, adjusted for amortization of premiums and accretion of discounts to maturity computed under the effective interest method. Such amortization is included in investment income. Interest on securities classified as held-to-maturity is included in investment income. With respect to debt securities, when the fair value of a debt security classified as held-to-maturity or available for sale is less than its amortized cost, management assesses whether or not: (i) it has the intent to sell the security or (ii) it is more likely than not that the Company will be required to sell the security before its anticipated recovery. If either of these conditions is met, the Company must recognize as other-than-temporary impairment through earnings for the difference between the debt security’s amortized cost basis and its fair value, and such amount is included in net securities gains (losses). For debt securities that do not meet the above criteria and the Company does not expect to recover a security’s amortized cost basis, the security is considered other-than-temporarily impaired. For these debt securities, the Company separates the total impairment into the credit loss component and the amount of the loss related to other factors. In order to determine the amount of the credit loss for a debt security, the Company calculates the recovery value by performing a discounted cash flow analysis based on the current cash flows and future cash flows management expects to recover. The discount rate is the effective interest rate implicit in the underlying debt security. The amount of the total other-than-temporary impairment related to credit loss is recognized in earnings and is included in net securities gains (losses). The amount of the total other-than-temporary impairment related to other factors is recognized in other comprehensive income. For debt securities that have recognized as other-than-temporary impairment through earnings, if through subsequent evaluation there is a significant increase in the cash flow expected, the difference between the amortized cost basis and the cash flows expected to be collected is accreted as interest income. On July 8, 2014, we invested in a debt security that we have classified as held-to-maturity as we currently meet the criteria for this debt investment classification. As of December 31, 2014, the amortized cost value is $7,999,553 with an unrealized gain of $19,889 and a fair value of $7,999,778. The debt security matured on January 5, 2015 and is a foreign debt obligation. We have not recognized an other- than-temporary impairment gain or loss or a comprehensive gain or loss to-date. We have recorded investment income of $19,664 for the year ended December 31, 2014 associated with this debt security. There were no debt securities in 2013. Fair Value of Financial Instruments—We measure certain financial assets and liabilities at fair value based on the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. The carrying amounts of our financial instruments, including cash equivalents, accounts payable, and accrued liabilities, approximate fair value due to their short maturities. 37 Table of Contents The carrying amount of our warrant liabilities and our derivative liability related to the Senior Convertible Notes were marked to market each reporting date until the warrants and derivative liability were settled. Prior to the IPO Date, the fair value of the financing warrant market each reporting date until the warrants and derivative liability were settled. Prior to the IPO Date, the fair value of the financing warrant liability and derivative liability were estimated using a Monte Carlo option-pricing model, which takes into consideration the market values of comparable public companies, considering among other factors, the use of multiples of earnings, and adjusted to reflect the restrictions on the ability of our securities to trade in an active market. As of the IPO Date, the fair value of the remaining warrants and the financing warrant liability and derivative liability, were estimated using a Black-Scholes option valuation technique as it embodies all of the requisite assumptions (including trading volatility, remaining term to maturity, market price, strike price, and risk free rates) necessary to fair value these instruments. Estimates of expected term were based on the estimated time to expiration. The risk-free interest rate was based on the U.S. Treasury yield for a term consistent with the estimated expected term. We have never declared or paid any cash dividends and do not presently plan to pay cash dividends in the foreseeable future. Consequently, we use an expected dividend yield of zero. Our expected volatility was derived from the historical volatilities of several public companies in similar industries because we have limited information on the volatility of the price of our common stock because we have no trading history. When making the selections of our industry peer companies to be used in the volatility calculation, we consider operational area, size, business model, industry and the business of potential comparable companies. These historical volatilities are weighted based on certain qualitative factors and combined to produce a single volatility factor. All of the warrant liabilities and the derivative liability are valued using level 3 inputs. Prior to the IPO Date, the determination of the value of our common stock, and for purposes of establishing the value of the warrants and derivatives related to the bridge financing, the senior convertible notes, the subordinated convertible notes and the consulting warrants, management considered several factors and the probability of achieving each one of them. The significant factors were (1) securing adequate funding to complete the single-band commercial surface acoustic wave, or SAW, duplexer design under the terms of the development agreement with our first customer; (2) developing a working duplexer product that meets the specifications of our first customer; and (3) our first customer exercising its licensing option if the duplexer product met its specifications. The probabilities for achieving each of these factors changed during the periods from January 31, 2013 to June 16, 2013 and December 31, 2013. These probabilities were affected by our ability to hire technical personnel to develop the technology and design the product, establish a management team to develop a business plan, secure financing, execute the business plan, and interact with our first customer to achieve the milestones contained in the development agreement with our first customer. As we made progress in each of these areas over the period from January 31, 2013 through December 31, 2013 the probability elements in each of these factors changed and increased. These increases resulted in higher valuations of our common stock and accordingly the values of the warrants and derivatives at each of these periods. Following the IPO Date, we used the current market value of our common stock to assist in determining the value of the warrants and stock options using the Black-Scholes option valuation model. Deferred Finance Costs—Costs relating to our senior convertible note and subordinated convertible note financings were capitalized and amortized over the term of the related debt using the effective interest method. Due to the conversion of these notes to common stock in connection with the IPO, the unamortized deferred finance costs of $358,000 were fully expensed as of the IPO Date. Amortization of deferred financing costs, including the write-off due to the conversion, were charged to interest expense and totaled $51,000, and $745,000, respectively, for the period from June 17, 2013 to December 31, 2013 and for the twelve months ended December 31, 2014. There was no expense for the period January 1, 2013 to June 16, 2013. Research and Development—Costs and expenses that can be clearly identified as research and development are charged to expense as incurred in accordance with Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC, Topic 730- 10, Research and Development. Derivative Instruments—We account for free-standing derivative instruments and hybrid instruments that contain embedded derivative features in accordance with ASC Topic 815, Accounting for Derivative Instruments and Hedging Activities, or ASC 815, as well as related interpretations of this topic. In accordance with this topic, derivative instruments and hybrid instruments are recognized as either assets or liabilities in the balance sheet and are measured at fair values with gains or losses recognized in earnings. Embedded derivatives that are not clearly and closely related to the host contract are bifurcated and are recognized at fair value with changes in fair value recognized as either a gain or loss in earnings. We determine the fair value of derivative instruments and hybrid 38 Table of Contents instruments based on available market data using appropriate valuation models, giving consideration to all of the rights and obligations of each instrument. We estimate fair values of derivative instruments and hybrid instruments using various techniques (and combinations thereof) that are considered to be consistent with the objective of measuring fair values. In selecting the appropriate technique, we consider, among other factors, the nature of the instrument, the market risks that it embodies and the expected means of settlement. For less complex instruments, such as free-standing warrants, we generally use the Black-Scholes option valuation model, adjusted for the effect of dilution, because it embodies all of the requisite assumptions (including trading volatility, estimated terms, dilution and risk free rates) necessary to fair value these instruments. Estimating fair values of derivative financial instruments requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. Under ASC 815, increases in the trading price of our common stock and increases in fair value during a given financial quarter result in the application of non-cash derivative expense. Conversely, decreases in the trading price of our common stock and decreases in fair value during a given financial quarter would result in the application of non-cash derivative income. In situations where the Black-Scholes option valuation model is not deemed appropriate, we will use a Monte Carlo option-pricing model to determine the fair value of derivative instruments. Stock-Based Compensation—We account for stock options in accordance with ASC Topic 718, Compensation-Stock Compensation. For stock options issued to employees and directors we use an option pricing model for estimating fair value at the date of grant. We account for restricted stock units issued to employees at fair value, based on the market price of our stock on the date of grant, net of estimated forfeitures. Compensation expense is recognized for the portion of the award that is ultimately expected to vest over the period of estimated forfeitures. Compensation expense is recognized for the portion of the award that is ultimately expected to vest over the period during which the recipient renders the required services to the Company generally using the straight-line single option method. The fair value of non-employee restricted stock units awarded are remeasured as the awards vest, and the resulting increase in fair value, if any, is recognized as compensation expense in the period the related services are rendered. Income Taxes—We account for income taxes in accordance with ASC Topic 740, Income Taxes, or ASC 740, which requires the recognition of deferred tax assets and liabilities for the future consequences of events that have been recognized in our condensed consolidated financial statements or tax returns. The measurement of the deferred items is based on enacted tax laws. In the event the future consequences of differences between financial reporting bases and the tax bases of our assets and liabilities result in a deferred tax asset, ASC 740 requires an evaluation of the probability of being able to realize the future benefits indicated by such asset. A valuation allowance related to a deferred tax asset is recorded when it is more likely than not that some portion or the entire deferred tax asset will not be realized. As part of the process of preparing our consolidated financial statements, we are required to estimate our income tax expense in each of the jurisdictions in which we operate. We also assess temporary differences resulting from differing treatment of items for tax and accounting differences. We record a valuation allowance to reduce the deferred tax assets to the amount of future tax benefit that is more likely than not to be realized. For the period when we were organized as a limited liability company, we were treated as a partnership for federal and state income tax purposes under the entity classification domestic default rules. As of December 31, 2014, no liability for unrecognized tax benefits was required to be reported. We recognize interest and penalties related to income tax matters in income taxes, and there were none for the period January 1, 2013 to June 16, 2013 and the period from June 17, 2013 to December 31, 2013 and for year ended December 31, 2014, respectively. We have filed, or are in the process of filing, tax returns that are subject to audit by the respective tax authorities. Although the ultimate outcome would be unknown, we believe that any adjustments that may result from tax return audits are not likely to have a material, adverse effect on our consolidated results of operations, financial position or cash flows. Earnings Per Share, or EPS—EPS is computed in accordance with ASC Topic 260, Earnings per Share, and is calculated using the weighted average number of common shares outstanding during each period. Diluted EPS assumes the conversion, exercise or issuance of all potential common stock equivalents unless the effect is to reduce a loss or increase the income per share. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options (using the treasury stock method), the exercise and/or conversion of our convertible notes and warrants (using the if-converted method). Recently Issued and Adopted Accounting Pronouncements Development Stage Enterprise—Effective June 2014 the FASB issued amendment 2014-10 for ASC Topic 915, Development Stage Entities. The amendment has eliminated the reporting distinction for development stage entities. We have adopted this amendment effective with our June 30, 2014 reporting period. ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK Not applicable. Table of Contents 39 ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAL DATA Index to Consolidated Financial Statements Report of Independent Registered Public Accounting Firm Consolidated Balance Sheets of Resonant Inc. as of December 31, 2013 and December 2014 Consolidated Statements of Operations of Resonant LLC for the period from January 1, 2013 to June 16, 2013, and Resonant Inc. for the period from June 17, 2013 to December 31, 2013 and for the year ended December 31, 2014 Consolidated Statements of Stockholders’ Equity (Deficit) of Resonant LLC for the period from June 1, 2013 to June 16, 2013, and Resonant Inc. for the period from June 17, 2013 to December 31, 2013 and the year ended December 31, 2014 Consolidated Statements of Cash Flows of Resonant LLC for the period from January 1, 2013 to June 16, 2013, and Resonant Inc. for the period from June 17, 2013 to December 31, 2013, and the year ended December 31, 2014 Notes to Consolidated Financial Statements 40 Page 41 42 43 44 45 46 Table of Contents REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors and Stockholders of Resonant Inc. We have audited the accompanying consolidated balance sheets of Resonant Inc. (the ‘‘Company’’), as of December 31, 2013 and December 31, 2014, and the related consolidated statements of operations, stockholders’ equity (deficit) and cash flows of Resonant LLC for the period January 1, 2013 to June 16, 2013, and of Resonant Inc. for the period June 17, 2013 to December 31, 2013 and the year ended December 31, 2014. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audit. We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company was not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion. In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Resonant Inc. as of December 31, 2013 and 2014, and the results of operations and cash flows of Resonant LLC for the period January 1, 2013 to June 16, 2013, and Resonant Inc. for the period June 17, 2013 to December 31, 2013 and the year ended December 31, 2014, in conformity with accounting principles generally accepted in the United States of America. /s/ Squar, Milner, Peterson, Miranda & Williamson, LLP Los Angeles, California March 26, 2015 Table of Contents Item 1. Financial Statements 41 PART I: FINANCIAL INFORMATION RESONANT INC. Consolidated Balance Sheets ASSETS CURRENT ASSETS Cash and cash equivalents Prepaid expenses and other current assets Investment held-to-maturity Deferred finance costs TOTAL CURRENT ASSETS PROPERTY AND EQUIPMENT Fixed assets Less: Accumulated depreciation and amortization PROPERTY AND EQUIPMENT, NET NONCURRENT ASSETS Patents and domain names, net Other assets TOTAL NONCURRENT ASSETS TOTAL ASSETS LIABILITIES AND STOCKHOLDERS’S EQUITY (DEFICIT) CURRENT LIABILITIES Accounts payable Accrued expenses Accrued salaries and payroll related expenses Deferred rent, current portion Derivative liabilities Convertible notes TOTAL CURRENT LIABILITIES December 31, 2013 December 31, 2014 $ $ $ $ 3,338,979 182,930 — 745,039 4,266,948 5,802,593 105,815 7,999,553 — 13,907,961 231,120 (7,360) 223,760 379,703 11,782 391,485 1,248,509 (207,761) 1,040,748 500,010 14,656 514,666 4,882,193 $ 15,463,375 $ 91,974 163,375 13,504 3,876 5,056,502 7,740,843 13,070,074 222,893 145,785 314,889 36,204 — — 719,771 LONG-TERM LIABILITIES Warrants Deferred rent TOTAL LIABILITIES Commitments and contingencies (Note 9) STOCKHOLDERS’ EQUITY (DEFICIT) 3,276,084 — — 53,665 16,346,158 773,436 Common stock, $0.001 par value, 10,000,000 authorized and 999,999 outstanding as of December 31, 2013, and 47,000,000 authorized and 6,931,984 outstanding as of December 31, 2014 Preferred stock, $0.001 par value, none authorized or outstanding as of December 31, 2013, and 3,000,000 authorized and none outstanding as of December 31, 2014 Additional paid-in capital Accumulated deficit TOTAL STOCKHOLDERS EQUITY (DEFICIT) 1,000 6,931 — 1,000 (11,465,965) (11,463,965) — 35,880,183 (21,197,175) 14,689,939 TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) $ 4,882,193 $ 15,463,375 Table of Contents See Notes to Consolidated Financial Statements 42 RESONANT INC. Consolidated Statements of Operations REVENUES OPERATING EXPENSES Research and development expenses General and administrative expenses Depreciation and amortization TOTAL OPERATING EXPENSES OPERATING LOSS OTHER INCOME (EXPENSE) Interest and investment income Interest expense Fair value adjustments to warrant and derivative liabilities Bridge warrant expense Other income (expense) TOTAL OTHER INCOME (EXPENSE) LOSS BEFORE INCOME TAXES Provision for income taxes NET LOSS NET LOSS PER SHARE - BASIC AND DILUTED Resonant LLC Period from January 1, 2013 to June 16, 2013 Resonant Inc. Period from June 17, 2013 to December 31, 2013 Resonant Inc. for the Year Ended December 31, 2014 $ — $ — $ — 195,403 135,993 4,905 336,301 (336,301) — (199,961) — (247,669) — (447,630) 926,095 1,485,313 14,424 2,425,832 (2,425,832) 1,327 (1,356,752) (4,520,736) (312,486) (333) (6,188,980) (783,931) (800) (784,731) $ (8,614,812) (1,256) (8,616,068) — $ (8.62) $ $ $ $ 2,947,485 2,931,860 219,736 6,099,081 (6,099,081) 28,816 (2,807,862) (2,015,599) — 1,163,772 (3,630,873) (9,729,954) (1,256) (9,731,210) (2.16) Weighted average shares outstanding — basic and diluted — 999,999 4,510,242 See Notes to Consolidated Financial Statements 43 Table of Contents RESONANT INC. RESONANT INC. Consolidated Statements of Stockholders’ Equity (Deficit) of Resonant LLC for the Period from January 1, 2013 to June 16, 2013, and Resonant Inc. for the Period from June 17, 2013 to December 31, 2013 and the Year Ended December 31, 2014 Class B Member’s Capital Units Class C Member’s Capital Units Common Stock Shares Amount Additional Paid-in Capital Accumulated Deficit Total Stockholders’ Equity (Deficit) 500,000 $ — — — 500,000 — 300,000 $ 46,351 — 22,338 — — — — — (68,689) — — — 300,000 — $ — — — — — $ — — — — — $ — 1,000 — 1,000 — $ — — (716,042) (716,042) 46,351 22,338 1,000 (784,731) (715,042) — — (300,000) — — — — (2,133,855) (2,133,855) — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — 999,999 — — — — 1,000 — — (1,000) 1,000 — — — (8,616,068) — 1,000 (8,616,068) — 999,999 1,000 1,000 (11,465,965) (11,463,965) — 3,105,000 3,105 18,626,895 — 18,630,000 — — — — — (2,388,026) — 3,658,411 — 2,787,667 2,787 9,397,213 — — — 5,526,003 — 39,318 — — 39 — — 1,000 — 1,087,278 — — — — — — — — — — — — — (2,388,026) 3,658,411 9,400,000 5,526,003 39 1,000 1,087,278 — — (29,591) — — (9,731,210) (29,591) (9,731,210) Balance, December 31, 2012 Capital contributions Sale of warrants Net loss Balance, June 16, 2013 Exchange of Class C member’s units for subordinated note Exchange of Class B member’s units for subordinated note Sale of warrants Net loss Balance, December 31, 2013 Sale of common stock in our initial public offering Offering costs of our initial public offering Reclassification of warrant liabilities Conversion of convertible notes Write-off of derivative liability upon conversion of notes payable Vesting of restricted stock units Sale of warrants Stock-based compensation Tax withholding on net exercise of stock- based awards Net loss Balance, December 31, (500,000) — — — — — — — — — — — — — 2014 — $ — $ — 6,931,984 $ 6,931 $ 35,880,183 $ (21,197,175) $ 14,689,939 See Notes to Consolidated Financial Statements 44 Table of Contents RESONANT INC. Consolidated Statements of Cash Flows CASH FLOWS FROM OPERATING ACTIVITIES Net Loss Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization Resonant LLC Period from January 1, 2013 to June 16, 2013 Resonant Inc. Period from June 17, 2013 to December 31, 2013 Resonant Inc. for the Year Ended December 31, 2014 $ (784,731) $ (8,616,068) $ (9,731,210) 4,905 14,424 219,736 Depreciation and amortization Amortization of deferred finance costs Stock-based compensation Non-cash rent expense Non-cash investment income Bridge warrant expense Gain on extinguishment of derivative liability Fair value adjustments to warrant and derivative liabilities Changes in assets and liabilities: Prepaids and other current assets Other assets Accounts payable Accrued expenses Accrued compensation Other liabilities Net cash used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES Capital expenditures Expenditures for patents and domain names Purchase of investment held-to-maturity Net cash used in investing activities CASH FLOWS FROM FINANCING ACTIVITIES Payment of note payable Proceeds from bridge loan Payment of bridge loan Proceeds from issuance of convertible note Deferred financing cost Proceeds from sale of common stock from the IPO IPO costs Proceeds from issuance of warrants Payment of withholding tax on net exercise of stock-based awards Net cash provided by financing activities NET INCREASE (DECREASE) IN CASH CASH — Beginning of period CASH — End of period SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION Interest Taxes SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES Issuance of subordinated note in exchange for Class C units Charge to equity for difference in fair value of subordinate note Debt discount in conjunction with senior note Debt discount in conjunction with senior note Debt discount in conjunction with senior note-derivative Conversion of senior note Conversion of subordinated note Extinguishment of derivative liability Reclassification of warrant liabilities to additional paid-in capital Issuance of common stock in exchange for Class B units $ $ $ $ $ $ $ $ $ $ $ $ $ 4,905 200,000 — 22,338 — 247,669 — — (108,722) — 332,044 (75,489) — — (161,986) — (75,696) — (75,696) — 200,000 — — — — — 1,000 — 201,000 (36,682) 89,044 52,362 $ 14,424 1,351,085 715,794 — — 313,352 — 4,520,736 21,841 (11,782) (293,922) 105,394 11,201 3,876 (1,864,069) (231,120) (89,959) — (321,079) (100,000) — (200,000) 7,000,000 (1,154,235) — (75,000) 1,000 — 5,471,765 3,286,617 52,362 3,338,979 — $ — $ 6,442 800 $ $ $ — $ — $ — $ — $ — $ — $ — $ — $ — $ — $ 2,400,000 2,133,855 266,144 329,886 2,005,015 $ $ $ $ $ — $ — $ — $ — $ $ 1,000 219,736 2,404,196 1,087,278 — (19,664) — (1,163,772) 2,015,599 77,115 (2,874) 130,919 (17,590) 301,385 85,993 (4,612,889) (1,017,389) (139,642) (7,979,889) (9,136,920) — — — — — 18,630,000 (2,388,027) 1,000 (29,550) 16,213,423 2,463,614 3,338,979 5,802,593 413,754 800 — — — — — 7,000,000 2,400,000 5,526,003 3,658,413 — Table of Contents See Notes to Consolidated Financial Statements 45 RESONANT INC. Notes to Consolidated Financial Statements NOTE 1—ORGANIZATION AND DESCRIPTION OF BUSINESS Overview Resonant Inc. is a late-stage development company located in Santa Barbara, California. We are the successor of Resonant LLC, a limited liability company formed on May 29, 2012 (our inception date). We were incorporated on January 19, 2012 as a wholly-owned subsidiary of Superconductor Technologies Inc., or STI, and became an independent company on July 6, 2012. As a result of an exchange transaction that occurred on June 17, 2013, the units of membership interest issued by Resonant LLC were exchanged for shares of our common stock, resulting in a change in the form of ownership of our Company. The consolidated statements of operations presented in our common stock, resulting in a change in the form of ownership of our Company. The consolidated statements of operations presented in our consolidated financial statements represent the activities of Resonant LLC, as the predecessor company, for the periods from January 1, 2013 to June 16, 2013, and the activities of Resonant Inc., as the successor company, for the period from June 17, 2013 to December 31, 2013 and the year ended December 31, 2014. The consolidated balance sheets presented in the consolidated financial statements represent the activities of Resonant Inc., as the successor company, as of December 31, 2013 and December 31, 2014. We are creating innovative filter designs for radio frequency, or RF, front-ends for the mobile device industry. The RF front-end is the circuitry in a mobile device responsible for analog signal processing and is located between the device’s antenna and its digital baseband. We use a fundamentally new technology called Infinite Synthesized Networks®, or ISN®, to configure and connect resonators, the building blocks of RF filters. Filters are a critical component of the RF front-end used to select desired radio frequency signals and reject unwanted signals. We are using ISN to develop new classes of filter designs. We believe licensing our designs is the most direct and effective means of delivering our solutions to the market. Our target customers make part or all of the RF front-end. We intend to retain ownership of our designs, and we expect to be compensated through license fees and royalties based on sales of RF front-end modules that incorporate our designs. We do not intend to manufacture or sell any physical products or operate as a contract design company developing designs for a fee. We are currently developing our first design, a duplexer, for our first customer, a leading manufacturer of RF front-ends for mobile devices. Duplexers are two filters combined into a single component which simultaneously selects both the transmit and receive signals. Our customer has an option to license our duplexer design at already agreed-upon royalty rates upon completion. We recently delivered a completed duplexer design to the customer for consideration. Our design does not meet all the specifications in the development agreement; however we believe our design delivers competitive performance and is competing with other products. The customer is evaluating our design, and there is no assurance that it has acceptable performance and therefore will be used. Even if it has acceptable performance, there are a number of other considerations influencing the customer’s decision whether to use our design, many of which are beyond our control. There is no assurance that our design will be selected by the customer for use in its products. We were founded as Resonant LLC on May 29, 2012 (our inception date). We commenced business on July 6, 2012 with initial contributions from our founders and Superconductor Technologies Inc., or STI. The founders contributed $200,000 and agreed to work full-time without pay until we secured adequate funding. STI contributed a patent portfolio, software, equipment, temporary office space and an early version of the development agreement with our first customer. The founders loaned us an aggregate of $200,000 during the first quarter of 2013, and we issued a series of warrants to the founders in connection with these loans. We refer to the founder loans as Bridge Loans and the founder warrants as Bridge Loan Warrants. We repaid the Bridge Loans in the second quarter of 2013. We changed our form of ownership from a limited liability company to a corporation in an exchange transaction on June 17, 2013. The founders exchanged all of their units and warrants of Resonant LLC for common stock and warrants of Resonant Inc. STI exchanged all of its units of Resonant LLC for a $2.4 million subordinated convertible note of Resonant Inc., or Subordinated Convertible Note. The Subordinated Convertible Note was scheduled to mature on September 17, 2014, was interest free, was secured by all of our assets and was subordinated to our senior convertible notes. This note was converted into common stock in our initial public offering, or IPO. 46 Table of Contents We closed our first financing on June 17, 2013. We issued $7.0 million of Senior Convertible Notes in a private placement. The notes were to mature on September 17, 2014, bore interest at 6.0% per annum, were secured by all of our assets and would automatically convert into 2,087,667 shares of our common stock upon consummation of a qualified offering. Interest was payable in cash or shares of common stock. We paid a placement agent a commission of $700,000 and issued the agent warrants to purchase 208,763 shares of our common stock at an exercise price of $3.35 per share. We also issued the placement agent a warrant to purchase 222,222 shares of our common stock for business consulting services at an exercise price of $0.01 per share. These notes were converted into common stock in our IPO. Initial Public Offering We closed an initial public offering, or IPO, of 3,105,000 shares of common stock (which includes the exercise in full by the underwriter of its over-allotment option) at a price of $6.00 per share on June 3, 2014. We received aggregate net proceeds, after deducting underwriting discounts and commissions and estimated offering expenses, of approximately $16.2 million. Our common stock commenced trading on the Nasdaq Capital Market under the symbol “RESN” on May 29, 2014, or IPO Date. The Securities and Exchange Commission declared effective a registration statement relating to these securities on May 28, 2014. MDB Capital Group, LLC, or MDB, acted as the sole underwriter for our IPO. Simultaneous with the funding of the IPO, we issued the underwriter a 5-year warrant to purchase 310,500 shares of common stock at an exercise price of $7.50 per share, which we refer to as the Underwriting Warrant. The warrant was not exercisable until November 24, 2014 (180-days from the date of the underwriting agreement). Our Senior Convertible Notes automatically converted into 2,087,667 shares of common stock effective upon the completion of the IPO. We paid in cash the accrued interest of $403,667. Similarly, our Subordinated Convertible Note automatically converted into 700,000 shares of common stock. There was no accrued interest on this note. The shares issued on conversion of the Senior Convertible Notes were subject to a 180-day lockup which expired November 24, 2014, and the shares issued on conversion of the Subordinated Convertible Note are subject to a 12-month lockup expiring May 28, 2015. are subject to a 12-month lockup expiring May 28, 2015. Capital Resources and Liquidity We have earned no revenue since inception, and our operations have been funded with capital contributions and debt. We have incurred accumulated losses totaling $21.2 million through December 30, 2014. These losses are primarily the result of research and development costs associated with commercializing our technology, combined with start-up and financing costs. We expect to continue to incur substantial costs for commercialization of our technology on a continuous basis because our business model involves developing and licensing custom filter designs. Our consolidated financial statements contemplate the continuation of our business as a going concern. However, we are subject to the risks and uncertainties associated with a new business. We do not yet have the ability to earn revenue and have incurred significant losses from operations since inception. At December 31, 2013 and December 31, 2014, we had an accumulated deficit of $11.5 million and $21.2 million, respectively, and cash and cash equivalents of $3.3 million and $5.8 million, respectively. Additionally, as of December 31, 2014, we had $8.0 million in short-term investments. We completed an initial public offering in the second quarter of 2014 to raise additional capital. Our principal sources of liquidity consist of existing cash balances and investments of $13.8 million. We believe our current resources will provide sufficient funding for planned operations into the first half of 2016. If we do not generate adequate cash from revenues in 2016 in order to reach positive cash flows, we likely will be required to obtain additional financing to continue with our plan of commercialization. There is no assurance that additional financing (public or private) will be available on acceptable terms or at all. If we issue additional equity securities to raise funds, the ownership percentage of our existing stockholders would be reduced. New investors may demand rights, preferences or privileges senior to those of existing holders of common stock. If we cannot raise any needed funds, we might be forced to make substantial reductions in our operating expenses, which could adversely affect our ability to implement our business plan and ultimately our viability as a company. 47 Table of Contents NOTE 2—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Use of Estimates—The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States, or U.S. GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Significant estimates made in preparing these financial statements include (a) assumptions to calculate the fair values of financial instruments, derivative, warrants and equity instruments and other liabilities and the deferred tax asset valuation allowance and (b) the useful lives for depreciable and amortizable assets. Actual results could differ from those estimates. In the opinion of management, all adjustments, including normal recurring accruals considered necessary for a fair presentation, have been included. Reclassifications—Certain amounts in the consolidated statement of operations for the period from June 17, 2013 to December 31, 2013 have been reclassified to conform to the current year presentation. Investments—Securities held-to-maturity: Management determines the appropriate classification of debt securities at the time of purchase and reevaluates such designation as of each statement of financial position date. Debt securities are classified as held-to-maturity when we have the positive intent and ability to hold the securities to maturity. Held-to-maturity securities are stated at amortized cost, adjusted for amortization of premiums and accretion of discounts to maturity computed under the effective interest method. Such amortization is included in investment income. Interest on securities classified as held-to-maturity is included in investment income. With respect to debt securities, when the fair value of a debt security classified as held-to-maturity or available for sale is less than its amortized cost, management assesses whether or not: (i) we have the intent to sell the security or (ii) it is more likely than not that we will be required to sell the security before its anticipated recovery. If either of these conditions is met, we must recognize as other-than-temporary impairment through earnings for the difference between the debt security’s amortized cost basis and its fair value, and such amount is included in net securities gains (losses). For debt securities that do not meet the above criteria and are not expected to be recovered at the amortized cost basis, the security is considered other-than-temporarily impaired. For these debt securities, we separate the total impairment into the credit loss component and the amount of the loss related to other factors. In order to determine the amount of the credit loss for a debt security, we calculate the recovery value by performing a discounted cash flow analysis based on the current cash flows and future cash flows management expects to recover. The discount rate is the effective interest rate implicit in the underlying debt security. The amount of the total other-than-temporary impairment related to credit loss is recognized in earnings and is included in net securities gains (losses). The amount of the total other-than- temporary impairment related to other factors is recognized in other comprehensive income. For debt securities that have recognized as other- than-temporary impairment through earnings, if through subsequent evaluation there is a significant increase in the cash flow expected, the difference between the amortized cost basis and the cash flows expected to be collected is accreted as interest income. On July 8, 2014, we invested in a debt security that we have classified as held-to-maturity as we currently meet the criteria for this debt investment classification. As of December 31, 2014, the amortized cost value is $7,999,553 with an unrealized gain of $19,889 and a fair value of $7,999,778. The debt security matured on January 5, 2015 and is a foreign debt obligation. We have not recognized an other- than-temporary impairment gain or loss or a comprehensive gain or loss to-date. We have recorded investment income of $19,664 for the year ended December 31, 2014 associated with this debt security. There were no debt securities in 2013. Fair Value of Financial Instruments—We measure certain financial assets and liabilities at fair value based on the exchange price Fair Value of Financial Instruments—We measure certain financial assets and liabilities at fair value based on the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. The carrying amounts of our financial instruments, including cash equivalents, accounts payable, and accrued liabilities, approximate fair value due to their short maturities. 48 Table of Contents The carrying amount of our warrant liabilities and our derivative liability related to the Senior Convertible Notes were marked to market each reporting date until the warrants and derivative liability were settled. Prior to the IPO Date, the fair value of the financing warrant liability and derivative liability (see Note 5 and Note 6) were estimated using a Monte Carlo option-pricing model, which takes into consideration the market values of comparable public companies, considering among other factors, the use of multiples of earnings, and adjusted to reflect the restrictions on the ability of our securities to trade in an active market. As of the IPO Date, the fair value of the remaining warrants and the financing warrant liability and derivative liability, were estimated using a Black-Scholes option valuation technique as it embodies all of the requisite assumptions (including trading volatility, remaining term to maturity, market price, strike price, and risk free rates) necessary to fair value these instruments. Estimates of expected term were based on the estimated time to expiration. The risk-free interest rate was based on the U.S. Treasury yield for a term consistent with the estimated expected term. We have never declared or paid any cash dividends and do not presently plan to pay cash dividends in the foreseeable future. Consequently, we use an expected dividend yield of zero. Our expected volatility was derived from the historical volatilities of several public companies in similar industries because we have limited information on the volatility of the price of our common stock because we have no trading history. When making the selections of our industry peer companies to be used in the volatility calculation, we consider operational area, size, business model, industry and the business of potential comparable companies. These historical volatilities are weighted based on certain qualitative factors and combined to produce a single volatility factor. All of the warrant liabilities and the derivative liability are valued using level 3 inputs (see Note 10 for the range of assumptions used). Prior to the IPO Date, the determination of the value of our common stock, and for purposes of establishing the value of the warrants and derivatives related to the bridge financing, the senior convertible notes, the subordinated convertible notes and the consulting warrants, management considered several factors and the probability of achieving each one of them. The significant factors were (1) securing adequate funding to complete the single-band commercial surface acoustic wave, or SAW, duplexer design under the terms of the development agreement with our first customer; (2) developing a working duplexer product that meets the specifications of our first customer; and (3) our first customer exercising its licensing option if the duplexer product met its specifications. The probabilities for achieving each of these factors changed during the periods from January 31, 2013 to June 16, 2013 and December 31, 2013. These probabilities were affected by our ability to hire technical personnel to develop the technology and design the product, establish a management team to develop a business plan, secure financing, execute the business plan, and interact with our first customer to achieve the milestones contained in the development agreement with them. As we made progress in each of these areas over the period from January 31, 2013 through December 31, 2013 the probability elements in each of these factors changed and increased. These increases resulted in higher valuations of our common stock and accordingly the values of the warrants and derivatives at each of these periods. Following the IPO Date, we used the current market value of our common stock to assist in determining the value of the warrants and stock options using the Black- Scholes option valuation model. Operating Leases—We lease office space and research facilities under operating leases. Certain lease agreements contain free or escalating rent payment provisions. We recognize rent expense under such leases on a straight-line basis over the term of the lease. Lease renewal periods are considered on a lease-by-lease basis in determining the lease term. Cash and Cash Equivalents—We consider all liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. Concentration of Credit Risk—We maintain checking accounts at one financial institution. These accounts are insured by the Federal Deposit Insurance Corporation (FDIC) for up to $250,000 per account. Management believes we are not exposed to significant credit risk due to the financial position of the depository institution in which these deposits are held. Property and Equipment—Property and equipment consists of leasehold improvements associated with our new corporate office, software purchased during the normal course of business, computer equipment and office furniture and fixtures, all of which are recorded at cost. Depreciation and amortization is recorded using the straight-line method over the respective useful lives of the assets ranging from three to five years. Long-lived assets, including software are reviewed for impairment whenever events or circumstances indicate that the carrying amount of these assets may not be recoverable. 49 Table of Contents Intangible Assets Subject to Amortization—At December 31, 2013 and December 31, 2014, intangible assets subject to amortization include patents and a domain name purchased for use in operations. Intangible assets are reviewed for impairment whenever events or circumstances indicate that the carrying amount of these assets may not be recoverable. Deferred Finance Costs—Costs relating to our senior convertible note and subordinated convertible note financings were capitalized and amortized over the term of the related debt using the effective interest method. Due to the conversion of these notes to common stock in connection with the IPO, the unamortized deferred finance costs of $358,390 were fully expensed as of the IPO Date. Amortization of deferred financing costs, including the write-off due to the conversion, were charged to interest expense and totaled $51,102 and $745,039 for the period from June 17, 2013 to December 31, 2013 and for year ended December 31, 2014, respectively. There was no and $745,039 for the period from June 17, 2013 to December 31, 2013 and for year ended December 31, 2014, respectively. There was no expense for the period January 1, 2013 to June 16, 2013. Research and Development—Costs and expenses that can be clearly identified as research and development are charged to expense as incurred in accordance with Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC, Topic 730- 10, Research and Development. Stock-Based Compensation—We account for stock options in accordance with ASC Topic 718, Compensation-Stock Compensation, or ASC 718. For stock options issued to employees and directors we use an option pricing model for estimating fair value at the date of grant. We account for restricted stock units issued to employees at fair value, based on the market price of our stock on the date of grant, net of estimated forfeitures. Compensation expense is recognized for the portion of the award that is ultimately expected to vest over the period during which the recipient renders the required services to the Company generally using the straight-line single option method. The fair value of non-employee restricted stock units awarded are remeasured as the awards vest, and the resulting increase in fair value, if any, is recognized as compensation expense in the period the related services are rendered. Earnings Per Share, or EPS—EPS is computed in accordance with ASC Topic 260, Earnings per Share, and is calculated using the weighted average number of common shares outstanding during each period. Diluted EPS assumes the conversion, exercise or issuance of all potential common stock equivalents unless the effect is to reduce a loss or increase the income per share. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options (using the treasury stock method), the exercise and/or conversion of our convertible notes and warrants (using the if-converted method). The shares used to compute net loss per share represent the weighted-average common shares outstanding for the period June 17, 2013 to December 31, 2013 and for the year ended December 31, 2014. EPS is not presented for the period from January 1, 2013 to June 16, 2013 because we were a limited liability company. The following table presents the number of anti-dilutive shares excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods below: Common stock warrants Common stock options Convertible debt Total shares excluded from net loss per share attributable to common stockholders For the Period June 17, 2013 to December 31, 2013 680,984 — 2,787,667 3,468,651 For the Year ended December 31, 2014 1,039,484 491,200 — 1,530,684 Derivative Instruments—We account for free-standing derivative instruments and hybrid instruments that contain embedded derivative features in accordance with ASC Topic 815, Accounting for Derivative Instruments and Hedging Activities, or ASC 815, as well as related interpretations of this topic. In accordance with this topic, derivative instruments and hybrid instruments are recognized as either assets or liabilities in the balance sheet and are measured at fair values with gains or losses recognized in earnings. Embedded derivatives that are not clearly and closely related to the host contract are bifurcated and are recognized at fair value with changes in fair value recognized as either a gain or loss in earnings. We determine the fair value of derivative instruments and hybrid instruments based on available market data using appropriate valuation models, giving consideration to all of the rights and obligations of each instrument. 50 Table of Contents We estimate fair values of derivative instruments and hybrid instruments using various techniques (and combinations thereof) that are considered to be consistent with the objective of measuring fair values. In selecting the appropriate technique, we consider, among other factors, the nature of the instrument, the market risks that it embodies and the expected means of settlement. For less complex instruments, such as free-standing warrants, we generally use the Black-Scholes option valuation model, adjusted for the effect of dilution, because it embodies all of the requisite assumptions (including trading volatility, estimated terms, dilution and risk free rates) necessary to fair value these instruments. Estimating fair values of derivative financial instruments requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. Under ASC 815, increases in the trading price of our common stock and increases in fair value during a given financial quarter result in the application of non-cash derivative expense. Conversely, decreases in the trading price of our common stock and decreases in fair value during a given financial quarter would result in the application of non-cash derivative income. In situations where the Black-Scholes option valuation model is not deemed appropriate, we will use a Monte Carlo option-pricing model to determine the fair value of derivative instruments. Income Taxes—We account for income taxes in accordance with ASC Topic 740, Income Taxes, or ASC 740, which requires the recognition of deferred tax assets and liabilities for the future consequences of events that have been recognized in our condensed consolidated financial statements or tax returns. The measurement of the deferred items is based on enacted tax laws. In the event the future consequences of differences between financial reporting bases and the tax bases of our assets and liabilities result in a deferred tax asset, ASC 740 requires an evaluation of the probability of being able to realize the future benefits indicated by such asset. A valuation allowance related to a deferred tax asset is recorded when it is more likely than not that some portion or the entire deferred tax asset will not be realized. As part of the process of preparing our consolidated financial statements, we are required to estimate our income tax expense in each of the jurisdictions in which we operate. We also assess temporary differences resulting from differing treatment of items for tax and accounting differences. We record a valuation allowance to reduce the deferred tax assets to the amount of future tax benefit that is more likely than not to be realized. For the period when we were organized as a limited liability company, we were treated as a partnership for federal and state to be realized. For the period when we were organized as a limited liability company, we were treated as a partnership for federal and state income tax purposes under the entity classification domestic default rules. As of December 31, 2013 and December 31, 2014, no liability for unrecognized tax benefits was required to be reported. We recognize interest and penalties related to income tax matters in income taxes, and there were none for the period January 1, 2013 to June 16, 2013 and the period from June 17, 2013 to December 31, 2013 and for year ended December 31, 2014, respectively. We have filed, or are in the process of filing, tax returns that are subject to audit by the respective tax authorities. Although the ultimate outcome would be unknown, we believe that any adjustments that may result from tax return audits are not likely to have a material, adverse effect on our consolidated results of operations, financial position or cash flows. Recent Accounting Pronouncements Development Stage Enterprise—Effective June 2014 the FASB issued amendment 2014-10 for ASC Topic 915, Development Stage Entities. The amendment has eliminated the reporting distinction for development stage entities. We have adopted this amendment effective with our June 30, 2014 reporting period. NOTE 3—PATENTS AND DOMAIN NAME We acquired patents from STI as a result of an asset contribution, and recorded them at their carryover basis. In June 2013, when STI exchanged its membership interest in Resonant LLC for a subordinated convertible note, the only assets of Resonant LLC other than cash were patents. The fair value of the patents remained substantially the same as their carrying value at the exchange date. In addition, we acquired other patents and the domain name www.resonant.com through the normal course of business. Issued patents are amortized over their approximate useful life of 17 years, or 20 years in the case of new patents, once they are approved by their respective regulatory agency. For the patents acquired from STI, we are amortizing them over the remaining useful life of 2 to 14 years as of December 31, 2104. The domain name is amortized over the approximate useful life of 10 years. See the 51 Table of Contents table below for a summary of patents (issued and pending) and domain name costs capitalized and amortized at December 31, 2013 and December 31, 2014: Balance at December 31, 2012 Amortization Legal fees for pending patents Purchase of domain name Balance at December 31, 2013 Amortization Legal fees for pending patents Balance at December 31, 2014 Total 226,018 (11,969) 143,949 21,705 379,703 (19,335) 139,642 500,010 $ $ Amortization expense for the patents issued and the domain name for each of the five fiscal years through December 31, 2019 and thereafter is estimated as follows: Years ending December 31, 2015 2016 2017 2018 2019 2020 and thereafter Total amortization expense $ $ 21,475 21,475 20,954 20,780 20,780 148,424 253,888 NOTE 4—PROPERTY AND EQUIPMENT, NET Property and equipment, net consists of the following: Cost: Computers, peripheral and scientific equipment Software Leasehold Improvements Office furniture and equipment Construction-in-process Less accumulated depreciation and amortization Property and equipment, net 2013 2014 $ $ 23,659 136,668 — 33,377 37,416 231,120 (7,360) 223,760 $ $ 144,652 463,821 283,014 174,953 182,069 1,248,509 (207,761) 1,040,748 There was no depreciation expense for the period from January 1, 2013 to June 16, 2013. Depreciation expense for the period from There was no depreciation expense for the period from January 1, 2013 to June 16, 2013. Depreciation expense for the period from June 17, 2013 to December 31, 2013 was $7,360, and for the year ended December 31, 2014 depreciation expense was $200,401. No property was disposed of in 2013 or 2014. NOTE 5—BRIDGE LOANS, MEMBER LOAN AND CONVERTIBLE DEBT Senior Convertible Note We entered into a securities purchase agreement on June 17, 2013 for the sale to multiple investors of $7.0 million in principal amount of senior secured convertible promissory notes, which we refer to as Senior Convertible Notes. MDB served as placement agent in this financing. We closed the sale on the same day and issued $7.0 million in principal amount of Senior Convertible Notes. We also paid $700,000 to MDB as a placement agent fee. The net cash proceeds were $6.3 million. We also issued to MDB a warrant to purchase shares of our common 52 Table of Contents stock as consideration for its financing services, and another warrant to purchase shares of our common stock as consideration for business consulting services. The Senior Convertible Notes bore interest at a 6% per annum and were scheduled to mature on September 17, 2014 unless earlier converted. The conversion feature included in the terms of the Senior Convertible Notes was determined to be a derivative liability that we bifurcated for accounting purposes. We measured the derivative liability at fair value at the issue date of Senior Convertible Notes based on a Monte Carlo option-pricing model and determined the value to be $1.9 million. The derivative liability was recorded with a corresponding debit to debt discount that was amortized as interest expense using the effective interest method over the life of the instrument. At the time of issuance, the Senior Convertible Notes and derivative liability were recorded on the balance sheet as a long-term note because the notes mature on September 17, 2014 (greater than one year). At December 31, 2013, these amounts are included in current liabilities. Upon a Qualified IPO, or other event that results in the conversion of the notes into common stock, a portion of the carrying value of the derivative liability would be accounted for as an extinguishment of debt and any remaining unamortized debt discount would be expensed at such date. At December 31, 2013, the Monte Carlo option-pricing model used the following assumptions to estimate fair value: equity value of $20.0 million, different conversion prices for different scenarios, time to maturity of 9-15 months under the scenarios based on the expected date of a Qualified IPO, volatility of 102.1% and risk free rate of 0.19%. As noted above, in connection with the Senior Convertible Notes and as a result of the warrants issued to MDB as consideration for its placement agent services, we determined that an additional discount to the debt should be recorded in the amount of $300,000, and we were amortizing this amount using the effective interest method over the life of the instrument. The Senior Convertible Notes did not include any financial covenants. Upon the completion of the IPO, which was considered a Qualified IPO under the Senior Convertible Note agreement, the Senior Convertible Notes were converted into 2,087,667 shares of common stock as of the date of the IPO and unpaid interest of $403,667 was paid from the proceeds of the IPO. Additionally, the unamortized debt discount of $780,147 was fully amortized to interest expense for the year ended December 31, 2014. Interest expense, excluding the unamortized debt discount write-off, was $379,362 for the period from June 17, 2013 to December 31, 2013 and was $727,601 for year ended December 31, 2014. There was no expense for the period from January 1, 2013 to June 16, 2013. Subordinated Convertible Note On June 17, 2013, we issued to STI a subordinated senior secured convertible note in the principal amount $2.4 million, which we refer to as the Subordinated Convertible Note, as consideration for our acquisition from STI of its 300,000 Class C units of Resonant LLC and 100 shares of our common stock. The Subordinate Convertible Note did not bear interest and was scheduled to mature on September 17, 2014 unless earlier converted. The Subordinated Convertible Note was non-interest bearing. We considered the effective interest rate of the Subordinated Convertible Note to be at least 11.8% per annum as the Subordinated Convertible Note was subordinated to the Senior Convertible Notes and had greater inherent risk, and, therefore, it should carry a higher interest rate than that of the Senior Convertible Notes. We calculated a discount to the face value of the Subordinated Convertible Note of $300,000, which we recorded as debt discount and were amortizing as interest expense over the life of the Subordinated Convertible Note using the effective interest rate method. The Subordinated Convertible Note did not include any financial covenants. Upon the completion of the IPO, which was considered a Qualified IPO under the Subordinated Convertible Note agreement, the Subordinated Convertible Note was converted into 700,000 shares of common stock as of the date of the IPO and there was no unpaid interest. Additionally, the unamortized debt discount of $60,917 was fully amortized to interest expense for the year ended December 31, 2014. Interest expense, excluding the unamortized debt discount write-off, was $61,509 for the period from June 17, 2013 to December 31, 2013 and was $90,489 for the year ended December 31, 2014. There was no expense for the period from January 1, 2013 to June 16, 2013. 53 Table of Contents NOTE 6—WARRANT LIABILITIES From time to time, we and Resonant LLC have issued warrants to purchase shares of common stock and units of membership interest, respectively. These warrants have been issued in connection with the financing transactions and consulting services. Our warrants are subject to standard anti-dilution provisions applicable to shares of our common stock. Bridge Warrants In connection with and as an inducement to make the bridge loans in January and March 2013, Resonant LLC issued to each of our three founders five-year warrants to purchase Class B units of Resonant LLC at an exercise price of $0.40 per unit, which we refer to as the Bridge Warrants. The Bridge Warrants were issued in two tranches, at the same time the bridge loan was funded, with each founder receiving warrants for 20,833 Class B units on each of January 31, 2013 (for a total of 62,499 Class B units) and March 19, 2013 (for a total of 62,499 Class B units). The founders paid an aggregate of $1,000 in cash for the Bridge Warrants. We estimated the initial fair value of the Bridge Warrants issued in January 2013 to be $200,000 using the Black-Scholes option valuation model and the following assumptions: exercise price of $0.40 per unit; implied unit price of $3.75; expected volatility of 60%; expected dividend rate of 0%; risk free interest rate of 0.88%; and expiration date of 5 years. We estimated the initial fair value of the Bridge Warrants issued in March 2013 to be $200,000 using the Black-Scholes option valuation model and the following assumptions: exercise price of $0.40 per unit; implied unit price of $3.60; expected volatility of 60%; expected dividend rate of 0%; risk free interest rate of 0.80%; and expiration date of 5 years. (See Note 2). On June 17, 2013, in connection with our acquisition of all of the outstanding membership interests of Resonant LLC in an exchange transaction, the founders exchanged their Bridge Warrants to purchase an aggregate of 124,998 Class B units of Resonant LLC for Bridge Warrants to purchase an aggregate of 249,999 shares of our common stock at an exercise price of $0.20 per share. All other terms of the Bridge Warrants remained the same. We revalued the Bridge Warrants on June 17, 2013 to $400,000 using the Black-Scholes option valuation model with the following assumptions: exercise price of $0.20 per share; implied stock price of $3.23; expected volatility of 60%; expected dividend rate of 0%; risk free interest rate of 1.06%; and expiration date of 5 years. At each reporting period up through the IPO Date, any changes to the fair value of the Bridge Warrants were recorded in the consolidated statements of operations. (See Note 10). Consulting Warrant, Financing Warrant and Underwriting Warrant Upon consummation of our Senior Convertible Note financing, (see Note 5), for business consulting services provided by MDB, we issued to MDB a seven-year warrant to purchase 222,222 shares of our common stock at an exercise price of $0.01 per share, which we refer to as the Consulting Warrant. The Consulting Warrant is exercisable six months after the completion of our initial public offering and prior to June 15, 2020. We estimated the initial fair value of the Consulting Warrant to be $700,000 using the Black-Scholes option valuation model with the following assumptions: exercise price of $0.01 per share; implied stock price of $3.23; expected volatility of 68.8%; expected dividend rate of 0%; risk free interest rate of 1.57%; and expiration date of 7 years. (See Note 2). In addition, for placement agent services provided by MDB in connection with our Senior Convertible Note financing, we issued to MDB a seven-year warrant to purchase shares of our common stock, which we refer to as the Financing Warrant. The Financing Warrant is exercisable six months after the completion of our IPO and prior to June 15, 2020. The Financing Warrant is exercisable for a number of shares of our common stock equal to $700,000 divided by the Financing Warrant’s exercise price. Prior to consummation of our Qualified IPO, the exercise price is equal to $6,000,000 divided by the Fully Diluted Shares. Upon consummation of our Qualified IPO, the exercise price is adjusted to be equal to the conversion price of our Senior Convertible Notes. As the value of the Financing Warrant depended on future price movements of our equity, we estimated the fair value of the Financing Warrant at December 31, 2013 to be $700,000 using a Monte Carlo option-pricing model with the following assumptions: equity value of $20 million, different conversion prices for different scenarios, time to maturity of 6.5 years, volatility of 65.3% and risk free rate of 2.28%. (See Note 2). 54 Table of Contents In connection with the closing of our IPO, we also issued a third warrant to MDB related to their role as the sole underwriter for our IPO, we refer to this as the Underwriting Warrant. We issued them a 5-year warrant to purchase 310,500 shares of common stock at an exercise price of $7.50 per share. The warrant was not exercisable until November 24, 2014 (180-days from the date of the underwriting agreement) and expires May 28, 2019. We estimated the fair value of the Underwriting Warrant at issuance date to be $901,185 using the Black-Scholes option valuation model with the following assumptions: market price of the stock of $6.00 per share, time to maturity of 5 years, volatility of 63.1%, zero expected dividend rate and risk free rate of 1.5%. (See Note 2). In August 2014 and October 2014, we entered into an agreement with our investor relations firm, or IR Firm, and an IR consultant to provide us with investor relations services. Pursuant to the IR Firm agreement, in addition to monthly cash compensation of $8,500 per month, we issued to the IR Firm a 3-year consulting warrant, or IR Consulting Warrant, for the purchase of 42,000 shares of common stock. The IR Consulting Warrant has an exercise price of $8.31 and expires on July 17, 2017. We estimated the fair value of the IR Consulting Warrant at issuance date to be $119,238 using the Black-Scholes option valuation model with the following assumptions: market price of the stock of $6.91 per share, time to maturity of 3 years, volatility of 69.7%, zero expected dividend rate and risk free rate of 0.88%. Pursuant to the IR consultant agreement, in addition to monthly cash compensation of $5,000 per month, we issued to the IR consultant a 4-year consulting warrant, or IR Warrant, for the purchase of 6,000 shares of common stock that vests monthly over twelve months. The IR Warrant has an exercise price of $6.50 and expires on September 30, 2018. We estimated the fair value of the IR Warrant over the three monthly periods of vesting to be $7,821 using the Black-Scholes option valuation model with the following assumptions: market prices of the stock of $6.00 - $11.62 per share, time to maturity of 4 years, volatility of ranges of 64.78% to 81.8%, zero expected dividend rate and risk free rate range of 0.95% to 1.1%. We recorded $57,502 of stock-based compensation related to the IR warrants during the year ended December 31, 2014 which was included in general and administration expense. A roll-forward of warrant activity from January 1, 2013 to December 31, 2013 is shown in the following table: Issued and Outstanding Warrants as of January 1, 2013 249,999 222,222 208,763 680,984 Warrants Issued Warrants Exercised/ Expired — — — — Issued and Outstanding Warrants as of December 31, 2013 249,999 222,222 208,763 680,984 — — — — Bridge Warrants Consulting Warrant Financing Warrant(1) A roll-forward of warrant activity from January 1, 2014 to December 31, 2014 is shown in the following table: Bridge Warrants Consulting Warrant Financing Warrant(1) Underwriting Warrant IR consulting warrants Issued and Outstanding Warrants as of January 1, 2014 249,999 222,222 208,763 — — 680,984 Warrants Issued Warrants Exercised/ Expired — — — 310,500 48,000 358,500 Issued and Outstanding Warrants as of December 31, 2014 249,999 222,222 208,763 310,500 48,000 1,039,484 — — — — — — (1) The number of shares of common stock underlying the Financing Warrant was determined using an exercise price of $3.35 per share, assuming the IPO price of our common stock in a Qualified IPO would be at least $5.59 per share. Upon completion of the IPO with a price of $6.00 per share, the number of shares was considered unchanged and final. 55 Table of Contents The fair value of the Bridge, Consulting, Financing and Underwriting warrant liabilities was $3.3 million at December 31, 2013. Due to the expiration of the redemption and put option features included in these warrants, the warrants are no longer included as liabilities after the IPO Date. During the period from June 17, 2013 to December 31, 2013 and the year ended December 31, 2014, we recorded a loss of $1.5 million and $382,327, respectively, for the change in fair value of the warrants. There was no expense for the period from January 1, 2013 to June 16, 2013. For periods prior to the IPO Date, we used the Monte-Carlo option pricing model which takes into consideration the historical volatilities of comparable public companies using data from Capital IQ and implied volatiles from Bloomberg considering the differences in size among the public companies and us, and the warrant’s time to expiration. Estimates of expected term were based on the estimated time to expiration. The risk-free interest rate was based on the U.S. Treasury yield for a term consistent with the estimated expected term. The Monte-Carlo model used daily steps, assuming 252 trading days per year, which was based on 52 weeks of 5 trading days less 8 holidays, a standard assumption in the industry. NOTE 7—STOCKHOLDERS’ EQUITY (DEFICIT) Upon the formation of Resonant LLC, STI contributed assets to Resonant LLC in exchange for 300,000 Class C units, which constituted a 37.5% ownership interest in Resonant LLC. Our three founders simultaneously contributed $200,000 ($66,667 each) to Resonant LLC in exchange for 500,000 Class B units (166,667 units each), or a 62.5% ownership interest in Resonant LLC. In connection with this investment, each founder retained the right, but not the obligation, to require Resonant LLC to repurchase all of the Class B units held by the founder only if: (i) the founder’s service agreement with Resonant LLC was terminated; (ii) Resonant LLC and the other members of Resonant LLC declined to exercise their right to purchase the founder’s Class B units following termination of his services agreement; and (iii) the founder desired to work for a third party that, among other activities, engaged in a competing business. Upon exercise by a founder of his put right, Resonant LLC was obligated to purchase the founder’s Class B units at a price equal to the founder’s capital account balance in Resonant LLC. As a result of the allocation of the losses to the Class B unit holders, their capital account balances became zero. The operating agreement provided that members did not have any voting rights except for those significant business matters expressly listed in the operating agreement, including the operating budget and hiring of key executives. The majority vote of each class of units was required for those matters. In addition, the Class B unit holders designated two managers and the Class C unit holder designated one manager. Although the managers ran the day- to-day business, all key business activities and decisions required the approval of a majority of the Class B unit holders and the Class C unit holder as noted above. Because STI was a member of Resonant LLC, with a 50% control factor, the value of the assets STI contributed to Resonant LLC was recorded at their carryover bases. Resonant LLC reserved 200,000 Class A units for issuance as equity compensation, but no Class A units were ever issued. Resonant Inc. was organized on January 14, 2012 by STI but had not conducted any operations through June 16, 2013. The common stock originally issued to STI on formation was surrendered and cancelled in the exchange transaction pursuant to which common stock originally issued to STI on formation was surrendered and cancelled in the exchange transaction pursuant to which Resonant LLC became our wholly-owned subsidiary. (See Note 1 and Note 6). NOTE 8— STOCK-BASED COMPENSATION 2014 Omnibus Incentive Plan In January 2014, our board of directors approved the 2014 Omnibus Incentive Plan and amended and restated the plan in March 2014. Our stockholders approved the Amended and Restated 2014 Omnibus Incentive Plan, or the 2014 Plan, in March 2014. Our 2014 Plan permits for the issuance of equity based instruments covering up to an initial total of 1,400,000 shares of common stock. 56 Table of Contents Option Valuation We have computed the fair value of options granted to employees and non-employees using the Black-Scholes option valuation model. The compensation costs of non-employee arrangements are subject to re-measurement at each reporting period over the vesting terms as earned. Option forfeitures are estimated at the time of valuation and reduce expense ratably over the vesting period. This estimate will be adjusted periodically based on the extent to which actual option forfeitures differ, or are expected to differ, from the previous estimate, when it is material. The expected term used for options issued to non-employees is the contractual life and the expected term used for options issued to employees is the estimated period of time that options granted are expected to be outstanding. We have estimated the expected life of our employee stock options using the “simplified” method, whereby, the expected life equals the arithmetic average of the vesting term and the original contractual term of the option due to our lack of sufficient historical data. Since our stock has not been publicly traded for a sufficiently long period of time, we are utilizing an expected volatility figure based on a review of the historical volatilities, over a period of time, equivalent to the expected life of the instrument being valued, of similarly positioned public companies within our industry. The risk- free interest rate was determined from the implied yields from U.S. Treasury zero-coupon bonds with a remaining term consistent with the expected term of the instrument being valued. Stock Options to Employees and Consultants During the year ended December 31, 2014, we granted incentive stock options for the purchase of 491,200 shares of our common stock to our employees and consultants. The options have an exercise price range of $5.79 per share to $8.06 per share with a term ranging from three years to ten years. The options vest over various periods, generally quarterly over sixteen quarters. The options had an aggregate grant date fair value of $2.0 million utilizing the Black-Scholes option valuation model. We estimated the fair value of stock options awarded during the year ended December 31, 2014 using the Black-Scholes option valuation model. The fair values of stock options granted for the year were estimated using the following assumptions: Stock Price Dividend Yield Expected Volatility Risk-free interest rate Expected Life Option Grants Awarded During the Year Ended December 31, 2014 $5.79 to $8.06 0% 56.6% - 82.2% 1.52% - 2.56% 4 to 7 years Stock-based compensation expense related to stock options for both employees and consultants was $697,211 for the year ended December 31, 2014 and there was no expense for the year ended December 31, 2013. As of December 31, 2014, the unamortized portion will be expensed over a weighted average period of 3.2 years. We are also required to estimate forfeitures at the time of grant, and revise those estimates in subsequent periods if actual forfeitures differ from our estimates. We use historical data to estimate pre-vesting option forfeitures and record stock-based compensation expense only for those awards that are expected to vest. To the extent that actual forfeitures differ from our estimates, the difference is recorded as a cumulative adjustment in the period the estimates were revised. For the year ended December 31, 2014, there was no forfeiture rate applied as there have not been any forfeitures since the grant of awards nor currently do we expect to incur any for those shares currently awarded. 57 Table of Contents Stock Option Award Activity There were no stock options issued in 2013. The following is a summary of our stock option activity during the year ended December 31, 2014: Weighted Average Weighted Average Weighted Average Remaining Total Grant Number of Options Average Exercise Price Average Grant Date Fair Value Remaining Life In Years Total Grant Date Fair Value Outstanding, January 1, 2014 — $ — $ Granted Exercised Forfeited Outstanding, December 31, 2014 491,200 — — 491,200 $ 6.29 — — 6.29 $ Exercisable, January 1, 2014 — $ — $ Vested Exercised Forfeited Exercisable, December 31, 2014 142,895 — — 142,895 $ 6.02 — — 6.02 $ — 4.14 — — 4.14 — 4.01 — — 4.01 — $ 9.42 — — 9.42 $ — 2,033,709 — — 2,033,709 — $ 9.41 — — 9.41 $ — 573,691 — — 573,691 The following table presents information related to stock options outstanding and exercisable at December 31, 2014: Options Outstanding Options Exercisable Exercise Price $5.79 - 6.00 6.49 – 6.97 7.20 – 8.06 Outstanding Number of Options 369,000 47,500 74,700 491,200 Weighted Average Remaining Life In Years 9.41 9.69 8.40 9.41 Exercisable Number of Options 139,250 2,813 832 142,895 As of December 31, 2014, there was $1,233,327 of unrecognized compensation expense related to unvested employee stock option agreements, which is expected to be recognized over a weighted-average period of approximately 3.2 years. Restricted Stock Units Activity We account for restricted stock units issued to employees at fair value, based on the market price of our stock on the date of grant, net of estimated forfeitures. The fair value of non-employee restricted stock units awarded are remeasured as the awards vest, and the resulting increase in fair value, if any, is recognized as expense in the period the related services are rendered. We recorded $332,563 of stock-based compensation related to the 174,500 restricted stock unit shares that were granted during the year ended December 31, 2014. Shares vested during the year ended December 31, 2014 were 43,233 shares of which 3,915 shares were surrendered by the employees for payment of payroll tax withholding liabilities. A summary of restricted stock unit activity for the years ended December 31, 2014 is as follows: Outstanding at January 1, 2014 Granted Vested Cancelled Outstanding at December 31, 2014 58 Number of Restricted Share Units Weighted-Average Grant-Date Fair Value — $ 174,500 (43,233) — 131,267 $ — 6.00 6.00 — 6.00 Table of Contents As of December 31, 2014, there was $604,321 of unrecognized compensation expense related to unvested employee restricted stock unit agreements which is expected to be recognized over a weighted-average period of approximately 1.6 years. For restricted stock unit awards subject to graded vesting, we recognize compensation cost on a straight-line basis over the service period for the entire award. Total equity-based compensation cost recorded in the consolidated statements of operations, which includes the value of stock options and restricted stock units issued to employees, directors and non-employees for services, is allocated as follows: Research and development Employees Non-employees General and administrative Employees and directors Non-employees For the year ended December 31, 2014 $ $ 320,114 71,528 413,733 224,399 1,029,774 NOTE 9—COMMITMENT AND CONTINGENCIES In October 2013, we signed a lease for new office space for our corporate headquarters, and moved into the new location in the first quarter of 2014. The lease had a term of 38 months and a rental cost of approximately $5,412 per month, increasing 3% annually after the first fourteen months. In addition, our share of building operating costs were estimated to be $2,101 per month. In April 2014, we amended the lease to add additional space which increased our rent to $8,286 per month beginning August 1, 2014 plus estimated monthly operating costs of $3,154 and extended the lease term through July, 2017. We have a renewal option for an additional 3 year term. The original lease included a tenant improvement allowance of $72,160 and the amended lease included an additional tenant improvement allowance of $38,320. The allowances were used to construct our office build-out and have been capitalized as leasehold improvements and construction- in-process as of December 31, 2014. The capitalized costs are being amortized over the amended lease term through July 2017. In November 2013, we signed a lease for our satellite development office in Burlingame, CA. The lease has a two-year term, and rental costs of approximately $4,169 per month. We have a renewal option to extend the lease for two additional years. Rent expense related to our facilities and equipment for the period January 1, 2013 to June 16, 2013 and the period June 17, 2013 to December 31, 2013 was $22,338 and $27,256, respectively, and was $128,322 for the year ended December 31, 2014. Future minimum rent payments are as follow: Years ending December 31, 2015 2016 2017 Total minimum rent payments $ $ 183,402 142,823 84,931 411,156 Legal Proceedings—As of December 31, 2014, we were not involved in, but may in the future be involved in, legal proceedings, claims and governmental investigations in the normal course of business. Legal fees and other costs associated with such actions are expensed as incurred. We assess, in conjunction with our legal counsel, the need to record a liability for litigation and contingencies. Litigation accruals are recorded when and if it is determined that a loss related matter is both probable and reasonably estimable. Material loss contingencies that are reasonably possible of occurrence, if any, are subject to disclosure. As of December 31, 2013 and December 31, 2014, there was no litigation or contingency with at least a reasonable possibility of a material loss. No losses have been recorded during the period from January 1, 2013 to June 16, 2013 and the period from June 17, 2013 to December 31, 2013 and the year ended December 31, 2014 with respect to litigation or loss contingencies. (See Note 14 for an update.) 59 Table of Contents NOTE 10—FAIR VALUE MEASUREMENTS AND DERIVATIVE INSTRUMENTS We measure our financial assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., exit price) in an orderly transaction between market participants at the measurement date. Additionally, we are required to provide disclosure and categorize assets and liabilities measured at fair value into one of three different levels depending on the assumptions (i.e., inputs) used in the valuation. Level 1 provides the most reliable measure of fair value while Level 3 generally requires significant management judgment. Financial assets and liabilities are classified in their entirety based on the lowest level of input significant to the fair value measurement. The fair value hierarchy is defined as follows: Level 1—Valuations are based on unadjusted quoted prices in active markets for identical assets or liabilities. Level 2—Valuations are based on quoted prices for similar assets or liabilities in active markets, or quoted prices in markets that are not active for which significant inputs are observable, either directly or indirectly. Level 3—Valuations are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. Inputs reflect management’s best estimate of what market participants would use in valuing the asset or liability at the measurement date. Our common stock purchase warrants issued in conjunction with debt and consulting services are detachable, or free standing, instruments. In addition, we have recorded a derivative liability associated with the conversion feature in our Senior Convertible Note. We estimate fair values of these warrants and derivative liabilities utilizing Level 3 inputs for all classes of warrants and derivative liabilities issued. Other than the Financing Warrant and Senior Convertible Note derivative liability, we use the Black-Scholes option valuation technique as it embodies all of the requisite assumptions (including trading volatility, remaining term to maturity, market price, strike price, and risk free rates) necessary to fair value these instruments. To determine the value of the Financing Warrant and Senior Convertible Note derivative liability, we used a Monte Carlo option-pricing model, which takes into consideration the market values of comparable public companies, considering among other factors, the use of multiples of earnings, and adjusted to reflect the restrictions on the ability of our shares to trade in an active market. We determined that as the Financing Warrant and debt conversion can only be exercised upon the probability of satisfying a performance condition such as a Qualifying IPO or Fundamental Transaction, as provided for in the applicable instrument, and thus a closed-form model such as the Black-Scholes option valuation model would not be appropriate. (See Note 6). The following assumptions were used in the Monte Carlo option-valuation model to determine the fair value of the Financing Warrant and Senior Convertible Note derivative liability during the period from June 17, 2013 to December 31, 2013: Warrant and Senior Convertible Note derivative liability during the period from June 17, 2013 to December 31, 2013: Financing Warrant Senior Convertible Note Derivative Liability Expected Life (Years) 6.5 - 7 0.75 - 1.75 Risk Free Rate 1.57% - 2.28% 0.19% - 0.24% Volatility 65.3% - 68.6% 81.0% - 102.1% Probability of a Capital Raise — 75% - 90% The following assumptions were used in the Black-Scholes option-pricing model to determine the fair value of the warrant liabilities: Assumptions: Risk-free interest rate Expected dividend yield Expected volatility Expected term (in years) Table of Contents December 31, 2013 IPO Date 0.8% - 2.45% 0% 60.0% - 65.6% 4.08 - 7.0 1.25% - 2.31% 0% 64.0% - 69.6% 3.58 – 5.95 60 We used a fair value per share of our common stock of $5.54 and $6.00 as of December 31, 2013 and the IPO Date, respectively, to determine the fair value of derivative and warrant liabilities. Liabilities measured at fair value on a recurring basis as of December 31, 2013 are as follows: Liabilities: Senior convertible note derivative Bridge loan warrants Consulting warrant Financing warrant Total Balance as of December 31, 2013 $ $ 5,056,502 1,338,071 1,228,616 709,397 8,332,586 $ $ Fair Value Measurements Using Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) — $ — — — — $ — $ — — — — $ 5,056,502 1,338,071 1,228,616 709,397 8,332,586 We estimated the fair value of our warrants and Senior Convertible Note derivative at the time of issuance and subsequently remeasured the fair value using the Black-Scholes option valuation model or Monte Carlo option-pricing model as discussed above, at each reporting date through the IPO Date, using the following inputs: the risk-free interest rates; the expected dividend rates; the remaining expected life of the warrants; and the expected volatility of the price of the underlying common stock. Under the Monte Carlo option-pricing model we estimated the fair value of the Senior Convertible Note derivative liability and Financing Warrant liability at the time of issuance and subsequent remeasurement dates considering the probability of achieving a milestone, the cost of capital, and the estimated time period the right would be outstanding. The estimates were based, in part, on subjective assumptions and could differ materially following the measurement date (see Note 6). Changes to these assumptions as well as our stock price on the reporting date could have had a significant impact on the fair value of the warrant liabilities until the IPO Date. As a result of the expiration of the redemption and put option features included in the Bridge Warrants, Consulting Warrant and Financing Warrant as of the IPO Date, under accounting rules, these warrant liabilities are no longer classified as liabilities. There are no warrant liabilities or other liabilities to be measured at fair value on a recurring basis as of December 31, 2014. The following table provides a reconciliation of all liabilities measured at fair value using Level 3 significant unobservable inputs: Balance at January 1, 2013 Issuance of warrant and derivative liabilities Change in fair value Balance at December 31, 2013 Issuance of warrant and derivative liabilities Change in fair value Write-off due to conversion and IPO Balance at December 31, 2014 Warrant Liabilities(1) Senior Convertible Note Derivative Liability(2) $ $ $ — $ 1,806,701 1,469,383 3,276,084 — 382,327 (3,658,411) $ — $ — 2,005,015 3,051,487 5,056,502 — 1,633,272 (6,689,774) — (1) The change in the fair value of the warrants was recorded as a reduction to other income in the consolidated statement of operations of $1.5 million and $382,327 for the period June 17, 2013 to December 31, 2013 and the year ended December 31, 2014, respectively. Due to the expiration of the redemption and put option features included in the Bridge Warrants, Consulting Warrant respectively. Due to the expiration of the redemption and put option features included in the Bridge Warrants, Consulting Warrant and Financing Warrant as of the IPO Date, these warrant liabilities were recorded as an increase of $3.7 million to additional paid-in capital in the consolidated balance sheet as of December 31, 2014. (2) The change in the fair value of the senior convertible note derivative liability was recorded as a reduction to other income (expense) in the consolidated statement of operations of $3.0 million for the period from June 17, 2013 to December 31, 2013. The extinguishment of the senior convertible note derivative liability was recorded as an increase of $5.5 million to additional paid-in capital and a gain of $1.6 million to other income in the consolidated statement of operations for the year ended December 31, 2014. 61 Table of Contents NOTE 11—INCOME TAXES On May 29, 2012, we adopted ASC 740. There was no cumulative effect recorded as a charge to retained earnings from the adoption of ASC 740-10 for uncertain tax positions. The income taxes by jurisdiction consist of the following for the period from January 1, 2013 to June 16, 2013, the period from June 17, 2013 to December 31, 2013 and for the year ended December 31, 2014: U.S. federal Current Deferred Total U.S. federal U.S. state and local Current Deferred Total U.S. state and local Total income taxes Resonant LLC From the period January 1, 2013 to June 16, 2013 Resonant Inc. From the period June 17, 2013 to December 31, 2013 Resonant Inc. For the Year ended December 31, 2014 $ $ — $ — — 800 — 800 800 $ — $ — — 1,256 — 1,256 1,256 $ — — — 1,256 — 1,256 1,256 Income taxes differ from the amounts computed by applying the U.S. federal income tax rate to pretax income (loss) before income taxes as a result of the following for the period from January 1, 2013 to June 16, 2013, the period from June 17, 2013 to December 31, 2013 and the year ended December 31, 2014: Expected income tax expense State income tax (benefit), net of federal benefit Valuation Allowance Permanent Differences: Change in Fair Market Value — Financing Warrant Expenses Other Interest Expenses — Disqualified Debt Research & Development Credit Adjustment to Deferred Taxes Change of tax stats Total provision for income taxes $ $ 62 Resonant LLC From the period January 1, 2013 to June 16, 2013 — $ Resonant Inc. From the period June 17, 2013 to December 31, 2013 (2,929,037) 557 2,693,235 431,771 1,437 25,074 (34,178) — (187,603) 1,256 $ Resonant Inc. For the Year ended December 31, 2014 $ $ (3,308,184) 829 2,868,159 129,992 146,715 514,466 (168,576) (182,145) — 1,256 800 — — — — — — — 800 Table of Contents For the period from January 1, 2013 to June 16, 2013, the period from June 17, 2013 to December 31, 2013 and the year ended December 31, 2014, income tax expense was $800, $1,256, and $1,256, respectively. Deferred income tax reflects the tax effects of temporary differences that gave rise to significant portions of our deferred tax assets and liabilities and consisted of the following as of December 31, 2013 and December 31, 2014: Resonant Inc. From the period June 17, 2013 to For the Year Deferred tax assets—current: Accrued Expenses Accrued Payroll Deferred Rent Less: Valuation Allowance Total current assets Deferred tax assets—long term: Fixed assets Intangibles Organization Cost Start-up Expenditures OID—Consulting Warrant Research & Development Credit Derivatives Net Operating loss Stock Compensation New Jobs Credit Less: Valuation Allowance Total long-term assets Total deferred tax assets Deferred tax liabilities—current: Total current liabilities Deferred tax liabilities—long term: Fixed Assets OID—Financing Warrant Total long-term liabilities Total deferred tax liabilities Net deferred tax assets 2013 to December 31, 2013 For the Year ended December 31, 2014 $ $ 64,220 — 1,543 (65,763) — 45,386 30,486 19,905 244,539 636,646 57,004 1,497,550 583,117 — — (3,104,539) 10,094 10,094 — — — (10,094) (10,094) (10,094) $ — $ 2,719 6,517 35,933 (45,169) — — 778,742 16,793 1,690,555 — 492,357 — 1,374,431 140,192 6,931 (4,474,825) 25,176 25,176 — — (25,176) — (25,176) — — We recorded a full valuation allowance against our net deferred tax assets at December 31, 2013 and December 31, 2014. In determining the need for a valuation allowance, we reviewed all available evidence pursuant to the requirements of FASB ASC 740. Based upon our assessment of all available evidence, we have concluded that it is more likely than not that the net deferred tax assets will not be realized. For the period from December 31, 2013 to December 31, 2014, the valuation allowance increased by $1,349,692. This net increase included a decrease in valuation allowance of $2,209,541 due to the reversal of the deferred tax asset associated with Derivatives, which were recorded to additional paid-in capital during the year. For operations through June 17, 2013, we were treated as a partnership for federal and state income tax under the entity classification domestic default rules. Our losses passed through to the partners who receive the tax benefit. As of December 31, 2014, we had federal net operating loss carryforwards of approximately $3.5 million and state net operating loss carryforwards of approximately $3.5 million. The federal net operating loss carryforwards will begin to expire in 2033, and the state net operating loss carryforwards will begin to expire in 2033. Our ability to utilize net operating loss carryforwards may be limited in the event that a change in ownership, as defined in Section 382 of the Internal Revenue Code, occurs in the future. In the event a change of ownership occurs, it will limit the annual usage of the carryforwards in future years. Management believes that certain changes in control have occurred which resulted in limitations on our net operating loss carryforwards; however, management has determined that these limitations will not impact the ultimate utilization of the net operating loss carryforwards. 63 Table of Contents We recognize interest and penalties related to income tax matters in income taxes, and there were none during the period from June 17, 2013 to December 31, 2013 and for the year ended December 31, 2014. The adoption of ASC 740 guidance required us to identify, evaluate and measure all uncertain tax positions taken or to be taken on tax returns and to record liabilities for the amount of these positions that may not be sustained, or may only partially be sustained, upon examination by the relevant taxing authorities. Although we believe that our estimates and judgments were reasonable, actual results may differ from these estimates. Some or all of these judgments are subject to review by the taxing authorities. We have no significant uncertain tax positions for the period from June 17, 2013 to December 31, 2013 and for the year ended December 31, 2014. Our annual income taxes and the determination of the resulting deferred tax assets and liabilities involve a significant amount of judgment. Our judgments, assumptions and estimates relative to current income taxes take into account current tax laws, their interpretation of current tax laws and possible outcomes of future audits conducted by domestic tax authorities. We operate within federal and state taxing jurisdictions and are subject to audit in these jurisdictions. These audits can involve complex issues which may require an extended period of time to resolve. We are currently not being examined by any tax authorities. The following table sets forth the changes in the valuation allowance, for all periods presented: The following table sets forth the changes in the valuation allowance, for all periods presented: Balance at January 1, 2013 Additions Balance at December 31, 2013 Additions Balance at December 31, 2014 NOTE 12—RELATED PARTY TRANSACTIONS Valuation Allowance — 3,170,302 3,170,302 1,349,692 4,519,994 $ $ We rented office space from STI at a rate of $3,723 per month pursuant to a month-to-month lease from July 2013 to March 2014. In addition, we received free rent from STI as we used office space owned by STI from July 2012 to June 2013. We recorded the cost of the free rent as a capital contribution from STI, the holder of Class C units with a corresponding charge to rent expense. The amount of the free rent charged to expense was $22,338 for the period from January 1, 2013 to June 16, 2013. Total rent expense recorded for STI for the period from January 1, 2013 to June 16, 2013 and the period from June 17, 2013 to December 31, 2013 was $23,338 and $23,336, respectively and was $5,411 for the year ended December 31, 2014. We began paying rent to STI upon completion of our Secured Convertible Note financing. There were no other related party transactions in 2013 or 2014. NOTE 13—EMPLOYEE BENEFIT PLAN We have a 401(k) Savings Retirement Plan that covers substantially all full-time employees who meet the plan’s eligibility requirements and provides for an employee elective contribution. We did not make any matching contributions to the plan for the period from January 1, 2013 to June 16, 2013 and the period from June 17, 2013 to December 31, 2013 though we did contribute an additional $12,282 related to discrimination testing funding requirements. We recorded matching contributions to the plan of $104,936 for the year ended December 31, 2014. NOTE 14—SUBSEQUENT EVENTS In March 2015, two putative class action lawsuits were filed against the Company and certain of our members of the Board of Directors and executives, as described in Item 3-Legal Proceedings. Although the Company denies the material allegations of both lawsuits and intends to defend vigorously both, defending the lawsuits could result in substantial costs beyond our current insurance coverages. We have not recorded a reserve or expense for these lawsuits due to the early nature of the lawsuits. We evaluated subsequent events through March 26, 2015, the date of issuance of the consolidated financial statements for the year ended December 31, 2014. 64 Table of Contents ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE None. ITEM 9A. CONTROLS AND PROCEDURES Evaluation of Disclosure Controls and Procedures The phrase “disclosure controls and procedures” refers to controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934, as amended, or the Exchange Act, such as this Annual Report on Form 10-K, is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the U.S. Securities and Exchange Commission, or SEC. Disclosure controls and procedures are also designed to ensure that such information is accumulated and communicated to our management, including our chief executive officer, or CEO, and chief financial officer, or CFO, as appropriate to allow timely decision regarding required disclosure. Our management, with the participation of our CEO and CFO, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a- 15(e) and 15d- 15(e) under the Exchange Act), as of December 31, 2014, the end of the period covered by this Annual Report on Form 10-K. Based on such evaluation, our CEO and CFO have concluded that as of December 31, 2014, our disclosure controls and procedures were designed at a reasonable assurance level and were effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure. Management’s Report on Internal Control over Financial Reporting The Annual Report on Form 10-K does not include a report of management’s assessment regarding internal control over financial reporting or an attestation report of our independent registered public accounting firm due to a transition period established by the rules of the SEC for newly public companies. SEC for newly public companies. Changes in Internal Controls over Financial Reporting Other than the material weakness discussed below that was identified during the quarter ended September 30, 2014 and subsequently remediated during the quarter ended December 31, 2014, there was no change in our internal control over financial reporting identified in management’s evaluation pursuant to Rules 13a-15(d) or 15d-15(d) of the Exchange Act during the quarter ended December 31, 2014 that materially affected, or is reasonable likely to materially affect, our internal control over financial reporting. Remediation of a Material Weakness in Internal Control over Financial Reporting We recognize the importance of the control environment as it sets the overall tone for the organization and is the foundation for all other components of internal control. Consequently, we designed and implemented remediation measures to address the material weakness identified during the quarter ended September 30, 2014 and enhance our internal control over financial reporting. The material weakness related to our lack of sufficient policies and procedures in the review of complex financial instruments and a clerical error in the computation of loss per share. The material weakness resulted in restatements to our financial statements included in our previously filed Quarterly Report on Form 10-Q for the period ended June 30, 2014, and we filed an Amendment No. 1 to Quarterly Report on Form 10-Q/A on October 10, 2014 to amend and restate our unaudited condensed consolidated financial statements and related disclosures contained in the original filing. The following actions, which we believe have remediated the material weakness in internal control over financial reporting, were completed during the quarter ended December 31, 2014: 65 Table of Contents · Our finance team revised its policies and procedures with regards to the review of complex financial instruments to thoroughly analyze all terms and conditions of an agreement from a legal and accounting standpoint; and · We added an additional level of review of the analysis of the earnings per share calculation. We are committed to a strong internal control environment and will continue to review the effectiveness of our internal controls over financial reporting and other disclosure controls and procedures. As we continue to evaluate and work to improve our internal control over financial reporting, management may determine to take additional measures. Limitations on Effectiveness of Controls and Procedures In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs. ITEM 9B. OTHER INFORMATION None. 66 Table of Contents PART III ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE The information required by this item is incorporated by reference to the disclosure appearing under the headings “Proposal 1: Election of Directors,” “Executive Officers,” “Board of Directors and Corporate Governance” and “Other Matters” in our Proxy Statement for our 2015 Annual Meeting of Stockholders to be filed with the SEC within 120 days of the fiscal year ended December 31, 2014. ITEM 11. EXECUTIVE COMPENSATION The information required by this item is incorporated by reference to the disclosure appearing under the heading “Executive Compensation and Related Information” in our Proxy Statement for the 2015 Annual Meeting of Stockholders to be filed with the SEC within 120 days of the fiscal year ended December 31, 2014. Severance and Change in Control Agreements On March 23, 2015, we entered into severance and change in control agreements with our senior management, including Terry Lingren, John Philpott, Robert Hammond, Neal Fenzi, Daniel Christopher and Mike Eddy, which agreements provide these employees with severance benefits upon the employee’s termination of employment in certain circumstances with certain additional benefits following a change in control of the company. These benefits provide the participating employees with enhanced financial security and incentive to change in control of the company. These benefits provide the participating employees with enhanced financial security and incentive to remain with the company notwithstanding their at-will employment with us and the possibility of a change in control. Termination Without Change in Control If we terminate the participant’s employment with the company for a reason other than cause, the participant becoming disabled or the participant’s death, and the termination does not occur within twelve months immediately following a “change in control,” the participant will receive the following severance benefits: Accrued Compensation: The participant will receive all accrued but unpaid paid time off, expense reimbursements, wages, and other benefits due to the participant under any company-provided plans, policies, and arrangements. Severance Payment: The participant will receive a lump-sum severance payment in an amount equal to eighteen (18) months of the participant’s base salary as in effect immediately prior to the date of the participant’s termination of employment, less all required tax withholdings and other applicable deductions, payable as soon as practicable following the participant’s termination of employment. Pro-Rated Bonus Payment: The participant will receive as soon as practicable following termination of employment a lump-sum severance payment equal to one hundred percent (100%) of the participant’s full target bonus for the fiscal year in which the termination occurs, pro-rated for the portion of the fiscal year that the participant was employed by us. Continued Health Insurance Benefits: We will reimburse the participant for premiums for coverage of the participant and his or her eligible dependents pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”) (at the coverage levels in effect immediately prior to termination of employment) until the earliest to occur of (A) a period of twelve (12) months from the last date of employment with us, (B) the date upon which the participant becomes eligible for coverage under a health, dental, or vision insurance plan of a subsequent employer, and (C) the date the participant or his or her dependents cease to be eligible for COBRA coverage. Equity: All of the participant’s unvested and outstanding equity awards that would have become vested had the participant remained in our employ for the twelve (12)-month period following termination of employment shall immediately vest and become exercisable as of the date of termination, and the participant will have six (6) months following termination of employment in which to exercise any stock options, stock appreciation rights, or similar rights to acquire our common stock, but in no event will such equity award be permitted to be exercised beyond the original maximum term of such equity award. 67 Table of Contents Outplacement Benefits. If requested by the participant, we will pay the expense for outplacement benefits provided by a service to be determined by us for a period of six (6) months, up to a maximum dollar value of five thousand dollars ($5,000) per participant. Termination Following Change in Control If during the twelve-month period immediately following a change in control of the company, (x) we terminate the participant’s employment with us for a reason other than cause, the participant becoming disabled or the participant’s death, or (y) the participant resigns his employment for good reason, then the participant will receive the following benefits from us in lieu of the benefits described above under “Termination Without Change in Control”: Accrued Compensation: The participant will receive all accrued but unpaid paid time off, expense reimbursements, wages, and other benefits due to the participant under any company-provided plans, policies, and arrangements. Severance Payment: The participant will receive a lump sum severance in an amount equal to eighteen (18) months of the participant’s base salary as in effect immediately prior to the date of the participant’s termination of employment, less all required tax withholdings and other applicable deductions, paid as soon as practicable following the participant’s termination of employment. Target Bonus Payment: The participant will receive a lump sum severance payment equal to one hundred percent (100%) of the participant’s full target bonus for the fiscal year in effect at the date of such termination of employment (or, if greater, as in effect for the fiscal year in which the change in control occurs). Continued Health Insurance Benefits: We will reimburse the participant for premiums for coverage of the participant and his or her eligible dependents pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”) (at the coverage levels in effect immediately prior to termination of employment) until the earliest to occur of (A) a period of twelve (12) months from the last date of employment with us, (B) the date upon which the participant becomes eligible for coverage under a health, dental, or vision insurance plan of a subsequent employer, and (C) the date the participant or his or her dependents cease to be eligible for COBRA coverage. Equity: All of the participant’s unvested and outstanding equity awards shall immediately vest and become exercisable as of the date of termination, and the participant will have six (6) months following termination of employment in which to exercise any stock options, stock appreciation rights, or similar rights to acquire our common stock, but in no event will such equity award be permitted to be exercised beyond the original maximum term of such equity award. Outplacement Benefits. If requested by the participant, we will pay the expense for outplacement benefits provided by a service to be determined by us for a period of six (6) months, up to a maximum dollar value of five thousand dollars ($5,000) per participant. ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS The information required by this item is incorporated by reference to the disclosure appearing under the headings “Security Ownership of Certain Beneficial Owners and Management” and “Executive Compensation — Equity Compensation Plan Information” in our Proxy Statement for the 2015 Annual Meeting of Stockholders to be filed with the SEC within 120 days of the fiscal year ended December 31, 2014. ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE The information required by this item is incorporated by reference to the disclosure appearing under the heading “Related Party Transactions” and “Board of Directors and Corporate Governance — Director Independence” in our Proxy Statement for the 2015 Annual Meeting of Stockholders to be filed with the SEC within 120 days of the fiscal year ended December 31, 2014. 68 Table of Contents ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES The information required by this item is incorporated by reference to the disclosure appearing under the heading “Proposal 2 — Ratification of Appointment of Independent Registered Public Accounting Firm” in our Proxy Statement for the 2015 Annual Meeting of Stockholders to be filed with the SEC within 120 days of the fiscal year ended December 31, 2014. 69 Table of Contents PART IV ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES We have filed the following documents as part of this Annual Report on Form 10-K: 1. Consolidated Financial Statements Our consolidated financial statements are listed in the “Index to Consolidated Financial Statements” under Part II, Item 8 of this Annual Report on Form 10-K. 2. Financial Statement Schedules All schedules have been omitted because they are not required, not applicable, not present in amounts sufficient to require submission of the schedule, or the required information is otherwise included in our consolidated financial statements and related notes. 3. Exhibits See the Exhibit Index immediately following the signature pages of this Annual Report on Form 10-K. Table of Contents 70 SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: March 27, 2015 Resonant Inc. By: /s/ JOHN PHILPOTT JOHN PHILPOTT Chief Financial Officer (Principal Financial and Accounting Officer) POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Terry KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Terry Lingren and John Philpott, and each of them, as his true and lawful attorneys-in-fact and agents, with full power of substitution for him, and in his name in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, and any of them or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof. Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated. Signature Title /s/ Terry Lingren Terry Lingren /s/ Robert Hammond Robert Hammond /s/ Janet K. Cooper Janet K. Cooper /s/ Richard Kornfeld Richard Kornfeld /s/ John E. Major John E. Major Table of Contents Date March 27, 2015 Chief Executive Officer and Chairman of the Board of Directors (Principal Executive Officer) Chief Technology Officer and Director March 27, 2015 Director Director Director S-1 EXHIBIT INDEX March 27, 2015 March 27, 2015 March 27, 2015 Exhibit Number Exhibit Description Form Incorporated by Reference Exhibit File Number Filing Date Filed Herewith 3.1 3.2 4.1 4.2 10.1* 10.2 10.3* 10.4* 10.5* 10.6* Amended and Restated Certificate of Incorporation of the Registrant Amended and Restated Bylaws of the Registrant 8-K 001-36467 8-K 001-36467 Form of the Registrant’s common stock certificate S-1/A 333-193552 Form of Underwriter’s Warrant S-1/A 333-193552 S-1 333-193552 3.1 3.2 4.1 4.2 10.1 6-5-14 6-5-14 4-11-14 5-16-14 1-24-14 Form of Indemnification Agreement between the Registrant and each of its directors and officers Registrant’s amended and restated 2014 Omnibus Incentive Plan, including form agreements Offer Letter between the Registrant and Terry Lingren, dated June 17, 2013 Offer Letter between the Registrant and Robert Hammond, dated June 17, 2013 Offer Letter between the Registrant and Neal Fenzi, dated June 17, 2013 Offer Letter between the Registrant and Daniel Christopher, dated December 18, 2013 S-1/A 333-193552 10.2 4-11-14 S-1 333-193552 10.3 1-24-14 S-1 333-193552 10.4 1-24-14 S-1 333-193552 10.5 1-24-14 S-1 333-193552 10.6 1-24-14 10.7* Outside Director Compensation Policy 10.8 Exchange Agreement, dated June 17, 2013, by and among the Registrant, Resonant LLC, Terry S-1 S-1 333-193552 333-193552 10.7 10.8 1-24-14 1-24-14 and among the Registrant, Resonant LLC, Terry Lingren, Robert Hammond, Neal Fenzi and Superconductor Technologies Inc. 10.9 Subordinated Senior Secured Convertible Note, dated June 17, 2013, in the principal amount of $2.4 million, issued by the Registrant in favor of Superconductor Technologies Inc. S-1 333-193552 10.9 1-24-14 10.10 Security Agreement, dated June 17, S-1 333-193552 10.10 1-24-14 EX-1 Table of Contents Exhibit Number 10.11 10.12 10.13 10.14 10.15 10.16 10.17 10.18 10.19 Exhibit Description 2013, between Registrant and Superconductor Technologies Inc. Secured Subsidiary Guaranty, dated June 17, 2013, between Resonant LLC and Superconductor Technologies Inc. Security Agreement, dated June 17, 2013, between Resonant LLC and Superconductor Technologies Inc. Stockholders Agreement, dated June 17, 2013, by and among the Registrant, Terry Lingren, Robert Hammond, Neal Fenzi, Superconductor Technologies Inc. and MDB Capital Group LLC Securities Purchase Agreement, dated June 17, 2013, by and among the Registrant and the investors listed on the Schedule of Buyers attached thereto Amendment to Securities Purchase Agreement, dated September 14, 2013, by and among the Registrant and the Required Holders party thereto Amendment No. 2 to Securities Purchase Agreement, dated December 9, 2013, by and among the Registrant and the Required Holders party thereto Form of Senior Secured Convertible Note, dated June 17, 2013, issued by the Registrant in favor of convertible note investors Amendment to Securities Purchase Agreement and Senior Secured Convertible Notes, dated January 17, 2014, by and among the Registrant and the Required Holders party thereto Security Agreement, dated June 17, 2013, among the Registrant and the secured parties listed on the signature pages thereto Form Incorporated by Reference Exhibit File Number Filing Date Filed Herewith S-1 333-193552 10.11 1-24-14 S-1 333-193552 10.12 1-24-14 S-1 333-193552 10.13 1-24-14 S-1 333-193552 10.14 1-24-14 S-1 333-193552 10.15 1-24-14 S-1 333-193552 10.16 1-24-14 S-1 333-193552 10.17 1-24-14 S-1 333-193552 10.18 1-24-14 S-1 333-193552 10.19 1-24-14 EX-2 Table of Contents Exhibit Number 10.20 Exhibit Description Secured Subsidiary Guaranty, dated June 17, 2013, between Resonant LLC and Daniel Landry in his capacity as collateral agent for the Form S-1 Incorporated by Reference Exhibit 10.20 File Number 333-193552 Filing Date 1-24-14 Filed Herewith 10.21 10.22 10.23 10.24 10.25 10.26 10.27 10.28 Landry in his capacity as collateral agent for the Secured Parties Security Agreement, dated June 17, 2013, between Resonant LLC and Daniel Landry in his capacity as collateral agent for the Secured Parties Subordination Agreement, dated June 17, 2013, among the investors listed on the signature pages thereto and Superconductor Technologies Inc. Registration Rights Agreement for Investors, dated June 17, 2013, by and among the Registrant and the persons listed on Schedule A thereto Registration Rights Agreement for Warrants, dated June 17, 2013, by and among the Registrant and MDB Capital Group LLC Amended and Restated Warrant to Purchase Common Stock, dated November 15, 2013, issued by the Registrant in favor of MDB Capital Group LLC for 222,222 shares of common stock Amended and Restated Warrant to Purchase Common Stock, dated November 15, 2013, issued by the Registrant in favor of MDB Capital Group LLC for a to-be-determined number of shares of common stock Warrant to Purchase Common Stock (No. A-1), dated June 17, 2013, issued by the Registrant in favor of Terry Lingren for 41,666 shares of common stock Warrant to Purchase Common Stock (No. A-2), dated June 17, 2013, issued by the Registrant in favor of Robert Hammond for 41,666 shares of common stock S-1 333-193552 10.21 1-24-14 S-1 333-193552 10.22 1-24-14 S-1 333-193552 10.23 1-24-14 S-1 333-193552 10.24 1-24-14 S-1 333-193552 10.25 1-24-14 S-1 333-193552 10.26 1-24-14 S-1 333-193552 10.27 1-24-14 S-1 333-193552 10.28 1-24-14 EX-3 Table of Contents Exhibit Number 10.29 10.30 10.31 10.32 Exhibit Description Warrant to Purchase Common Stock (No. A-3), dated June 17, 2013, issued by the Registrant in favor of Neal Fenzi for 41,666 shares of common stock Warrant to Purchase Common Stock (No. A-4), dated June 17, 2013, issued by the Registrant in favor of Terry Lingren for 41,667 shares of common stock Warrant to Purchase Common Stock (No. A-5), dated June 17, 2013, issued by the Registrant in favor of Robert Hammond for 41,667 shares of common stock Warrant to Purchase Common Stock (No. A-6), dated June 17, 2013, issued by the Registrant in favor of Neal Fenzi for 41,667 shares of common stock Form S-1 Incorporated by Reference Exhibit 10.29 File Number 333-193552 Filing Date 1-24-14 Filed Herewith S-1 333-193552 10.30 1-24-14 S-1 333-193552 10.31 1-24-14 S-1 333-193552 10.32 1-24-14 10.33.1 Multi-Tenant Industrial Lease, dated August 9, 2013, between the Registrant and Nassau Land S-1 333-193552 10.33 1-24-14 10.33.2 10.33.3 10.34 10.35† 10.36 2013, between the Registrant and Nassau Land Company, L.P. First Amendment to Lease, dated March 20, 2014, between Registrant and Nassau Land Company, L.P. Second Amendment to Lease, dated September 15, 2014, between Registrant and Nassau Land Company, L.P. Standard Multi-Tenant Office Lease—Gross, dated November 14, 2013, between the Registrant and SeaBreeze I Venture—TIC. Amended and Restated Development Agreement, dated as of May 8, 2013, between Skyworks Solutions, Inc. and Resonant LLC Contribution Agreement, dated July 6, 2012, between Superconductor Technologies Inc. and Resonant LLC X X S-1 333-193552 10.34 1-24-14 S-1/A 333-193552 10.35 4-11-14 S-1/A 333-193552 10.36 3-24-14 10.37* Offer Letter between the Registrant S-1/A 333-193552 10.37 3-24-14 EX-4 Table of Contents Exhibit Number 10.38 10.39 10.40 10.41* 10.42* 21.1 23.1 24.1 31.1 31.2 32.1# Exhibit Description Form and John Philpott, dated March 10, 2014 Incorporated by Reference Exhibit File Number Filing Date Filed Herewith Amendment No. 3 to Securities Purchase Agreement and Consents and Waivers, by and among the Registrant, the Required Holders party thereto and MDB Capital Group, LLC S-1/A 333-193552 10.38 5-16-14 Warrant Agreement issued to MZ Group 10-Q 001-36467 10.3 8-8-14 Warrant Agreement issued to Investor Relations Consultant Form of Severance/Change-in-Control Agreement Offer Letter between the Registrant and Mike Eddy, dated August 16, 2014 List of Subsidiaries S-1 333-193552 21.1 1-24-14 Consent of Squar, Milner, Peterson, Miranda & Williamson, LLP Power of Attorney (included on signature page) Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a- 14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a- 14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 EX-5 X X X X X X X X Table of Contents Exhibit Number Exhibit Description Form Incorporated by Reference Exhibit File Number Filing Date 101.INS XBRL Instance Document 101.SCH XBRL Taxonomy Extension Schema Document 101.CAL XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF XBRL Taxonomy Extension Definition Linkbase Document 101.LAB XBRL Taxonomy Extension Label Linkbase Document 101.PRE XBRL Taxonomy Extension Presentation Linkbase Document Filed Herewith X X X X X X * Each a management contract or compensatory plan or arrangement required to be filed as an exhibit to this annual report on Form 10-K. # The information in this exhibit is furnished and deemed not filed with the Securities and Exchange Commission for purposes of section 18 of the Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of Resonant Inc. under the Securities Act of 1933, as amended, or the Exchange Act of 1934, as amended, whether made before or after the date hereof, regardless of any general incorporation language in such filing. † Confidential treatment has been granted for certain portions omitted from this exhibit pursuant to an order granted by the Commission under Rule 406 of the General Rules and Regulations under the Securities Act of 1933. Confidential portions of this exhibit have been separately filed with the Securities and Exchange Commission. EX-6 FIRST AMENDMENT TO LEASE Exhibit 10.33.2 This First Amendment to Lease (the “Amendment”), dated March 20, 2014 for references purposes only, is made and entered into by and between Nassau Land Company, L.P., a California limited partnership (the “Landlord”), and Resonant, Inc., a Delaware corporation (the “Tenant”), with reference to the following facts: RECITALS: A. Landlord is the owner of the real property and improvements consisting of approximately 26,639 square feet of leasable space located in the Castilian Technical Center situated at 110 Castilian Drive, Goleta, California (the “Building”). B. Landlord and Tenant entered into a Multi-Tenant Industrial Lease dated August 9, 2013 (the “Original Lease”), whereby Landlord leased to Tenant, and Tenant leased from Landlord, approximately 3,608 square feet of leasable space located within the Project and commonly known as 110 Castilian Drive, Suite 100, Goleta, California (the “Original Premises”). C. Landlord and Tenant wish to amend the leased Premises to include the space adjacent to the Original Premises commonly known as Suite 103 located in the Building consisting of approximately 1,916 leasable square feet (the “Expansion Premises”), and to address other matters, including, without limitation, changes to the amount of Rent. E. The current Term of the Lease shall expire June 30, 2017. F. The parties have agreed to execute this Amendment in order to memorialize their understandings regarding certain amendments to the Lease. G. All capitalized terms that appear in this Amendment and are not defined herein shall have the meaning ascribed thereto in the Lease. AGREEMENTS: NOW THEREFORE, the parties hereto, intended to be legally bound, do hereby agree and further amend the Lease as follows: 1. AMENDMENTS TO LEASE. Notwithstanding any other provisions of the Lease to the contrary, effective as of the date set forth above, the Lease is hereby amended as follows: 1.1 Delivery Date. Landlord shall deliver the Expansion Premises to Tenant, vacant and ready for any Tenant improvement work, on July 1, 2014 (the “Delivery Date”). 1.2 Premises. Effective as of the Delivery Date, the Expansion Premises shall be part of the Premises under this Lease, so that the term “Premises” in this Lease shall refer to the Current Premises plus the Expansion Premises, as outlined in the Site Plan attached as Exhibit A to this Amendment, and the leased Premises shall consist of a total of 5,524 leasable square feet. 1.3 Lease Term. The Term of the Lease shall be extended to three (3) years and one (1) month from July 1, 2014 (the “Extended Period”). The last day of the Extended Period shall be July 31, 2017. 1.4 Rent. (a) Minimum Monthly Rent. Effective August 1, 2014, the Minimum Monthly Rent shall be the sum of $1.50 square foot per month payable in equal monthly installments of $8,286.00 (NNN). 1 (b) Adjustments to Minimum Monthly Rent. To be made at one (1)-year intervals in accordance with the provisions of the Original Lease. The Adjustment Dates shall be March 1, 2015 and on the first (1 ) day of March every year thereafter. st 1.5 Operating Expenses. Effective August 1, 2014, Tenant’s proportionate share of the Building Operating Expenses shall be twenty and seventy-four hundredths percent (20.74%) and Tenant’s proportionate share of the Project Operating Expenses shall be eight and sixty-two hundredths percent (8.62%). 1.6 Security Deposit. Effective on the Delivery Date, Tenant’s Security Deposit shall be increased by $2,874.00 to $10,487.00. 1.7 Preparation of the Expansion Premises. The Expansion Premises shall be leased to Tenant in its “as-is” condition, except that Landlord shall, at its sole cost and expense prior to the Delivery Date: (i) paint and install new light fixtures in the first (1 ) floor restrooms using Landlords standard choice of materials; and (ii) provide Tenant with an additional one-time tenant improvement allowance (the “Additional Allowance”), under the same terms and conditions set forth in Exhibit B to the Original Lease, in an amount not to exceed st (the ), under the same terms and conditions set forth in Exhibit B to the Original Lease, in an amount not to exceed $20 per square foot of the Expansion Premises ($38,320.00) to be used for interior improvements. Tenant Improvements shall be consistent and similar to the scope of the existing improvements in the Current Premises. If Tenant does not utilize the Additional Allowance by June 30, 2015, the Additional Allowance shall become null and void and Tenant shall forever lose its right to utilize said allowance. 1.8 Parking. Effective on the Delivery Date, Tenant shall have the right to the non-exclusive use of the common area parking lot of six (6) additional spaces at no charge to Tenant during the Extended Period and any Option Term. 2. MISCELLANEOUS. 2.1 In the event of any conflict between the terms of this Amendment and the terms of the Lease, the terms of this Amendment shall control. 2.2 This Amendment is the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior contemporaneous oral and written agreements and discussions with respect to the subject matter hereof. 2.3 Landlord and Tenant represent and warrant that all signatories hereto signing in a representative capacity have been duly authorized by and on behalf of their respective principals to execute this Amendment. th AGREED THIS 18 day of April 2014. LANDLORD: NASSAU LAND COMPANY, L.P. a California limited partnership By: Michael Towbes Construction & Development, Inc., a California corporation Its: General Partner By: /s/ [ILLEGIBLE] Its: Vice President TENANT: RESONANT INC., a Delaware corporation By: /s/ Dan Christopher Its: VP & General Counsel 2 Exhibit 10.33.3 TENANT ORIGINAL SECOND AMENDMENT TO LEASE This Second Amendment to Lease (the “Amendment”), dated September 15, 2014 for references purposes only, is made and entered into by and between Nassau Land Company, L.P., a California limited partnership (the “Landlord”), and Resonant, Inc., a Delaware corporation (the “Tenant”), with reference to the following facts: RECITALS: A. Landlord is the owner of the real property and improvements consisting of approximately 26,639 square feet of leasable space located in the Castilian Technical Center situated at 110 Castilian Drive, Goleta, California (the “Building”). B. Landlord and Tenant entered into a Multi-Tenant Industrial Lease dated August 9, 2013 (the “Original Lease”), whereby Landlord leased to Tenant, and Tenant leased from Landlord, approximately 3,608 square feet of leasable space located within the Project and commonly known as 110 Castilian Drive, Suite 100, Goleta, California (the “Original Premises”). C. Landlord and Tenant entered into a written First Amendment to Lease dated March 20, 2014 expanding the leased Premises to include the space adjacent to the Original Premises commonly known as Suite 103 located in the Building consisting of approximately 1,916 leasable square feet (the “Expansion Premises”). D. Landlord and Tenant wish to amend the leased Premises to temporarily include four (4) offices located on the second nd (2 ) floor of the Building as outlined in the Site Plan attached as Exhibit A to this Amendment (the “Temporary Premises”), and to address other matters, including, without limitation, changes to the amount of Rent. E. The parties have agreed to execute this Amendment in order to memorialize their understandings regarding certain amendments to the Lease. F. All capitalized terms that appear in this Amendment and are not defined herein shall have the meaning ascribed thereto in the Lease. AGREEMENTS: NOW THEREFORE, the parties hereto, intended to be legally bound, do hereby agree and further amend the Lease as follows: 1. AMENDMENTS TO LEASE. Notwithstanding any other provisions of the Lease to the contrary, effective as of the date set forth above, the Lease is hereby amended as follows: 1.1 Delivery Date. Landlord shall deliver the Temporary Premises to Tenant, in its “as is” condition, on September 4, 2014 (the “Temporary Delivery Date”). 1.2 Premises. Effective as of the Temporary Delivery Date, the Temporary Premises shall be part of the Premises under this Lease, so that the term “Premises” in this Lease shall refer to the Current Premises plus the Expansion Premises plus the Temporary Premises through the end of the Temporary Term (as defined below). 1.3 Temporary Term. The Lease Term for the Temporary Premises (the “Temporary Term”) shall commence upon the Temporary Delivery Date and shall expire December 31, 2014. At the expiration of the Temporary Term, Tenant shall return the Temporary Premises to Landlord in accordance with Section 25.1 (Surrender of the Premises) of the Original Lease. 1 1.5 Monthly Base Rent. During the Temporary Term, the Monthly Base Rent for the Temporary Premises shall be the sum of $1,000.00 (gross) per month, all payable in advance in the amount totaling $3,900.00. 2. MISCELLANEOUS. 2.1 In the event of any conflict between the terms of this Amendment and the terms of the Lease, the terms of this Amendment shall control. 2.2 This Amendment is the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior contemporaneous oral and written agreements and discussions with respect to the subject matter hereof. 2.3 Landlord and Tenant represent and warrant that all signatories hereto signing in a representative capacity have been duly authorized by and on behalf of their respective principals to execute this Amendment. AGREED THIS 24 day of September 2014. th LANDLORD: NASSAU LAND COMPANY, L.P. a California limited partnership By: Michael Towbes Construction & Development, Inc., a California corporation Its: General Partner By: /s/ [ILLEGIBLE] Its: President TENANT: RESONANT INC., a Delaware corporation By: /s/ Dan Christopher Its: VP & General Counsel 2 [L O G O ] RESONANT INC. Exhibit 10.40 THE WARRANT EVIDENCED HEREBY AND THE SHARES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE OFFERED OR SOLD WITHOUT REGISTRATION UNLESS AN EXEMPTION FROM REGISTRATION IS AVAILABLE UNDER SUCH ACT OR THE RULES OR REGULATIONS PROMULGATED THEREUNDER. Expiration Date: September 30, 2018 Certificate No: F-1 WARRANT TO PURCHASE 6,000 Shares of Common Stock Resonant Inc., a Delaware corporation (the “Company”), for value received, hereby certifies that Ina McGuiness, an individual, (the “Holder”), is entitled to purchase from the Company up to and including 6,000 (the “Number of Shares”) duly authorized, validly issued, fully paid and nonassessable shares (the “Shares”) of the Company’s Common Stock, $0.001 par value per share (the “Common Stock”), on the terms set forth herein at an exercise price of Six Dollars Fifty Cents ($6.50) per share (the “Purchase Price”). The number of Shares and the Purchase Price may be adjusted from time to time as described in this Warrant. 1. Exercise. 1.1 Time for Exercise. Subject to the vesting provisions of the next sentence, this Warrant may be exercised in whole or in part at any time, and from time to time, during the period commencing on September 30, 2015 and expiring at 5:00 p.m. Pacific time on September 30, 2018 (the “Expiration Date”). 1.2 Vesting. Notwithstanding Section 1.1, the right to purchase Shares under this Warrant is subject to vesting at the rate of 500 shares per month of investor relations services under the Consulting Agreement with Holder dated October 1, 2014. In the event that your Service (as defined below) is terminated for Good Reason (as defined below) or for reasons other than an act of misconduct upon the occurrence of a Change in Control or within three (3) months prior thereto or twelve (12) months thereafter (a “Termination Event”), all of the unvested Options will vest immediately prior to the effective date of such Termination Event and the Options shall become fully exercisable. For purposes hereof, (i) “Service” means service to the Company or any of its Subsidiaries as an Employee, and (ii) “Good Reason” means any of the following (without your express written consent and provided you provide written notice stating in reasonable detail the basis for termination and a thirty (30)-day opportunity to cure to the Company): (i) a material reduction in your responsibilities or duties as such responsibilities or duties exist on the date that is three (3) months prior to the Change in Control, except in the event of a termination for an act of misconduct, death or disability or your resignation other than for Good Reason; (ii) a reduction of your compensation as it exists on the date that is three (3) months prior to the Change in Control; or (ii) any relocation by the Company of your place of employment that would increase your one-way commute to the place of employment by more than fifty (50) miles when compared to your commute immediately prior to the relocation. 1 1.3 Manner of Exercise. This Warrant may be exercised by delivering it to the Company with the attached exercise form duly completed and signed, specifying (i) the number of Shares as to which the Warrant is being exercised at that time (the “Exercise Number”), and (ii) whether the exercise is being made by “purchase” or “exchange,” and representing and warranting to the Company that the statements set forth in Section 7 hereof are true and correct with respect to the Holder as of the date of exercise. Company cash, a certified check or wire transfer of immediately available funds in an amount equal to the Exercise Number multiplied by the Purchase Price, and the Holder shall be entitled to receive the full Exercise Number of Shares. 1.3.1 Purchase. If the Holder elects the purchase option, the Holder shall simultaneously deliver to the to receive that number of Shares having an aggregate Market Value (determined as provided below) on the date of exercise equal to the difference between the Market Value of the Exercise Number of Shares and the aggregate Purchase Price thereof. 1.3.2 Exchange. If the Holder elects the exchange option, the Holder shall be entitled (without cash payment) 1.3.3 As used herein, “Market Value” for any security on any given date means (i) the average closing price for the prior ten (10) trading days for such security on the principal stock exchange on which such security is traded or (ii) if not so traded, the closing (or, if no closing price is available, the average of the bid and asked prices) for such period on NASDAQ if such security is listed on the NASDAQ or (iii) if not listed on any exchange or quoted on NASDAQ, such value as may be determined (without regard to illiquidity or minority status) in good faith by the Company’s Board of Directors, which determination shall be conclusively binding on the parties, except that, at the request of the Holder, the fair price shall be determined by an investment banking firm reasonably acceptable to the Company, whose fees will be paid by the Holder unless the Market Price so determined exceeds one hundred and ten percent (110%) of that set by the Board. exercise to the Holder (i) duly executed certificates in the name or names specified in the exercise notice representing the aggregate number of 1.4 Effect of Exercise. The Company shall deliver promptly (but in any case within ten business days) after any exercise to the Holder (i) duly executed certificates in the name or names specified in the exercise notice representing the aggregate number of Shares issuable upon such exercise, and (ii) if this Warrant is exercised only in part, a new Warrant of like tenor representing the balance of the Number of Shares. Such certificates shall be deemed to have been issued, and the person receiving them shall be deemed to be a holder of record of such Shares, as of the close of business on the date the actions required in Section 1.3 shall have been completed or, if on that date the stock transfer books of the Company are closed, as of the next business day. 2. Transfer of Warrant and Shares. 2.1 Transfer Restrictions. Neither this Warrant nor the securities issuable upon its exercise may be sold, transferred or pledged unless the Company shall have been supplied with reasonably satisfactory evidence that such transfer is not in violation of the Securities Act of 1933, as amended, and any applicable state securities laws. The Company may place a legend to that effect on this Warrant, any replacement Warrant and each certificate representing Shares issuable upon exercise of this Warrant. NOTWITHSTANDING THE FOREGOING, THIS WARRANT IS NOT TRANSFERRABLE BY THE HOLDER. 2.2 Manner of Transfer. Upon delivery of this Warrant to the Company with the attached assignment form duly completed and signed, the Company will promptly (but in any case within ten business days) execute and deliver to each transferee and, if applicable, the Holder, Warrants of like tenor evidencing the rights (i) of the transferee(s) to purchase the Number of Shares specified for each in the assignment forms, and (ii) of the Holder to purchase any untransferred portion, which in the 2 aggregate shall equal the Number of Shares of the original Warrant. If this Warrant is properly assigned in compliance with this Section 2, it may be exercised by an assignee without having a new Warrant issued. 2.3 Loss, Destruction of Warrant Certificates. Upon receipt of (i) evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of any Warrant and (ii) except in the case of mutilation, an indemnity or security reasonably satisfactory to the Company (the original Holder’s or institutional Holder’s indemnity agreed to be satisfactory), the Company will promptly (but in any case within ten business days) execute and deliver a replacement Warrant of like tenor representing the right to purchase the same Number of Shares. 3. Cost of Issuances. The Company shall pay all expenses, transfer taxes and other charges payable in connection with the preparation, issuance and delivery of unit certificates or replacement Warrants, except for any transfer tax or other charge imposed as a result of (i) any issuance of stock certificates in any name other than the name of the Holder upon exercise of the Warrant or (ii) any transfer of the Warrant. The Company shall not be required to issue or deliver any stock certificate or Warrant until it receives reasonably satisfactory evidence that any such tax or other charge has been paid by the Holder. 4. Adjustments. If any of the following events occur at any time hereafter during the term of this Warrant, then the Purchase Price and the Number of Shares immediately prior to such event shall be changed as described in order to prevent dilution: 4.1 Stock Splits and Reverse Splits. If at any time the outstanding shares of Common Stock are subdivided into a greater number of shares, then the Purchase Price will be reduced proportionately and the number of Shares will be increased proportionately. Conversely, if at any time the outstanding shares of Common Stock are consolidated into a smaller number of shares, then the Purchase Price will be increased proportionately and the Number of Shares will be reduced proportionately. 4.2 Distributions. In the event the Company declares a distribution upon the Common Stock, whether in cash, property or securities, at the time of subsequent exercise of this Warrant, the Company shall deliver both (i) the Number of Shares for which exercise is made plus (ii) such distribution as would have been previously distributed to the Holder if such exercise had been made on the date hereof. If the Company shall declare a distribution payable in cash on its Common Stock and shall at substantially the same time offer to its stockholders a right to purchase new shares from the proceeds of such distribution, or for an amount substantially equal to the distribution, the amount of shares so offered shall, for the purpose of this Warrant, be deemed to have been issued as a distribution with respect to such share. 4.3 Effect of Reorganization and Asset Sales. If any (i) reorganization or reclassification of the Common Stock, (ii) consolidation or merger of the Company with or into another entity, (iii) sale of all or substantially all of its operating assets to another person or entity, or (iv) sale of the Company substantially as a going concern followed by a liquidation of the Company (any such occurrence shall be an “Event”), is effected in such a way that holders of Common Stock (either directly or upon conversion into another class of equity) are entitled to receive securities and/or assets as a result of their ownership of Common Stock, then upon exercise of this Warrant the Holder will have the right to receive the securities or assets which they would have received if such rights had been fully exercised as of the record date for such Event. The Company will not affect any Event unless prior to or simultaneously with its consummation the successor entity resulting from the consolidation or merger (if other than the Company), or the entity purchasing the Company’s assets, assumes the performance 3 of the Company’s obligations under this Warrant (as appropriately adjusted to reflect such consolidation, merger or sale such that the Holder’s rights under this Warrant remain, as nearly as practicable, unchanged) by a binding written instrument. than Common Stock upon exercise of this Warrant, the number and purchase price of such securities shall thereafter be adjusted from time to 4.4 Other Securities Adjustments. If as a result of this Section 4, a Holder is entitled to receive any securities other than Common Stock upon exercise of this Warrant, the number and purchase price of such securities shall thereafter be adjusted from time to time in the same manner as provided pursuant to this Section 4 for Common Stock. To the extent that a right receivable on exercise of this Warrant has lapsed or been lost prior to the date of exercise, on exercise the Company shall pay in cash or in Common Stock based on its Market Value on the date of exercise an amount equal to the Market Value of the right which lapsed or was lost, determined as of the time which such right lapsed or was lost. The allocation of purchase price between various securities shall be made in writing by the Board of Directors of the Company in good faith at the time of the event by which the Holder becomes entitled to receive new securities, and a copy sent to the Holder. 4.5 Notices. 4.5.1 Notice of Adjustments. When any adjustment is required to be made under this Section 4, the Company shall promptly (i) determine such adjustments, (ii) prepare and retain on file a statement describing in reasonable detail the method used in arriving at the adjustment, and (iii) cause a copy of such statement, together with any agreement required by Section 4.3, to be mailed to the Holder within ten (10) days after the date on which the circumstances giving rise to such adjustment occurred. 4.5.2 Notice of Events. If at any time (i) the Company declares any distribution on the Common Stock, (ii) any Event is expected to occur, or (iii) there is a voluntary or involuntary dissolution, liquidation or winding up of the Company, then the Company shall give the Holder at least thirty (30) but not more than ninety (90) days written notice of the date on which the books of the Company will close or upon which a record will be taken with regard to such occurrence. Such notice will also specify the date as of which the holders of Common Stock will participate in the distribution or will be entitled to exchange their shares for securities or other property. The notice may state that the record date is subject to the effectiveness of a registration statement under the Securities Act or to a favorable vote or determination of equity holders or of any governmental agency. 4.6 Computations and Adjustments. Upon each computation of an adjustment under this Section 4, the Purchase Price shall be computed to the next lowest cent and the number of Shares shall be calculated to the next highest whole unit. However, the fractional amount shall be used in calculating any future adjustments. No fractional shares of Common Stock shall be issued in connection with the exercise of this Warrant, but the Company shall, in the case of the final exercise under this Warrant, make a cash payment for any fractional shares based on the value (determined without discount for illiquidity or minority status) as may be determined in good faith by the Company’s Board of Directors, which determination shall be conclusively binding on the parties. Notwithstanding any changes in the Purchase Price or the Number of Shares, this Warrant, and any Warrants issued in replacement or upon transfer thereof, may continue to state the initial Purchase Price and the initial Number of Shares. Alternatively, the Company may elect to issue a new Warrant or Warrants of like tenor for the additional shares purchasable hereunder or, upon surrender of the existing Warrant, to issue a replacement Warrant evidencing the aggregate Number of Shares to which the Holder is entitled after such adjustments. requiring an adjustment, but prior to the actual event, the Company may 4.7 Exercise Before Payment Date. In the event that this Warrant is exercised after the record date for any event 4 elect to defer issuing to the Holder any payment or additional securities required by such adjustment until the actual event occurs; provided, however, that the Company shall deliver a “due bill” or other appropriate instrument to the Holder transferable to the same extent as the shares issuable on exercise evidencing the Holder’s right to receive such additional payment or securities upon the occurrence of the event requiring such adjustment. 5. Covenants. The Company agrees that: 5.1 Reservation of Shares. During the period in which this Warrant may be exercised, the Company will reserve sufficient authorized but unissued securities (and, if applicable, property) to enable it to satisfy its obligations on exercise of this Warrant. If at any time the Company’s authorized securities shall not be sufficient to allow the exercise of this Warrant, the Company shall take such corporate action as may be necessary to increase its authorized but unissued securities to be sufficient for such purpose; 5.2 No Liens, etc. All securities that may be issued upon exercise of this Warrant will, upon issuance, be validly issued, fully paid, nonassessable and free from all taxes, liens and charges with respect to the issue thereof, and shall be listed on any exchanges or authorized for trading on any automated systems on which that class of securities is listed or authorized for trading; value; 5.3 No Diminution of Value. The Company will not take any action to terminate this Warrant or to diminish it in reports, proxy statements and other information which the Company shall have sent to its stockholders generally; and 5.4 Furnish Information. The Company will promptly deliver to the Holder copies of all financial statements, 5.5 Stock and Warrant Transfer Books. Except upon dissolution, liquidation or winding up or for ordinary holidays and weekends, the Company will not at any time close its stock or warrant transfer books so as to result in preventing or delaying the exercise or transfer of this Warrant. 6. Status of Holder. 6.1 Not a Stockholder. Except as otherwise provided in this Warrant, unless the Holder exercises this Warrant in writing, the Holder shall not be entitled to any rights (i) as a stockholder of the Company with respect to the shares as to which the Warrant is exercisable including, without limitation, the right to vote or receive dividends or other distributions, or (ii) to receive any notice of any proceedings of the Company. proceedings of the Company. hereunder shall not give rise to any liability for the Purchase Price, whether to the Company or its creditors. 6.2 Limitation of Liability. Unless the Holder exercises this Warrant in writing, the Holder’s rights and privileges 7. Representations and Warranties of the Holder. The Holder represents and warrants to the Company as follows: 7.1 Purchase for Own Account. This Warrant and the securities to be acquired upon exercise of this Warrant by the Holder will be acquired for investment for the Holder’s account, not as a nominee or agent, and not with a view to the public resale or distribution in violation of the Securities Act of 1933, as amended. 7.2 Disclosure of Information. The Holder has received or has had full access to all the information it considers necessary or appropriate to make an informed investment decision with respect to the acquisition of this Warrant and its underlying securities. The Holder further has had an 5 opportunity to ask questions and receive answers from the Company regarding the terms and conditions of the offering of this Warrant and its underlying securities and to obtain additional information (to the extent the Company possessed such information or could acquire it without unreasonable effort or expense) necessary to verify any information furnished to the Holder or to which the Holder has access. 7.3 Investment Experience. The Holder understands that the purchase of this Warrant and its underlying securities involves substantial risk. The Holder has experience as an investor in securities of companies in the development stage and acknowledges that the Holder can bear the economic risk of such Holder’s investment in this Warrant and its underlying securities and has such knowledge and experience in financial or business matters that the Holder is capable of evaluating the merits and risks of its investment in this Warrant and its underlying securities and/or has a preexisting personal or business relationship with the Company and certain of its officers, directors or controlling persons of a nature and duration that enables the Holder to be aware of the character, business acumen and financial circumstances of such persons. promulgated under the 1933 Act. 7.4 Accredited Investor Status. The Holder is an “accredited investor” within the meaning of Regulation D 7.5 The 1933 Act. The Holder understands that this Warrant and the underlying securities issuable upon exercise or conversion hereof have not been registered under the 1933 Act in reliance upon a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of the Holder’s investment intent as expressed herein. The Holder understands that this Warrant and underlying securities issued upon any exercise or conversion hereof must be held indefinitely unless subsequently registered under the 1933 Act and qualified under applicable state securities laws, or unless exemption from such registration and qualification are otherwise available. 8. General Provisions. 8.1 Complete Agreement; Modifications. This Warrant and any documents referred to herein or executed contemporaneously herewith constitute the parties’ entire agreement with respect to the subject matter hereof and supersede all agreements, representations, warranties, statements, promises and understandings, whether oral or written, with respect to the subject matter hereof. This Warrant may not be amended, altered or modified except by a writing signed by the parties. perform such other actions which may be or become necessary or expedient to effectuate and carry out this Warrant. 8.2 Additional Documents. Each party hereto agrees to execute any and all further documents and writings and to 8.3 Notices. All notices under this Warrant shall be in writing and shall be delivered by personal service, electronic mail, facsimile or certified mail (if certified mail is not available, then by first class mail), postage prepaid, to such address as may be designated from time to time by the relevant party, and which shall initially be: To the Company: Resonant Inc. 110 Castilian Drive, Suite 100 Santa Barbara, CA 93117 Attn: Terry Lingren, Chief Executive Officer Email: tlingren@resonant.com 6 To the Holder: Ina McGuinness [OMITTED] Email: ina@mcguinnessir.com Any notice sent by certified mail shall be deemed to have been given three (3) days after the date on which it is mailed. All other notices shall be deemed given when received. No objection may be made to the manner of delivery of any notice actually received in writing by an authorized agent of a party. 8.4 No Third-Party Benefits; Successors and Assigns. None of the provisions of this Warrant shall be for the benefit of, or enforceable by, any third-party beneficiary. Except as provided herein to the contrary, this Warrant shall be binding upon and inure to the benefit of the parties, their respective successors and permitted assigns. The Holder may assign its rights and obligations under this Warrant to any third party if done so in compliance with the requirements of Section 2. The Company may only assign its rights and obligations under this Warrant in connection with a merger, consolidation or sale of substantially all of its operating assets to the extent expressly permitted by, and in compliance with all the requirements of, Section 4.3. 8.5 Governing Law; Venue; Jurisdiction; Waiver of Jury Trial. This Warrant has been negotiated and entered into in the State of California, concerns a California business and all questions with respect to the Warrant and the rights and liabilities of the parties will be governed by the laws of California, regardless of the choice of law provisions of California or any other jurisdiction. Any and all disputes between the parties which may arise from or relate to this Warrant not covered by arbitration will be heard and determined exclusively before an appropriate federal or state court located in Los Angeles, California. Each party (i) irrevocably consents to the exclusive jurisdiction of the Los Angeles Superior Court and the Federal District Court for the Central District of California (or their successor courts) for all purposes in connection with any litigation that arises from or relates to this Warrant, (ii) agrees that any litigation arising from or relating to this Warrant shall be instituted and prosecuted only in such courts, (iii) waives any rights it may have to personal service of summons, complaint, or other process in connection therewith, and (iv) agrees that service may be made by certified mail addressed to such party sent to the addresses designated from time to time in accordance with Section 8.3. The parties hereby waive their respective rights to trial by jury of any cause of action, claim, counterclaim or cross-complaint in any action, proceeding and/or hearing on any matter arising from or relating to this Warrant. 8.6 Waivers Strictly Construed. With regard to any power, remedy or right provided herein or otherwise available to any party hereunder (i) no waiver or extension of time shall be effective unless expressly contained in a writing signed by the waiving party, and (ii) no alteration, modification or impairment shall be implied by reason of any previous waiver, extension of time, delay or omission in exercise, or other indulgence. one or more of its provisions shall be held to be invalid, illegal or unenforceable in any respect. 8.7 Severability. The validity, legality or enforceability of the remainder of this Warrant shall not be affected even if 8.8 Attorneys’ Fees. Should any litigation or arbitration be commenced (including any proceedings in a bankruptcy court) between the parties hereto or their representatives concerning any provision of this Warrant or the rights and duties of any person or entity hereunder, the party or parties prevailing in such proceeding shall be entitled, in addition to such other relief as may be granted, to the attorneys’ fees and court costs incurred by reason of such litigation or arbitration. 7 *** [NEXT PAGE IS SIGNATURE PAGE] *** 8 IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed on November 5, 2014. SIGNATURE PAGE TO WARRANT “Holder” /s/ Ina McGuinness Ina McGuinness “Company” RESONANT INC., a Delaware corporation /s/ Terry Lingren Authorized Signature Terry Lingren Print Name Chief Executive Officer Title i ASSIGNMENT FORM Signature Page (To Be Executed Upon Transfer of Warrant) FOR VALUE RECEIVED, hereby sells, assigns and transfers to the transferee named below [the rights to purchase of the number of Shares under] this Warrant, together with all rights, title and interest therein. [The rights to purchase the remaining number of Shares shall remain the property of the undersigned.] Such transferee hereby represents and warrants to the Company that the statements set forth in Section 7 of the Warrant are true and correct with respect to such transferee as of the date hereof as if such transferee were the “Holder” for purposes thereof. [NAME OF HOLDER] By: Name: Title: Address: Signature (Please Print) Dated: TRANSFEREE: Name: Address: (Please Print) EXERCISE FORM (To Be Executed Upon Exercise of Warrant) The undersigned hereby exercises the Warrant with regard to shares of Common Stock and herewith [makes payment of the purchase price in full] [or requests that the Company exchange the Warrant as provided in Section 1.3.2 of the Warrant]. The undersigned requests that the certificate(s) for such Shares [and the Warrant for the unexercised portion of this Warrant] be issued [to the Holder] [in the name set forth below]. The undersigned further hereby represents and warrants to the Company that the statements set forth in Section 7 of the Warrant are true and correct with respect to the undersigned as of the date hereof. [NAME OF HOLDER] By: Name: Title: Address: Signature (Please Print) Dated: TRANSFEREE: Name: Address: (Please Print) Exhibit 10.41 SEVERANCE AND CHANGE IN CONTROL AGREEMENT This Severance and Change in Control Agreement (the “Agreement”) is made and entered into by and between [·] (“Executive”) and Resonant Inc., a Delaware corporation (the “Company”), effective as of [·], 2015 (the “Effective Date”). Certain capitalized terms used in the Agreement are defined in Section 6 below. RECITALS A. The Compensation Committee (the “Committee”) of the Board of Directors of the Company (the “Board”) recognizes that it is possible that the Company could terminate Executive’s employment with the Company and from time to time the Company may consider the possibility of an acquisition by another company or other change in control transaction. The Committee also recognizes that such considerations can be a distraction to Executive and can cause Executive to consider alternative employment opportunities. The Committee has determined that it is in the best interests of the Company and its stockholders to assure that the Company will have the continued dedication and objectivity of Executive, notwithstanding the possibility, threat or occurrence of such a termination of employment or the occurrence of a Change in Control (as defined herein) of the Company. B. The Committee believes that it is in the best interests of the Company and its stockholders to provide Executive with an incentive to continue his or her employment with the Company and to motivate Executive to maximize the value of the Company for the benefit of its stockholders. C. The Committee believes that it is imperative to provide Executive with certain severance benefits upon Executive’s termination of employment and with certain additional benefits following a Change in Control. These benefits will provide Executive with enhanced financial security and incentive and encouragement to remain with the Company notwithstanding the possibility of a Change in Control. AGREEMENT NOW, THEREFORE, in consideration of the mutual covenants contained herein, the parties hereto agree as follows: 1. Term of Agreement. This Agreement will not terminate until all of the obligations of the parties hereto with respect to this Agreement have been satisfied. 2. At-Will Employment. The Company and Executive acknowledge that Executive’s employment is and will continue to be at-will, as defined under applicable law. If Executive’s employment terminates for any reason, including (without limitation) any termination of employment not set forth in Section 3, Executive will not be entitled to any payments, benefits, damages, awards or compensation other than the payment of accrued but unpaid wages, as required by law, and any unreimbursed reimbursable expenses or pursuant to written agreements with the Company, including equity award agreements. 3. Severance Benefits. the twenty-four (24)-month period (a) Termination without Cause or Resignation for Good Reason in Connection with a Change in Control. If during immediately following a Change in Control, (x) the Company terminates Executive’s employment with the Company for a reason other than Cause, Executive becoming Disabled or Executive’s death, or (y) Executive resigns from such employment for Good Reason, then, subject to Section 4, Executive will receive the following severance benefits from the Company in lieu of the benefits described in Section 3(a) above: reimbursements, wages, and other benefits due to Executive under any Company-provided plans, policies, and arrangements. (i) Accrued Compensation. The Company will pay Executive all accrued but unpaid PTO, expense months of Executive’s base salary as in effect immediately prior to the date of Executive’s termination of employment, less all required tax withholdings and other applicable deductions, which will be paid as practicable following Executive’s termination of employment. (ii) Severance Payment. Executive will receive a lump sum severance payment equal to eighteen (18) percent (100%) of Executive’s full target bonus for the fiscal year in effect at the date of such termination of employment (or, if greater, as in effect for the fiscal year in which the Change in Control occurs), less all required tax withholdings and other applicable deductions. (iii) Target Bonus Payment. Executive will receive a lump sum severance payment equal to one hundred (iv) Continued Health Insurance Benefits. If Executive is eligible for, and elects continuation coverage pursuant to COBRA for Executive and Executive’s eligible dependents (as applicable) under a health, dental, or vision plan sponsored by the Company, within the time period prescribed pursuant to COBRA, the Company will reimburse Executive, as and when due to the COBRA carrier, for the COBRA premiums for such coverage (at the coverage levels in effect immediately prior to Executive’s termination of employment) until the earliest to occur of (A) a period of twelve (12) months from the last date of employment of Executive with the Company, (B) the date upon which Executive becomes eligible for coverage under a health, dental, or vision insurance plan of a subsequent employer, and (C) the date Executive or his or her dependents cease to be eligible for COBRA coverage. These payments will be subject to employer, and (C) the date Executive or his or her dependents cease to be eligible for COBRA coverage. These payments will be subject to any applicable tax withholdings (including tax withholdings necessary to ensure that the provision of this benefit is not deemed a discriminatory practice giving rise to penalties to the Company under applicable laws) and will be counted as coverage pursuant to COBRA to the maximum extent permitted under applicable law. (v) Equity. Executive will be entitled to accelerated vesting as to one hundred percent (100%) of the then unvested portion of all of Executive’s outstanding equity awards. In addition, Executive will have six (6) months following any such termination of employment in which to exercise any stock options, stock appreciation rights, or similar rights to acquire Company common stock, but in no event will such equity award be permitted to be exercised beyond the earlier of the original maximum term of such equity award or ten (10) years from the original grant date of such equity award. benefits provided by a service to be determined by the Company in its discretion for a period of six (6) months, up to a maximum dollar value of five thousand dollars ($5,000) following Executive’s termination. (vi) Outplacement Benefits. If requested by Executive, the Company will pay the expense for outplacement from the Company as may be required by law. (vii) Payments or Benefits Required by Law. Executive will receive such other compensation or benefits (b) Termination without Cause and not in Connection with a Change in Control. If the Company terminates Executive’s employment with the Company for a reason other than Cause, Executive becoming Disabled or Executive’s death at any time other than during the twelve (12)-month period immediately following a Change in Control, then, subject to Section 4, Executive will receive the following severance benefits from the Company: (i) Accrued Compensation. The Company will pay Executive all accrued but unpaid paid time off (“PTO”), expense reimbursements, wages, and other benefits due to Executive under any Company-provided plans, policies, and arrangements. Executive’s base salary as in effect immediately prior to the date of Executive’s termination of employment, less all required tax withholdings and other applicable deductions, which will be paid as soon as practicable following Executive’s termination of employment. (ii) Severance Payment. Executive will receive severance in an amount equal to 18 (eighteen) months of (iii) Pro-Rated Bonus Payment. Executive will receive a lump-sum severance payment as soon as practicable following termination equal to one hundred percent (100%) of Executive’s full target bonus] as in effect for the fiscal year in which Executive’s termination occurs, pro-rated by multiplying such bonus amount by a fraction, the numerator of which shall be the number of days from and including the first day of such fiscal year through and including the date of Executive’s termination, and the denominator of which shall be three-hundred and sixty-five (365). (iv) Continued Health Insurance Benefits. If Executive is eligible for, and elects continuation coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”) for Executive and Executive’s eligible dependents (as applicable) under a health, dental, or vision plan sponsored by the Company, within the time period prescribed pursuant to COBRA, the Company will reimburse Executive, as and when due to the COBRA carrier, for the COBRA premiums for such coverage (at the coverage levels in effect immediately prior to Executive’s termination of employment) until the earliest to occur of (A) a period of twelve (12) months from the last date of employment of Executive with the Company, (B) the date upon which Executive becomes eligible for coverage under a health, dental, or vision insurance plan of a subsequent employer, and (C) the date Executive or his or her dependents cease to be eligible for COBRA coverage. These payments will be subject to any applicable tax withholdings (including tax withholdings necessary to ensure that the provision of this benefit is not deemed a discriminatory practice giving rise to penalties to the Company under applicable laws) and will be counted as coverage pursuant to COBRA to the maximum extent permitted under applicable law. (v) Equity. All of Executive’s unvested and outstanding equity awards that would have become vested had Executive remained in the employ of the Company for the twelve (12)-month period following Executive’s termination of employment shall immediately vest and become exercisable as of the date of Executive’s termination. In addition, Executive will have six (6) months following any such termination of employment in which to exercise any stock options, stock appreciation rights, or similar rights to acquire Company common stock, but in no event will such equity award be permitted to be exercised beyond the earlier of the original maximum term of such equity award or ten (10) years from the original grant date of such equity award. benefits provided by a service to be determined by the Company in its discretion for a period of six (6) months, up to a maximum dollar value of five thousand dollars ($5,000) following Executive’s termination. (vi) Outplacement Benefits. If requested by Executive, the Company will pay the expense for outplacement from the Company as may be required by law. (vii) Payments or Benefits Required by Law. Executive will receive such other compensation or benefits (c) Disability; Death. If Executive’s employment with the Company is terminated due to Executive becoming Disabled or Executive’s death, then Executive or Executive’s estate (as the case may be) will (i) receive the earned but unpaid base salary through the date of termination of employment, (ii) receive all accrued PTO, expense reimbursements and any other benefits due to Executive through the date of termination of employment in accordance with Company-provided or paid plans, policies and arrangements, and (iii) not through the date of termination of employment in accordance with Company-provided or paid plans, policies and arrangements, and (iii) not be entitled to any other compensation or benefits from the Company except to the extent required by law (for example, COBRA). All payments under clauses (i) through (ii) above shall in all cases be made within thirty (30) days of Executive’s termination of employment pursuant to this Section 3(c). (d) Voluntary Resignation; Termination for Cause. If Executive voluntarily terminates Executive’s employment with the Company (other than for Good Reason during the twelve (12)-month period immediately following a Change of Control) or if the Company terminates Executive’s employment with the Company for Cause, then Executive will (i) receive his or her earned but unpaid base salary through the date of termination of employment, (ii) receive all accrued PTO, expense reimbursements and any other benefits due to Executive through the date of termination of employment in accordance with established Company-provided or paid plans, policies and arrangements, and (iii) not be entitled to any other compensation or benefits from the Company except to the extent required by law (for example, COBRA). (e) Timing of Payments. Subject to any specific timing provisions in Section 3(a), 3(b) or 3(c) as applicable, or the provisions of Section 4, payment of the severance and benefits hereunder shall be made or commence to be made as soon as practicable following Executive’s termination of employment. (f) Exclusive Remedy. In the event of a termination of Executive’s employment with the Company, the provisions of this Section 3 are intended to be and are exclusive and in lieu of any other rights or remedies to which Executive or the Company may otherwise be entitled, whether at law, tort or contract, in equity, or under this Agreement (other than the payment of accrued but unpaid wages, as required by law, and any unreimbursed reimbursable expenses). Executive will be entitled to no other severance, benefits, compensation or other payments or rights upon a termination of employment, including, without limitation, any severance payments and/or benefits provided in the Employment Agreement, other than those benefits expressly set forth in Section 3 of this Agreement or pursuant to written equity award agreements with the Company. 4. Conditions to Receipt of Severance. (a) Release of Claims Agreement. The receipt of any severance payments or benefits pursuant to this Agreement is subject to Executive signing and not revoking a separation agreement and release of claims in a form acceptable to the Company (the “Release”), which must become effective no later than the sixtieth (60th) day following Executive’s termination of employment (the “Release Deadline”), and if not, Executive will forfeit any right to severance payments or benefits under this Agreement. To become effective, the Release must be executed by Executive and any revocation periods (as required by statute, regulation, or otherwise) must have expired without Executive having revoked the Release. In addition, in no event will severance payments or benefits be paid or provided until the Release actually becomes effective. If the termination of employment occurs at a time during the calendar year where the Release Deadline could occur in the calendar year following the calendar year in which Executive’s termination of employment occurs, then any severance payments or benefits under this Agreement that would be considered Deferred Payments (as defined in Section 4(c)(i)) will be paid on the first payroll date to occur during the calendar year following the calendar year in which such termination occurs, or such later time as required by (i) the payment schedule applicable to each payment or benefit as set forth in Section 3, (ii) the date the Release becomes effective, or (iii) Section 4(c)(ii); provided that the first payment shall include all amounts that would have been paid to Executive if payment had commenced on the date of Executive’s termination of employment. (b) Confidential Information and Invention Assignment Agreements. Executive’s receipt of any payments or benefits under this Agreement will be subject to Executive continuing to comply with the terms of any confidential information and invention assignment agreement executed by Executive in favor of the Company and the provisions of this Agreement. (c) Application of Section 409A. (i) Notwithstanding anything to the contrary in this Agreement, no severance pay or benefits to be paid or provided to Executive, if any, pursuant to this Agreement that, when considered together with any other severance payments or separation benefits, are considered deferred compensation not exempt under Section 409A (together, the “Deferred Payments”) will be paid or otherwise provided until Executive has a “separation from service” within the meaning of Section 409A. And for purposes of this Agreement, any reference to “termination of employment,” “termination” or any similar term shall be construed to mean a “separation from service” within the meaning of Section 409A. Similarly, no severance payable to Executive, if any, pursuant to this Agreement that otherwise would be exempt from Section 409A pursuant to Treasury Regulation Section 1.409A-1(b)(9) will be payable until Executive has a “separation from service” within the meaning of Section 409A. (ii) Notwithstanding anything to the contrary in this Agreement, if Executive is a “specified employee” within the meaning of Section 409A at the time of Executive’s termination of employment (other than due to death), then the Deferred Payments, if any, that are payable within the first six (6) months following Executive’s separation from service, will become payable on the first payroll date that occurs on or after the date six (6) months and one (1) day following the date of Executive’s separation from service. All subsequent Deferred Payments, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit. Notwithstanding anything herein to the contrary, if Executive dies following Executive’s separation from service, but prior to the six (6) month anniversary of the separation from service, then any payments delayed in accordance with this paragraph will be payable in a lump sum as soon as administratively practicable after the date of Executive’s death and all other Deferred Payments will be payable in accordance with the payment schedule applicable to each payment or benefit. Each payment, all other Deferred Payments will be payable in accordance with the payment schedule applicable to each payment or benefit. Each payment, installment and benefit payable under this Agreement is intended to constitute a separate payment for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations. term deferral” rule set forth in Section 1.409A-1(b)(4) of the Treasury Regulations is not intended constitute to Deferred Payments for purposes of clause (i) above. (iii) Without limitation, any amount paid under this Agreement that satisfies the requirements of the “short- (iv) Without limitation, any amount paid under this Agreement that qualifies as a payment made as a result of an involuntary separation from service pursuant to Section 1.409A-1(b)(9)(iii) of the Treasury Regulations that does not exceed the Section 409A Limit is not intended to constitute Deferred Payments for purposes of clause (i) above. Any payment intended to qualify under this exemption must be made within the allowable time period specified in Section 1.409A-1(b)(9)(iii) of the Treasury Regulations. (v) To the extent that reimbursements or in-kind benefits under this Agreement constitute non-exempt “nonqualified deferred compensation” for purposes of Section 409A, (1) all reimbursements hereunder shall be made on or prior to the last day of the calendar year following the calendar year in which the expense was incurred by Executive, (2) any right to reimbursement or in- kind benefits shall not be subject to liquidation or exchange for another benefit, and (3) the amount of expenses eligible for reimbursement or in-kind benefits provided in any calendar year shall not in any way affect the expenses eligible for reimbursement or in-kind benefits to be provided, in any other calendar year. Executive no later than December 31 of the calendar year following the calendar year in which Executive remits the related taxes. (vi) Any tax gross-up that Executive is entitled to receive under this Agreement or otherwise shall be paid to (vii) Notwithstanding any other provision of this Agreement to the contrary, in no event shall any payment under this Agreement that constitutes “nonqualified deferred compensation” for purposes of Code Section 409A be subject to offset by any other amount unless otherwise permitted by Code Section 409A. (viii) The payments and benefits provided under Sections 3(a) and 3(b) are intended to be exempt from or comply with the requirements of Section 409A so that none of the severance payments and benefits to be provided hereunder will be subject to the additional tax imposed under Section 409A, and any ambiguities or ambiguous terms herein will be interpreted to be exempt or so comply. The Company and Executive agree to work together in good faith to consider amendments to this Agreement and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition prior to actual payment to Executive under Section 409A. 5. Limitation on Payments. (a) Anything in this Agreement to the contrary notwithstanding, if any payment or benefit Executive would receive from the Company or otherwise (“Payment”) would (i) constitute a “parachute payment” within the meaning of Section 280G of the Code; and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then such Payment shall be equal to the Reduced Amount. The “Reduced Amount” shall be either (x) the largest portion of the Payment that would result in no portion of the Payment being subject to the Excise Tax; or (y) the largest portion, up to and including the total, of the Payment, whichever amount, after taking into account all applicable federal, state and local employment taxes, income taxes, and the Excise Tax (all computed at the highest applicable marginal rate), results in Executive’s receipt, on an after-tax basis, of the greater amount of the Payment. Any reduction made pursuant to this Section 5(a) shall be made in accordance with the following order of priority: (i) stock options whose exercise price exceeds the fair market value of the optioned stock (“Underwater Options”) (ii) Full Credit Payments (as defined below) that are payable in cash, (iii) non-cash Full Credit Payments that are taxable, (iv) non-cash Full Credit Payments that are not taxable, (v) Partial Credit Payments (as defined below) and (vi) non-cash employee welfare benefits. In each case, reductions shall be made in reverse chronological order such that the payment or benefit owed on the latest date following the occurrence of the event triggering the excise tax will be the first payment or benefit to be reduced (with reductions made pro-rata in the event payments or benefits are owed at the same time). “Full Credit Payment” means a payment, distribution or benefit, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise, that if reduced in value by one dollar reduces the amount of the parachute payment (as defined in Section 280G of the Code) by one dollar, determined as if such payment, distribution or benefit had been paid or distributed on the date of the event triggering the excise tax. “Partial Credit Payment” means any payment, distribution or benefit that is not a Full Credit Payment. In no event shall Executive have any discretion with respect to the ordering of payment reductions. (b) Unless the Company and Executive otherwise agree in writing, any determination required under this Section 5 will be made in writing by an independent firm (the “Firm”), whose determination will be conclusive and binding upon Executive and the Company for all purposes. For purposes of making the calculations required by this Section 5, the Firm may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code. The Company and Executive will furnish to the Firm such information and documents as the Firm may reasonably request in order to make a determination under this Section 5. The Company will bear all costs the Firm may reasonably incur in connection with any calculations contemplated by this Section 5. 6. Definition of Terms. The following terms referred to in this Agreement will have the following meanings: (a) Cause. “Cause” means (i) Executive’s willful failure to substantially perform his or her duties to the Company or deliberate and material violation of a Company policy; (ii) Executive’s commission of any act of fraud, embezzlement, dishonesty or any other willful misconduct that has caused or is reasonably expected to result in material injury to the Company; (iii) unauthorized use or disclosure by Executive of any proprietary information or trade secrets of the Company or any other party to whom Executive owes an obligation of nondisclosure as a result of his or her relationship with the Company; or (iv) Executive’s willful breach of any of Executive’s material obligations under any written agreement or covenant with the Company, in each case in the reasonable determination of the Board. For purposes of this definition, “Company” shall be interpreted to include any parent, subsidiary, affiliate or successor thereto, if appropriate. Notwithstanding the foregoing, Cause shall not exist based on conduct described in clause (i) unless the conduct has not been cured within 15 days following Executive’s receipt of written notice from the Company specifying the particulars of the conduct constituting Cause. (b) Change in Control. “Change in Control” shall have the meaning provided in the Resonant Inc. Amended and Restated 2014 Omnibus Incentive Plan. (c) Code. “Code” means the Internal Revenue Code of 1986, as amended. (d) Disability. “Disability” or “Disabled” means that Executive is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted, or can be expected to last, for a continuous period of not less than one (1) year. (e) Good Reason. “Good Reason” means the occurrence of one or more of the following, without Executive’s express written consent: nor reassignment following a Change in Control to a position that is substantially similar to the position held prior to the Change in Control shall constitute a material reduction in job responsibilities; (i) a material reduction in Executive’s job responsibilities, provided that neither a mere change in title alone Executive’s primary business location that increases Executive’s one way commute by more than 35 miles; or (ii) relocation by the Company or a subsidiary, parent, affiliate or successor thereto, as appropriate, of reduction in the salary level of all other employees or consultants in positions similar to Executive’s by the same percentage amount as part of a general salary level reduction shall not constitute such a salary reduction; (iii) a reduction in Executive’s then-current base salary by at least 10%, provided that an across-the-board provided, however, that in order for an event to qualify as Good Reason, Executive must (1) provide the Company with written notice of the acts or omissions constituting the grounds for Good Reason within 90 days of the initial existence of the grounds for Good Reason, (2) allow the Company at least 30 days from receipt of such written notice to cure such event, and (3) if such event is not reasonably cured within such period, Executive’s resignation from all positions then held by Executive with the Company must be effective not later than 30 days after the expiration of the cure period. (f) Section 409A. “Section 409A” means Code Section 409A, and the final regulations and any guidance promulgated thereunder or any state law equivalent. (g) Section 409A Limit. “Section 409A Limit” will mean two (2) times the lesser of: (i) Executive’s annualized compensation based upon the annual rate of pay paid to Executive during Executive’s taxable year preceding Executive’s taxable year of his or her separation from service as determined under Treasury Regulation Section 1.409A-1(b)(9)(iii)(A)(1) and any Internal Revenue Service guidance issued with respect thereto; or (ii) the maximum amount that may be taken into account under a qualified plan pursuant to Section 401(a)(17) of the Internal Revenue Code for the year in which Executive’s separation from service occurred. 7. Successors. (a) The Company’s Successors. Any successor to the Company (whether direct or indirect and whether by purchase, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company’s business and/or assets will assume the obligations under this Agreement and agree expressly to perform the obligations under this Agreement in the same manner and to the same extent as the Company would be required to perform such obligations in the absence of a succession. For all purposes under this Agreement, the term “Company” will include any successor to the Company’s business and/or assets which executes and delivers the assumption agreement described in this Section 7(a) or which becomes bound by the terms of this Agreement by operation of law. (b) Executive’s Successors. The terms of this Agreement and all rights of Executive hereunder will inure to the benefit of, and be enforceable by, Executive’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees. 8. Notice. (a) General. Notices and all other communications contemplated by this Agreement will be in writing and will be deemed to have been duly given when personally delivered or when mailed by U.S. registered or certified mail, return receipt requested and postage prepaid. In the case of Executive, mailed notices will be addressed to him or her at the home address which he or she most recently postage prepaid. In the case of Executive, mailed notices will be addressed to him or her at the home address which he or she most recently communicated to the Company in writing. In the case of the Company, mailed notices will be addressed to its corporate headquarters, and all notices will be directed to the attention of its General Counsel. (b) Notice of Termination. Any termination by the Company for Cause or by Executive for Good Reason will be communicated by a notice of termination to the other party hereto given in accordance with Section 8(a) of this Agreement. Such notice will indicate the specific termination provision in this Agreement relied upon, will set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination under the provision so indicated, and will specify the termination date (which will be not more than thirty (30) days after the giving of such notice), subject to any applicable cure period. The failure by Executive or the Company to include in the notice any fact or circumstance which contributes to a showing of Good Reason or Cause, as applicable, will not waive any right of Executive or the Company, as applicable, hereunder or preclude Executive or the Company, as applicable, from asserting such fact or circumstance in enforcing his or her or its rights hereunder, as applicable. 9. Miscellaneous Provisions. Agreement, nor will any such payment be reduced by any earnings that Executive may receive from any other source. (a) No Duty to Mitigate. Executive will not be required to mitigate the amount of any payment contemplated by this (b) Waiver. No provision of this Agreement will be modified, waived or discharged unless the modification, waiver or discharge is agreed to in writing and signed by Executive and by an authorized officer of the Company (other than Executive). No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the other party will be considered a waiver of any other condition or provision or of the same condition or provision at another time. not form a part of this Agreement. (c) Headings. All captions and section headings used in this Agreement are for convenient reference only and do (d) Entire Agreement. This Agreement constitutes the entire agreement of the parties hereto and supersedes in their entirety all prior or contemporaneous representations, understandings, undertakings or agreements (whether oral or written and whether expressed or implied) of the parties with respect to the subject matter hereof. Executive acknowledges and agrees that this Agreement encompasses all the rights of Executive to any severance payments and/or benefits based on the termination of Executive’s employment and Executive hereby agrees that he or she has no such rights except as stated herein. No waiver, alteration, or modification of any of the provisions of this Agreement will be binding unless in writing and signed by duly authorized representatives of the parties hereto and which specifically mention this Agreement. This Agreement does not supersede Executive’s employment letter, except with respect to the subject matter hereof, or the confidential information and invention assignment agreement to which Executive is a party. by the laws of the State of California without giving effect to provisions governing the choice of law. (e) Choice of Law. The validity, interpretation, construction and performance of this Agreement will be governed the validity or enforceability of any other provision hereof, which will remain in full force and effect. (f) Severability. The invalidity or unenforceability of any provision or provisions of this Agreement will not affect income, employment and other taxes, as determined in the Company’s reasonable judgment. (g) Withholding. All payments made pursuant to this Agreement will be subject to withholding of applicable all of which together will constitute one and the same instrument. (h) Counterparts. This Agreement may be executed in counterparts, each of which will be deemed an original, but [Signature Page to Follow] IN WITNESS WHEREOF, each of the parties has executed this Agreement, in the case of the Company by its duly authorized officer, as of the day and year set forth below. COMPANY: RESONANT INC. By: Name: Title: EXECUTIVE: By: Name: August 13, 2014 VIA EMAIL Mike Eddy [REDACTED] Re: Employment Terms Dear Mike: Exhibit 10.42 PERSONAL & CONFIDENTIAL I am pleased to extend this formal offer to join Resonant Inc. (the “Company”) as Vice President Marketing. You will report directly to me, but you will also work closely with Bob Hammond, our CTO, on market intelligence, patent strategy and customer directions. This is a key position within Resonant. I’m excited to have you joining us! This letter sets out the terms and conditions of your employment with Resonant. Your first day of employment will be Monday, September 8, 2014. We will pay you a base salary at an annualized rate of $170,000 for full- time employment. Base salary is payable in accordance with our regular payroll schedule which is currently every two weeks. You will be eligible for any bonus program adopted generally for all employees. You will also be considered for discretionary bonus payable in the sole discretion of our Board of Directors. You will be entitled to paid vacation in accordance with our vacation policy as generally applicable to all employees. Full-time employees currently accrue paid vacation at an annualized rate of three (3) weeks per year of service, up to a maximum of six (6) weeks of accrued vacation. You may take your vacation at times mutually acceptable to you and the Company. In this regard, we would appreciate as much advance warning of your vacations as reasonably possible so that your duties can be covered by others in your absence. You also will be entitled to our normal paid holidays (typically not fewer than ten (10) days per year). Your place of employment will be our corporate office in Santa Barbara, California. You will be required to devote your primary business time, energy, skill, and efforts to faithfully and diligently further the business interests of the Company. You will be entitled to participate in our employee benefit plans. These include, among other things, group health insurance and a 401K plan. We offer matching contributions under our 401K plan up to a maximum of 5% of base salary. Please note that, as with all companies, we reserve the right to change our employee benefit plans from time to time. The Company has adopted an equity incentive plan (the “Plan”). Subject to approval from our Compensation Committee, we will grant you an “incentive” stock option (the “Option”) to purchase Thirty Thousand (30,000) shares of our common stock (“Shares”) at an exercise price equal to the closing price on the NASDAQ Capital Market on the Thursday following your first day of employment. The Option is subject to all the terms and conditions of the Plan, as well as your execution of our standard equity award agreement. The Option is also subject to “vesting” which means that you must be employed by us (or are otherwise still rendering services to us) on the applicable vesting date. Your Option will vest over four (4) years according to the following schedule: · 1,875 Shares vesting on the first business day of your first full calendar quarter of employment; and · 1,875 Shares vesting on the first business day of each subsequent calendar quarter until fully vested (1,875 shares in the last quarter). Your employment will be on an at-will basis. This means that you will have the right to terminate your employment at any time with or without cause or notice, and the Company will reserve for itself an equal right. Upon any termination of your employment, you will be entitled to receive: · Any base salary earned but unpaid as of your termination or resignation date; · Payment in lieu of any vacation accrued but unused as of the date of your termination or resignation; · Any business expenses incurred but not reimbursed (in accordance with Company policy) as of your termination or resignation date; and · Any amounts or benefits under any Company compensation, incentive, or benefit plans vested but not paid as of your termination or resignation date (according to the payment provisions of such plans). Your employment is conditioned on your signing and returning the enclosed copies of our standard Employee Invention, Confidentiality and Non-Solicitation Agreement (the “Invention Agreement”) and Mutual Agreement to Arbitrate Claims (the “Arbitration Agreement”). This Letter, the Invention Agreement and the Arbitration Agreement will together form the entire agreement with respect to your employment and supersede any prior agreements between you and the Company on the subject, whether written or oral. The terms of your employment may only be changed by written agreement, although the Company may from time to time, in its sole discretion, adjust the benefits provided to you and its other employees. This employment letter is valid for ten (10) business days and will expire if we have not received by that date signed copies of this letter, the Invention Agreement and the Arbitration Agreement. Invention Agreement and the Arbitration Agreement. We look forward to working with you! Regards, /s/ Terry Lingren Terry Lingren Chairman, Chief Executive Officer and Co-Founder Enclosures (Invention Agreement and Arbitration Agreement) Cc: Bob Hammond, Chief Technology Officer and Co-Founder Neal Fenzi, Vice President Engineering and Co-Founder ACCEPTED AND AGREED: /s/ Mike Eddy Mike Eddy 2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 23.1 The Board of Directors and Shareholders Resonant Inc. We consent to the incorporation by reference in the Registration Statement on Form S-8 (File No. 333-196344) of our report dated March 26, 2015 related to consolidated balance sheets of Resonant Inc. as of December 31, 2013 and December 31, 2014, and the related consolidated statements of operations, stockholders’ equity (deficit) and cash flows of Resonant LLC for the period January 1, 2013 to June 16, 2013, and of Resonant Inc. for the period June 17, 2013 to December 31, 2013 and the year ended December 31, 2014, appearing in this Annual Report on Form 10-K. /s/ Squar, Milner, Peterson, Miranda & Williamson, LLP Los Angeles, California March 26, 2015 Certification of Principal Executive Officer Pursuant To Exchange Act Rules 13a-14(a) and 15d-14(a), As Adopted Pursuant To Section 302 of Sarbanes-Oxley Act of 2002 Exhibit 31.1 I, Terry Lingren, certify that: 1. I have reviewed this Annual Report on Form 10-K of Resonant Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. Date: March 27, 2015 /s/ Terry Lingren Terry Lingren Chief Executive Officer (Principal Executive Officer) Certification of Principal Financial Officer Pursuant To Exchange Act Rules 13a-14(a) and 15d-14(a), As Adopted Pursuant To Section 302 of Sarbanes-Oxley Act of 2002 Exhibit 31.2 I, John Philpott, certify that: 1. I have reviewed this Annual Report on Form 10-K of Resonant Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. Date: March 27, 2015 /s/ John Philpott John Philpott Chief Financial Officer (Principal Financial and Accounting Officer) Certifications of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant To Section 906 of the Sarbanes-Oxley Act of 2002 Exhibit 32.1 Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350), Terry Lingren, Chief Executive Officer (Principal Executive Officer) and John M. Philpott, Chief Financial Officer (Principal Financial and Accounting Officer) of Resonant Inc. (the “Company”), hereby certifies that, to the best of his knowledge: 1. Our Annual Report on Form 10-K for the year ended December 31, 2014, to which this Certification is attached as Exhibit 32.1 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Date: March 27, 2015 /s/ Terry Lingren Terry Lingren Chief Executive Officer (Principal Executive Officer) /s/ John M. Philpott John M. Philpott Chief Financial Officer (Principal Financial and Accounting Officer)